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CydDC of Escherichia coli is an ABC transporter that exports cysteine and glutathione 
from the cytoplasm to the periplasm to maintain redox homeostasis; its loss elicits a 
SOHLRWURSLFSKHQRW\SHDQGFDXVHVWKHSHULSODVPWREHFRPHµRYHU-R[LGLVLQJ¶,QDGGLWLRQ
the CydDC transporter is required for the assembly of cytochrome bd-I, a respiratory 
complex that provides tolerance to nitric oxide, a toxic radical produced by the host 
immune system in response to bacterial infection. The contribution of CydDC to nitric 
oxide tolerance and the pleiotropic phenotype of cydDC mutants implicates this 
exporter complex as a potential target for future therapies to combat E. coli infections. 
Indeed, given the rising incidence of multidrug-resistant bacterial infections, it is 
becoming increasingly important to develop novel strategies to combat infection. This 
thesis reports an investigation into the contribution of CydDC to NO tolerance, the 
relationship between CydDC expression and cytochrome bd-I assembly, adaptations 
resulting from loss of CydDC, and the requirement for CydDC for survival during 
infection. 
To gain a better understanding of how CydDC expression influences cytochrome 
bd-I assembly, cydDC cells were grown in the presence of exogenous cysteine and/or 
reduced glutathione. This work demonstrates for the first time that addition of cysteine 
and glutathione (i.e. both CydDC substrates) is necessary for cytochrome bd-I assembly 
in a cydDC strain. In vitro growth curves utilising a nitric oxide donor show that 
CydDC-mediated reductant export contributes to the tolerance of nitric oxide (NO) both 
via permitting cytochrome bd-I assembly and through a mechanism independent of this 
respiratory complex. This work is consistent with a model whereby NO-reactive thiols 
(i.e. cysteine and glutathione) exported to the periplasm can diminish the levels of NO 
that can enter the cytoplasm. 
The transcriptional response of cydDC mutants to exogenously added cysteine 
and glutathione was explored through microarray analysis in an attempt to gain a greater 
insight into the role of reduced thiol export to the periplasmic space. The addition of 
thiols affected genes involved in cell metabolism, respiration and led to the down-
regulation of motility-related genes, providing insights into how the presence of CydDC 
substrates contribute to diverse cellular processes.  
To investigate the contribution of CydDC to survival during infection, 
macrophage survival assays were performed along with an infection study using a 
mouse model of UTI (urinary tract infection). This work demonstrates that CydDC does 
not contribute to bacterial survival within NO-producing macrophage cells, and that loss 
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of CydDC has no significant effect on the ability to colonise the mouse lower urinary 
tract. We therefore conclude that while CydDC is important for cytochrome bd-I 
assembly and NO tolerance in vitro, it may not be a suitable drug target to combat 
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1D-1H NMR = 1-dimensional proton nuclear magnetic resonance 
ABC transporter = ATP±binding cassette type transporter  
B. abortus = Brucella abortus 
BMM = Bone marrow-derived macrophage 
Bp = Base pair 
Ccm = Cytochrome c maturation 
cDNA = (complementary) Deoxyribonucleic acid 
CO = Carbon monoxide 
cPTIO = 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide 
CFU = Colony forming units 
DEPC = Diethylpyrocarbonate 
Dha = Dihydroxyacetone 
dNTP = Deoxynucleoside triphosphate 
DSS =  4,4-dimethyl-4-silapentane-1-sulfonic acid 
DTT = Dithiothreitol  
E. coli =  Escherichia coli  
Fim = Type 1 fimbriae 
FRT = Flp recognition target 
GSH = Reduced glutathione 
GSSG = Glutathione disulphide 
H2O2 = Hydrogen peroxide 
IC50 = Half maximal inhibitory concentration 
kDa = Kilodalton 
koff = Dissociation constant  
LB = Luria Bertani medium 
LMW = Low-molecular weight 
MHz = Megahertz 
MOI = Multiplicity of infection  
MOPS = 3-(N-morpholino)-propanesulphonic acid  
mRNA = (messenger) Ribonucleic acid 
M. tuberculosis =  Mycobacterium tuberculosis 
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nm = Nanometres 
nM = Nanomolar 
NO = Nitric oxide 
NOC-12 = (1-hydrox-2-oxo-3-(N-ethyl-2-aminoethyl)-3-ethyl-1-triazene). 
NOS = Nitric oxide synthase 
OD = Optical density 
ONOOí = Peroxynitrite 
PBS = Phosphate buffered saline 
PCR = Polymerase chain reaction 
PMF = Proton motive force  
Ppm = Parts per million 
RNS = Reactive nitrogen species 
RMPI = Roswell Park Memorial Institute 
S. flexneri = Shigella flexneri 
SDS- PAGE = Sodium dodecyl sulphate - polyacrylamide gel electrophoresis 
SNP = Single nucleotide polymorphism 
TCA = Tricarboxylic acid  
UTI = Urinary tract infection 
UPEC = Uropathogenic E. coli  
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1.1 Maintaining redox homeostasis in the E. coli periplasm 
The periplasm of E. coli is an oxidising environment that is subject to a fine balancing 
of the redox systems. Disulphide bonds are created in proteins between two cysteine 
residues by the oxidation of their thiol groups, resulting in the loss of two protons and 
two electrons (Figure 1-1). Disulphide bonds have a large impact upon the structure of 
proteins and are necessary for stability, enzymatic activity and resistance to proteolytic 
digestion. In E. coli, the introduction of disulphide bonds into extracytoplasmic proteins 
occurs in the periplasm where the oxidoreductase system DsbAB catalyses disulphide 
folding. In addition, the DsbCD isomerase system is required to rearrange non-native 





Figure 1-1. Formation of disulphide bonds 
 
Within proteins disulphide bonds are created between two cysteine residues by the 
oxidation of their thiol groups, resulting in the loss of two protons and two electrons. 
 
The 21 kDa periplasmic protein DsbA is a member of the thioredoxin superfamily, 
containing a classic CXXC motif (Collet and Bardwell 2002). In the disulphide bond 
oxidative folding pathway, oxidised
 
DsbA catalyses the formation of disulphide bonds 
between cysteine residues of proteins located within the periplasm by accepting the 
proton and electrons from the protein thiol groups. DsbA is then re-oxidised by DsbB 
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(Bardwell et al. 1993; Missiakas et al. 1993), a membrane protein, anchored within the 
inner-membrane by four transmembrane helices.  Once reduced, DsbB donates electrons 
to oxidised ubiquinone (Figure 1-3) which in turn transfers the electrons to respiratory 
complexes such as the bd-type oxidases (Bader et al. 1999).  Mutations of dsbA or dsbB 
cause a pleiotropic phenotype, including sensitivity to some metal ions such as 
cadmium and mercury ions, alongside hypersensitivity to the reductant dithiothreitol 
(DTT), and benzylpenicillin (Missiakas, Georgopoulos and Raina 1993; Stafford, 
Humphreys and Lund 1999).  The oxidising environment of the E. coli periplasm 
created by DsbAB promotes the formation of non-native disulphide bonds that result in 
the loss of protein activity. The disulphide bond isomerisation pathway catalysed by 
DsbCD is responsible for the reshuffling of incorrect disulphide bonds. DsbC also 
contains a CXXC motif, and is kept in a reduced state within the oxidising environment 
of the periplasm by the inner membrane protein DsbD (DipZ) (Collet and Bardwell 
2002; Crooke and Cole 1995). DsbD in turn is reduced by the thioredoxin 
(TrxA)/thioredoxin reductase (TrxB) system in the periplasm (Figure 1-3).   
 
Reduced low-molecular weight (LMW) thiols exported to the periplasm from 
the cytoplasm are believed to accompany the action of DsbAB and DsbCD, by 
providing reducing power. The inner membrane complex CydDC of E. coli has been 
shown to export reduced glutathione and cysteine to the periplasm. Messens et al., 
(2007) demonstrated that to maintain the redox potential of the periplasm at ± 165mV, a 
combination of both the Dsb proteins and glutathione is required; deletion of cydD (or 
gshA required glutathione biosynthesis) increases the redox potential to -125mV. Thus 
glutathione does play a role in redox homeostasis of the periplasm, and is consequently 
predicted to play a role in disulphide folding as depicted in Figure 1-3. The combination 
of Dsb protein and reduced thiols in the periplasm, however, raises the question of how 
proteins and reduced thiols with opposing redox functions do not result in a futile cycle, 
i.e. what stops reduced glutathione reducing DsbA and vice versa? (Inaba 2008; Bader 
et al. 2001) suggest that cross talk between the oxidative DsbAB pathway and the 
DsbCD isomerisation pathway in the E. coli periplasm is prevented in a structural 
manner; DsbC has been shown to form a V-shaped homodimer [McCarthy, and Haebel, 
2000; Heras et al., 2004] that creates a hydrophobic cavity that prevents interaction with 
DsbB and separates the oxidative and isomerisation pathways to prevent futile cycling.  
Although DsbA can interact with GSH and cysteine, DsbA is believed to interact 
with proteins preferentially over small thiols such as GSH and cysteine (Frech et al. 
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1996); DsbA interacts with unfolded protein by both a covalent disulphide bond and 
non-covalent interactions within a putative polypeptide binding site of DsbA (Darby 
and Creighton 1995; Frech et al. 1996). This preferential oxidation of proteins over 
small thiol compounds would prevent futile cycling between reduced thiols exported to 
the periplasm via CydDC and DsbA.    
 
1.1.1. E. coli reductant exporters 
The cydDC operon of E. coli encodes an ABC-type transporter comprised of 
nonidentical subunits, which are located within the inner membrane (Figure 1-2). The 
CydDC complex was first identified because it is essential for the assembly of the 
cytochrome bd-I quinol oxidase (Georgiou, Hong and Gennis 1987; Poole et al. 1989). 
Assembly of c-type cytochromes and cytochrome b562 have also been shown to require 
CydDC (Poole et al. 1994; Goldman et al. 1996). 
DTNB (5,5'-dithiobis-(2-nitrobenzoic acid) RU (OOPDQ¶V UHDJHQW) is a colourless 
compound that reacts rapidly with thiol groups to produce thionitrobenzoic acid that is 
yellow in solution and can be measured spectrophotometrically at 412 nm using an 
extinction coefficient of 14.15 M-1 cm-1, comparing readings with a standard curve of a 
thiol containing compound such as cysteine allows the redox state to be measured 
(Riddles, Blakeley and Zerner. 1979). Treating wild type and cydC periplasmic fractions 
with DTNB showed that the normally oxidising environment of the periplasm is µRYHU-
R[LGLVLQJ¶LQWKHDEVHQFHRIcydC, which first indicated that CydDC exports a reduced 
substrate to the periplasm (Goldman, Gabbert and Kranz 1996b). This later prompted 
the use of everted membrane vesicles to demonstrate that CydDC exports the thiol-
containing amino acid cysteine (Pittman et al. 2002). French-pressure cell treatment was 
used to produce inside-out vesicles using either E. coli orf299 mutants or isogenic 
orf299, cydD double mutants. An orf299 deletion background was used because the 
product of this gene was thought to have a role in cysteine export (Daßler et al. 2000). It 
was shown that in orf299-derived vesicles, radio-labelled cysteine ([35S] cysteine) is 
transported inwards in a manner dependent upon ATP (Pittman et al. 2002). In contrast, 
deletion of cydD eliminated cysteine transport even after ATP addition. Inclusion of 
sodium orthovanadate, an inhibitor of ABC-type transport systems, eradicated cysteine 
transport, with an uptake rate comparable for that seen for cydD mutants. It was 
therefore concluded that CydDC is responsible for the uptake of cysteine in everted 
17 
 
membrane vesicles, corresponding to active export of cysteine to the periplasm within 
intact cells. 
Despite having an essential role in protein function, L-cysteine is toxic to cells, 
even at low concentrations in both eukaryotic and prokaryotic cells (Sørensen and 
Pedersen 1991). This may explain why E. coli strains lacking CydDC (and associated 
export of cysteine) are hypersensitive to cysteine, presumably accumulating higher 
cytoplasmic cysteine levels than wild type strains. Conversely, over-expressing CydDC 
increases resistance to cytotoxic levels of cysteine (Pittman et al. 2002), which is 
consistent with the hypothesis that cysteine is exported by CydDC. It is important to 
note, however, CydDC is not the only L-cysteine exporter found on the inner membrane 
of E. coli; EamA (YdeD), EamB (YfiK), and Bcr have also been shown to export L-
cysteine (Daßler et al. 2000; Franke et al. 2003; Yamada et al. 2006). At the outer 
membrane, the TolC porin has also been shown to be important for tolerance to L-
cysteine, and consequently is believed to play a role in release of L-cysteine from the 
periplasm into the medium either through passive or facilitated diffusion 
(Wiriyathanawudhiwong et al. 2009).  
Ohtsu et al. 2010, suggest that cysteine in the periplasm participates in 
combating oxidative stress; the group showed that the oxidised form of L-cysteine, L-
cystine is imported back into the cytoplasm of E. coli via FliY, a periplasmic L-cystine 
binding protein. They further showed that shutting of L-cysteine/L-cystine between the 
cytoplasm and periplasm is significantly induced at the transcriptional level in response 














Figure 1-2. CydDC of E. coli 
 
The heterodimeric complex CydDC exports the low-molecular weight thiols; reduced 
glutathione and cysteine from the cytoplasm to the periplasm. This process is dependent 
upon ATP hydrolysis. Loss of CydDC prevents the assembly of cytochrome bd-I 
(CydAB).  
 
The tripeptide glutathione (L-Ȗ-glutamylcysteinylglycine, GSH) is a major thiol-
disulphide redox buffer. Modulation of the ratio of reduced to oxidised glutathione 
(glutathione disulphide, GSSG) influences different redox equilibria in different 
subcellular compartments such as the periplasm. By considering the similar properties 
of GSH and cysteine along with the characteristic broad specificity of ABC transporters, 
it was hypothesised that GSH is also a substrate for CydDC  (Hosie and Poole 2001; 
Pittman, Robinson and Poole 2005). In everted membrane vesicles derived from wild 
type E. coli, no uptake of radio-labelled glutathione (GSH [35S]) was seen before ATP 
addition. However, with a maximal rate of 3.8 nmol min-1, GSH uptake was rapid after 
ATP addition. No GSH uptake was detected for the vesicles derived from the isogenic 
cydD mutant strain. Addition of sodium orthovanadate, an inhibitor of ABC-type 
transport systems, was shown to abolish GSH transport completely, proving that 
transport is dependent upon an ABC type transporter. GSH was therefore concluded to 
also be an allocrite of CydDC, and that transport of this redox active tripeptide is ATP-
dependent. No uptake of oxidised GSH (GSSG) in wild type cells could be 
demonstrated in the presence or absence of ATP. The rate of reduced glutathione (GSH) 
uptake was positively correlated with the concentration of GSH added. It is important to 
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note that the uptake rate of GSH was approximately five times higher than that of L-
cysteine for all equivalent concentrations of substrates added. While the evidence for 
CydDC-mediated GSH export is very strong, a later study reports that reduced 
glutathione is exported to the periplasm even in the absence of CydDC (Eser et al. 
2009), suggesting that additional mechanisms exist for the export of GSH. 
Once in the periplasm, GSH is expected to traverse the outer membrane via 
porin proteins, therefore GSH is expected to reach an equilibrium between the 
periplasmic space and growth media (Eser et al. 2009). Escherichia coli has been shown 
to excrete GSH into the growth medium during exponential and early stationary phase 
(Owens and Hartman 1986), and GSH has more recently been shown to be constantly 
cycled between cells and the external growth media in exponential phase (Smirnova, 
Muzyka and Oktyabrsky 2012). When cells advance further into stationary phase, 
glutathione in the periplasm is hydrolysed at the ɶ-glutamyl linkage by the periplasmic 
glutamyltranspeptide enzyme (GGT) (Suzuki, Hashimoto and Kumagai 1993; Suzuki, 
Kumagai and Tochikura 1987). The resultant cysteinylglycine and glutamic acid can 
then be imported into the cytoplasm where cysteinylglycine is subsequently cleaved into 
cysteine and glycine by aminopeptidases A, B, and N as well as dipeptidase D (Suzuki 
et al. 2001). Whole GSH is also imported from the periplasm via an ABC-type 
transporter, GsiABCD (YliABCD). It has been shown that this transporter and GGT 
enable E. coli to use GSH as a source of sulphur, cysteine and glycine (Suzuki et al. 
2005; Suzuki, Hashimoto and Kumagai 1993). Oxidised glutathione has also been 
shown to be utilised as a source of glycine and cysteine via GGT (Suzuki, Hashimoto 
and Kumagai 1993).  
 
1.1.2 Phenotypic characterisation of CydDC  
Loss of CydDC results in a pleiotropic phenotype which includes the loss of periplasmic 
c- and b-type cytochromes (Goldman, Gabbert and Kranz 1996b; Poole, Gibson and Wu 
1994); an increased sensitivity to high temperature, hydrogen peroxide (H2O2), azide, 
and Zn2+ ions (Delaney, Ang and Georgopoulos 1992; Goldman, Gabbert and Kranz 
1996b; Poole et al. 1989); hypersensitivity to both benzylpenicillin (Pittman et al. 2005) 
and DTT (Goldman et al. 1996) and the inability to exit stationary phase at 37 °C under 
aerobic conditions (Siegele, Imlay and Imlay 1996). Exogenous addition of the known 
allocrites of CydDC has been shown to restore the survival and temperature-sensitive 
phenotypes of a cydC mutant (Goldman, Gabbert and Kranz 1996a), and it has been 
shown that exogenous cysteine can also re-establish cell motility, resistance to 
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benzylpenicillin and DTT and can partially restore the assembly of cytochrome c 
(Pittman et al. 2002). These observations highlight the multiple cellular roles for 
reductant export by CydDC. Interestingly, restoration of cytochrome bd-I assembly has 
not previously been observed in a cydDC mutant by the addition of either cysteine or 
GSH, and thus, the mechanism via which CydDC contributes to cytochrome bd-I 
assembly remains unclear. 
       Since both GSH and cysteine are low-molecular weight thiols that can participate in 
disulphide exchange, following their identification as CydDC substrates it was deemed 
likely that this ABC transporter would have an impact upon disulphide bond formation 
in the E. coli periplasm. It is striking that some phenotypes of the cydD mutant, 
including hypersensitivity to benzylpenicillin (Pittman et al. 2005) and DTT (Goldman, 
Gabbert and Kranz 1996b), are shared not only by mutants defective in the dsbD 
reducing pathway (Missiakas et al. 1995) but also by dsbA and dsbB mutants (Fabianek, 
Hennecke and Thony-meyer 2000). The similarity of phenotypes presumably relates 
both to the requirement of CydDC for cytochrome bd-I assembly which provides an 
electron sink for DsbB (Korshunov and Imlay 2010), as well as a more direct role for 



































Figure 1-3. Disulphide folding within the E. coli periplasm  
 
The oxidative folding pathway (DsbAB) and disulphide bond isomerisation pathway 
(DsbCD) work to ensure that proteins in the periplasm are correctly folded. Reduced 
glutathione (GSH) and cysteine exported to the periplasm via the ABC transporter, 
CydDC, influence the redox balance of the periplasm and are thus thought to impact 
upon disulphide folding. The bd-type oxidases that require CydDC for assembly act as 




1.1.3. Periplasmic machinery is perturbed by redox imbalance 
The importance of periplasmic redox balance is highlighted by the pleiotropic 
phenotype observed for cells lacking CydDC, showing that a range of problems arise in 
cells that lack export of reduced low-molecular weight thiols to the periplasm. The 
correct folding required for structure and function of many proteins exported across the 
inner membrane rely upon the correct formation of disulphide bonds, and the absence of 
these bonds can result in protein degradation. Disruption of the periplasmic redox 
environment can therefore affect the functionality of a range of extracytoplasmic 
proteins including but not limited to; subunits of flagella needed for cell motility, c-type 
cytochromes involved in electron transfer, fimbrial subunits needed for cell adhesion, 
and secretion systems and other virulence factors required by pathogenic strains.  
Motility in bacteria relies mostly upon flagella; supramolecular structures that 
extend from the inside of the cytoplasm to outside of the cell.  The importance of redox 
homeostasis in motility is emphasised by the finding that deletion of dsbA or dsbB 
leaves many bacteria from different genera non-motile, due to the absence of functional 
flagella (Dailey and Berg 1993; Hayashi et al. 2000; Turcot et al. 2001; Agudo et al. 
2004; Burall et al. 2004; Bringer et al. 2007; Coulthurst et al. 2008). It has been shown 
in E. coli that DsbA introduces an intramolecular disulphide bond within FlgI , a 
component of the P-ring protein of the flagella motor found in the periplasm (Figure 1-
4) (Dailey and Berg 1993). In the absence of DsbA, FlgI is not folded correctly which is 
thought to prevent the incorporation of FliC, that makes up the filament, a major 
component of flagella. Mutation of dsbA has also been shown to abolish twitching 
motility in the pathogen P. aeruginosa (Ha, Wang and Jin 2003), a process that is 
















Figure 1-4. The structure of a flagellum 
 
Schematic of flagella structure and its juxtaposition to the inner and outer cell 
membranes. Flagella are supramolecular structures that extend from within the 
cytoplasm to the outside of the cell. The motor includes the P-ring encoded by flgI. In 
the absence of DsbA, FlgI is not folded correctly which is thought to prevent the 
incorporation of FliC, that makes up the filament. (Adapted from Pallen and Matzke 
2006) 
 
In the E. coli periplasm, the cytochrome c maturation (Ccm) pathway catalyses the 
formation of c-type cytochromes. Central to this process is the ligation of haem to 
apocytochrome c by a covalent linkage between cysteine residues and the haem cofactor 
(Thöny-meyer and Kunzler 1997). Two thioether bonds link the thiol groups of two 
cysteine residues to the vinyl groups of the haem cofactor. The cysteine residues are 
located in a conserved CXXCH cytochrome c haem binding motif, with the histidine 
residue providing the axial ligand for coordination of the central haem iron.  
As the maturation of c-type cytochromes occurs in the oxidising environment of 
the periplasm, redox control is important, as suggested by the requirement of the 
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disulphide bond (Dsb) machinery and thiol export by CydDC (Pittman et al. 2002; 
Poole, Gibson and Wu 1994). In vitro studies show that the ligation of haem to produce 
c-type cytochromes requires reducing power both to maintain the haem in the ferrous 
state, and also to avoid incorrect disulphide bonds forming with either of the cysteine 
residues within the CXXCH motif (Nicholson and Neupert 1989; Barker et al. 1995). 
Indeed, a disulphide bond between the two cysteines within the binding motif has been 
observed and shown to prevent haem ligation (Daltrop et al. 2002).  
Cytochrome c synthesis is unique in that the polypeptide folds around the haem 
only after ligation (unlike other cytochromes where protein folding occurs before haem 
binding). The apocytochrome is delivered to the periplasm by the Sec system (Thöny-
meyer and Kunzler 1997) in an unfolded state that is a more susceptible to DsbA-
catalysed disulphide bond formation. The Ccm system therefore involves 
apocytochrome c thiol-reduction by a highly specific thioredoxin-like protein, CcmG 
(DsbE), which is limited to use in cytochrome c maturation (Fabianek et al. 1997; 
Monika et al. 1997). CcmG is in turn re-reduced by DsbD (Katzen and Beckwith 2000).  
A wide range of bacterial virulence factors are both extracytoplasmic and 
disulphide-bonded, including proteins anchored to the cell surface needed for adhesion 
or cell motility, secreted proteins such as toxins and secretion systems. Systems that are 
paralogous to the Dsb proteins of E. coli exist in pathogenic strains of E. coli and in 
other bacterial species. The Dsb proteins and their homologs have been shown to be 
important in the correct folding of many virulence factors from a large variety of 
pathogens as discussed in depth in the following two review papers; àDVLFD DQG
Jagusztyn-Krynicka 2007; Heras et al. 2009).  
During infection, the adhesion of bacterial pathogens to host cells is primarily 
mediated by fimbriae or pili, hair-like structures found on the cell surface. Several types 
of fimbriae have been described, mainly from Gram-negative bacteria (Fronzes, Remaut 
and Waksman 2008). Pathogen adherence is particularly important for strains of 
uropathogenic E. coli (UPEC) that are exposed to the hydrodynamic force of urine flow 
that can prevent bacterial colonisation. Early establishment of UPEC in the human 
urinary tract has been shown to require P fimbriae (Wullt et al. 2000), which are 
assembled via the chaperone-usher pathway. When P fimbrial subunits emerge through 
the inner membrane in a Sec-dependent manner, they are bound by PapD, a periplasmic 
chaperone that targets them to the outer membrane usher PapC. Which in turn directs 
fimbrial assembly and secretion to the bacterial cell surface (Thanassi and Hultgren 
2000). DsbA permits the formation of an intramolecular disulphide bond within PapD, 
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folding the chaperone into its native confirmation and allowing binding to the P fimbrial 
subunits (Jacob-Dubuisson et al. 1994). The P fimbrial adhesin PapG, which recognises 
carbohydrate moieties on the host cell surface, also requires DsbA for the formation of 
an integral disulphide bond (Lund et al. 1987). In addition to the archetypal DsbABCD 
system, the pyelonephritis-causing CFT073 UPEC strain encodes an extended armoury 
of Dsb proteins (Sinha, Langford and Kroll 2004), with two paralogous disulphide bond 
systems; the DsbAB system, similar to that of E. coli K-12 and the DsbLI system 
(Grimshaw et al. 2008). A dsbAB deletion in CFT073, results in a lack of assembled P 
fimbriae and a severe attenuation of E. coli CFT073 in a mouse UTI model. Attenuation 
is likely to be a result of a combination of factors, for example, the deletion of dsbAB 
would not only affect P fimbriae formation but would also be detrimental to flagellum-
mediated motility. DsbA is thought to play a key role in host adherence in a range of 
other Gram-negative pathogens including Proteus mirabilis (Burall et al. 2004), 
Salmonella enterica subsp. enterica serovar Typhimurium (Bouwman et al. 2003), 
enteropathogenic E. coli (EPEC) (Zhang, H. Z. & Donnenberg 1996) and Vibrio 
cholerae (Peek and Taylor 1992). 
 
Toxins allow bacterial pathogens to promote their own growth by manipulating 
the host. Periplasmic redox homeostasis is required to ensure that bacterial toxins and 
the systems used to secret them are properly folded. Correct formation of the AB5 toxins 
of V. cholerae and E. coli have been shown to require DsbA for disulphide bond 
formation and functionality (Yu, Webb and Hirst 1992; Okamoto et al. 1998). 
 Balance in the redox environment of the periplasm is also important for 
secretion systems. Ipa is an extracellular invasin of S. flexneri, that aids both bacterial 
uptake into host cells (Ménard, Sansonetti and Parsot 1993) and the subsequent spread 
to new host cells (Yu et al. 2000). In the absence of DsbA, Ipa cannot be secreted, 
because the outer membrane protein Spa32, involved in Ipa secretion is not folded 
correctly, and so Ipa proteins  are confined to the periplasm  (Watarai et al. 1995). 
In summary, loss of DsbA and the resulting disruption to the redox homeostasis 
of the periplasm affects the folding and function of proteins involved in a range of 
functions including motility, adhesion and secretion. Periplasmic redox balance is 
therefore particularly important for pathogenic bacteria that rely upon multiple 





1.2 Transcriptional regulation of the cydDC operon 
The CydDC complex is a heterodimer and was the first bacterial example of an ABC 
transporter that is comprised of non-identical subunits; the CydD and CydC protein 
sequences still however, have a 50% similarity and 27% identity and have similar 
hydrophobicity plots (Poole et al. 1993). Genes encoding ABC transporters are 
frequently found adjacent to genes encoding the transported substrate (Salmond and 
Reeves 1993). This however is more often the case for ABC transporters with an import 
function; probably for the reason that it is prudent for expression of importers to be co-
ordinated with expression of enzymes required for catabolism of an incoming substrate, 
ensuring catabolism enzymes are only present when the relevant substrate is present. 
Immediately upstream of the cydDC operon is trxB gene, encoding thioredoxin 
reductase, an enzyme that supplies reducing power for the modulation of thiol redox 
state in the periplasm, which provided clues to the role in reductant export performed by 
CydDC. Despite the finding that trxB gene is not transcriptionally linked to cydDC 
(Cook, Membrillo-hernández and Poole 1997), looking at close relations of E. coli also 
found in the gammaproteobacter class reveals that trxB is consistenly found upstream of 
cydDC, this includes Salmonella spp., Yersinia pestis, Vibrio cholerae, Shigella flexneri 
and haemophilus influenze. This conservation is in agreement with the analysis 
perfomed by Cruz-Ramos et al. 2004 and indicates that it unlikely the close proximity 
of trxB to the cydDC operon is just due to chance. What advantage this proximity brings 
to gram-negative bacteria is unclear, however, this conservation of gene organisation 
disappears in Gram-positive organisms (Cruz-Ramos et al. 2004a).  
To elucidate how expression of cydDC is regulated and to define a role for this 
ABC-type transporter, a cydD-lacZ transcriptional fusion was used to study the 
expression of cydD (Cook, Membrillo-hernández and Poole 1997).
 
Initially, primer 
extension of a cydD messenger RNA (mRNA) transcript revealed a single 
transcriptional start site for cydDC 68 base pairs (bp) upstream of the translational start 
site. Northern blot analysis then confirmed that cydDC is transcribed as a polycistronic 
message independently of upstream gene trxB. 
The expression levels of cydD in aerobically grown cells vary depending upon 
the growth phase. For example, cydD-lacZ expression during exponential phase was 
approximately 2.5 times higher than cells in stationary phase (Cook, Membrillo-
hernández and Poole 1997). Cells grown anaerobically, however, displayed 5-fold lower 
cydD-lacZ activity compared to aerobically-grown cells, and this expression level was 
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unaffected by changes in growth phase. Antagonistic regulatory effects on cydAB, of 
ArcA (an activator) and FNR (a repressor) were subsequently demonstrated (Tseng et 
al. 1996), but neither mutation of arcA nor fnr had any significant effect on cydD-lacZ 
expression, consistent with the theory that cydDC and cydAB are independently 
regulated. Despite this, the observed changes in cydD expression between aerobically 
and anaerobically grown cells suggested that cydD is also regulated by oxygen tension. 
To investigate this, cydD transcription was measured at log phase under various oxygen 
tensions (Cook, Membrillo-hernández and Poole 1997). The level of cydD-lacZ 
increased as the efficiency of oxygen transfer rate increased in exponentially growing 
cultures, thus, demonstrating that cydD transcription is regulated by oxygen tension. 
Furthermore, mutations in cydAB did not affect expression of cydD-lacZ, and vice 
versa, expression of cydA-lacZ was unaffected by mutations in either cydD or cydC, 
indicating the regulation of the two operons is not coordinated, and that the structural 
cytochrome bd-I polypeptides are not required for cydD expression.
 
 
Periplasmic c-type cytochromes are only expressed in E. coli under anaerobic 
conditions in the presence of exogenous electron acceptors. Mirroring this regulation,  
expression of cydD-lacZ is elevated under anaerobic growth in the presence of the 
electron acceptors nitrate, nitrite or fumarate, when compared to anaerobically grown 
cells without alternative electron acceptors (Cook, Membrillo-hernández and Poole 
1997). As cydD strains fail to synthesise periplasmic c-type cytochromes (Poole, Gibson 
and Wu 1994), this suggested an important role for cydD during anaerobic growth on 
nitrite and nitrate. Nitrate/nitrite-responsive gene expression in E. coli is mediated by a 
two-component system involving the DNA binding response regulators NarL and NarP. 
Mutations in narL alone or together with mutations in narP significantly reduced cydD-
lacZ expression in the presence of nitrite or nitrate (Cook, Membrillo-hernández and 
Poole 1997). Expression of cydD-lacZ, however, was not as sensitive to narP mutations 
alone. Analysis of the promoter sequence for cydD led to the discovery of putative NarL 
binding sites that closely resemble the binding consensus sequence for NarL (Figure 1-
5). Together, these data support an important role for CydDC in adaptive growth of E. 
coli because cydDC mutants lack both cytochrome bd-I that scavenges oxygen in 
microaerobic environments and periplasmic cytochrome c that is required for anaerobic 












Figure 1-5. The cydDC locus of E. coli 
 
The CydDC ABC transporter is encoded by the cydDC operon, and trxB encodes 
thioredoxin. Putative NarL binding sites within the upstream trx gene control the 






1.3 Structure and membrane topology of the CydDC complex 
ATP-binding cassette proteins (ABC proteins) are well represented in both prokaryotes 
and eukaryotes. In E. coli the genes encoding these proteins are estimated to constitute 
5% of the genome and are the largest paralogous family of proteins which can be further 
categorised into 10 subfamilies (Linton and Higgins 1998).  Phylogenetic analysis 
sorted the CydD and CydC proteins into subfamily 6, alongside MsbA, a homodimeric 
lipid flippase involved in membrane biogenesis (Zhou et al. 1998). Regardless of 
function, all ABC transporters are composed of two transmembrane domains (TMDs) 
and two ATP binding domains, the members of subfamily 6 share the same organisation 
of these domains, with each transmembrane domain (TMD) being fused to one ATP 
binding domain. CydDC was first hypothesised to be an ABC protein when  
hydrophobicity analysis indicated that the N- terminal half of the CydD and CydC 
proteins consists of stretches of hydrophobic amino acids corresponding to 6 membrane 
spanning helices (Poole et al. 1993). Whereas the C-terminal half of the polypeptides 
were shown to be hydrophilic, containing ATP-binding sites. A later membrane 
topology study highlighted the similarity between the membrane topology of CydD and 
CydC, supporting the prediction that each of the proteins contains 6 TMDs. Protein 
fusions between CydD or CydC with alkaline phosphatase and ȕ-galactosidase were 
able to demonstrate the presence of two major cytoplasmic loops, three minor 
periplasmic loops as well as the cytoplasmic location of the N- and C- termini of CydD 
and CydC (Cruz-Ramos et al. 2004b). Figure 6 shows a topography model of CydDC 
created using a recent modelling programme (Omasits et al. 2014), the findings are 
consistent with previous work. The model highlights the Walker A motif (also known as 
the P-loop), that interacts with bound nucleotide, the Walker B motif that coordinates 
magnesium ions and is essential for ATP hydrolysis, as well as the conserved histidine 
residue common to all ABC transporters, that hydrogen bonds with the gamma 
phosphate of ATP (Figure 1-6). 
The stuctural properties of purified CydDC were analysed using electron microscopy 
(EM) alongside circular dichroism (CD) (Yamashita et al. 2014).  Purified CydDC 
reconstituted in membrane lipids was used to generate two-dimensional crystals, which 
were subsequently analysed by electron cryomicroscopy, this showed that the protein is 
made of two non-identical domains, corresponding to CydD and CydC. The resolution 
was unfortunately low (30 Å) due to poor crystal order, thought to reflect a high 
conformational flexibility, which is also seen by other ABC type transporters, for 
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example in the x-ray crystal structure of the CydDC homologue MsbA (Ward et al. 
2007).  
    Circular dichroism (CD) spectroscopy verified that CydDC is largely comprised of 
Į-helices, and that the binding of haem has no significant affect upon the secondary 
structure. SDS-PAGE indicated a 1:1 ratio of CydD:CydC, and EM analysis of purified 
CydDC particles incubated with Ni-NTA-nanogold, demonstrated that each particle 
contained a single CydC subunit (only CydC was tagged during affinity 
chromatography of the CydDC complex). 
 
ABC transporters utilise adenosine triphosphate (ATP) hydrolysis as the energy source 
to move substrates across cell membranes, often against a concentration gradient. There 
is a great diversity within ABC transporters in regards to function; working to either 
import or export a wide range of substrates (Higgins 2001), yet all contain two ATP 
binding domains that bind and hydrolyse ATP. These nucleotide binding domains 
(NBDs) are highly conserved and share motifs common to all ATPase proteins such as 
Walker A and B motifs, as well as motifs unique to ABC proteins including the 
signature sequence (LSGGQ) and a conserved histidine residue. This high level of 
conservation within NBDs suggests a common mechanism in the powering of substrate 
transport via ATP hydrolysis.  
CydDC is a substrate exporter and thus has no substrate binding protein like the 
periplasmic proteins of importers. The binding of substrates to ABC transporters 
commonly induces their ATPase activity (Jones and George, 2004). Accordingly 
ATPase activity of CydDC was shown to be stimulated 3- to 4-fold by the addition of 
cysteine or GSH, however it is unknown exactly where these substrates bind 
(Yamashita et al., 2014). Proteins related to CydDC, including the human P-
glycoprotein and the bacterial Sav1866, are believed to receive their substrate from the 
lipid bilayer (Moussatova et al., 2008). Transport of substrates is considered to be 
initiated by the binding of substrate causing a conformational change in the TMDs that 
is transmitted to the NBDs resulting in ATP hydrolysis.  
The presence of haem in the form of hemin boosted thiol-stimulation of CydDC ATPase 
activity (Yamashita et al., 2014). As haem transport to the periplasm has been shown to 
occur independently of CydDC, a regulatory role in CydDC thiol transport is expected 
for haem. Structural modelling has since located a putative haem-binding site on the 



















Figure 1-6. Predicted secondary structure of CydD and CydC 
 
Secondary structure prediction was performed using the Protter online tool (v1.0) (Omasits et al. 2014). Transmembrane helices are numbered 
sequentially, Walker A motifs are shown in red, Walker B motifs are shown in Blue, and the conserved histidine residues of ABC transporter subunits 
(Linton and Higgins 1998) are shown in Green (His542 and His531 in CydD and CydC, respectively).
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1.4. Role of CydDC in the formation of P-574, a novel haem compound  
When E. coli cells are grown anaerobically, overexpression of the cydDC genes using a 
multi-copy plasmid elicits an increase in the levels of cytochromes b and d, and 
strikingly also results in the formation of a novel haem-containing molecule P-574 
(Cook et al. 2002). This pigment has distinctive absorption characteristics at 574-579 
nm and 448 nm in reduced minus oxidised spectra. Cells expressing P-574 appear 
reddish in colour, suggesting an overexpression of haem-containing proteins. The 
presence of P-574 is dependent upon haem biosynthesis as shown by the absence of P-
574 in an E. coli strain auxotrophic for 5-aminolaevulinic acid (a precursor of haem 
biosynthesis) (Cook et al. 2002). In a cydAB mutant that is over-expressing cydDC, P-
574 continues to be detected, thus eliminating the possibility that P-574 is a modified 
form of cytochrome bd-I (Cook et al. 2002).  
Haem was originally thought to be the most likely substrate for CydDC as 
cytochrome bd-I subunits are detected in the membranes of cydDC mutants as 
apoproteins (Georgiou, Hong and Gennis 1987). The assembly of periplasmic 
cytochromes is also perturbed in this strain. The uptake, however, of radio-labelled 
haem into everted membrane vesicles is not affected by the deletion of cydDC, 
suggesting that haem is not exported by CydDC, instead entering the periplasm by 
another route which is as yet unknown (Pittman et al. 2002). Considering that CydDC 
exports the reduced low-molecular weight thiols glutathione and cysteine and that loss 
of the exporter leads to an over-oxidising periplasm, it is likely that the formation of P-
574 in cells over-expressing CydDC results from a perturbation of redox balance in the 
periplasm. Cook et al. suggested that P-574 may be an intermediate or by-product of 
haem biosynthesis caused by a loss of redox balance in the periplasm (Cook et al. 
2002). The authors further hypothesised that a derivative of haem biosynthesis could 
complex with the over-expressed polypeptides of CydDC. It has since been revealed, 
however, that P-574 is retained in a cut-off filter of only 50 kDa, indicating that this 
pigment is protein-bound, but not to the polypeptides of CydDC (Shepherd, Heath and 
Poole 2007). Furthermore, the majority of P-574 was shown to be located in the 
periplasm, rather than being membrane-bound like CydDC (Shepherd, Heath and Poole 
2007). NikA, a haem-binding periplasmic protein involved in nickel uptake has been 
implicated in the formation of P-574; mutation of NikA significantly reduces the levels 




1.5 The terminal oxidases of E. coli 
The boƍ and bd-type oxidases of Escherichia coli both catalyse the two-electron 
oxidation of ubiquinol by molecular oxygen within the cytoplasmic membrane, 
concomitantly generating a proton gradient across the membrane that can be utilised by 
bacterial cells to produce ATP for use as an energy source. A major phenotype of 
cydDC mutants is an inability to assemble the terminal resiratory oxidase cytochrome 
bd-I. The assembly of cytochrome boƍ is thought to be independent of CydDC activity, 
and is the only functional respiratory oxidase in mutants lacking CydDC. Despite the 
presence of this alternative terminal oxidase, that can compensate for the loss of 
cytochrome bd-I,  the two oxidases show variability in characteristics such as energy 
conservation and oxygen affinity that enable E. coli cells to adapt to their environment. 
This section discusses the alternative terminal oxidases of E. coli and highlights the 
significance of cytochrome bd-I deficiency.  
 
1.5.1 Cytochrome boƍ  
In addition to generating a proton gradient via the vectorial translocation of protons that 
is linked to quinol reduction and oxidation, cytochrome boƍ is also able to directly pump 
protons across the membrane (Puustinen, Finel and Haltia 1991) and has a H+:e- ratio of 
2. The site of oxygen reduction in cytochrome boƍ is a haem-copper binuclear oxygen-
reactive centre, making it a member of the haem-copper superfamily of terminal 
oxidases (Anraku 1988) that have been extensively studied. 
The cyoABCDE genes encode subunits I, II, III and IV of the cytochrome boƍ 
complex and a protohaem farnesyltransferase (haem o synthase) respectively 
(Minghetti, Goswitz and Gabriel 1992; Saiki, Mogi and Anraku 1992). The assembly 
pathway for cytochrome boƍ is an ordered process wherein subunits III and IV are 
assembled first, followed by subunit I, and finally subunit II (Stenberg, von Heijne and 
Daley 2007). CyoABC are homologous to the core subunits of the aa3-type cytochrome 
c oxidase (Lemieux et al. 1992) both in terms of their primary sequence (Saraste, 
Sibbalda and Wittinghoferb 1988; Cotter et al. 1990) and structure (Gohlke, Warne and 
Saraste 1997; Abramson et al. 2000). A crystal structure of the entire 
cytochrome boƍ terminal oxidase complex has been determined at a resolution of 3.5 Å 
(Abramson et al. 2000) and reveals 25 transmembrane helices with a ubiquinone 
binding site within the membrane domain of subunit I (Abramson et al. 2000). The 
entire complement of redox centres reside within the largest of the four subunits, 
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subunit I. A low-spin haem b associated with a copper ion (CuB)  (Puustinen, Finel and 
Haltia 1991; Puustinen and Wikstrom 1991) is thought to act as an electron donor to 
reduce a binuclear centre composed of a high-spin haem o and another copper ion 
(CuB): this is where oxygen reduction takes place (Salerno, Bolgiano and Poole 1990). 
The assembly of cytochrome boƍ is thought to be independent of CydDC activity, and is 
the only functional respiratory oxidase in mutants lacking CydDC. 
 
1.5.2 Cytochrome bd-I 
The terminal oxidase cytochrome bd-I is confined to the prokaryotic world and is well-
characterised in E. coli. Unlike cytochrome boƍ, cytochrome bd-I does not contain 
copper and so is not a member of the haem-copper oxidase superfamily. Instead, 
cytochrome bd-I utilises an unusual di-haem oxygen-reactive site (Rothery and 
Ingledew 1989; Junemann 1997; Borisov and Verkhovsky 2013). All known members 
of the bd-family use quinol as a substrate, receiving electrons commonly from either 
ubiquinol or menaquinol. A three dimensional structure has yet to be elucidated, 
existing data however, shows that cytochrome bd-I is a trimer of three integral 
membrane polypeptides, subunits I (CydA) and II (CydB) (Kita, Konishi and Anraku 
1984) and CydX (VanOrsdel et al. 2013). Secondary structure prediction models 
suggest that CydA contains nine membrane-spanning helices, that CydB contains eight 
membrane-spanning helices (Osborne and Gennis 1999) and that CydX consists of just 
a single membrane-spanning helix. A large periplasmic loop between helices 6 and 7 of 
VXEXQLW , LV LQYROYHG LQ TXLQRO ELQGLQJ DQG LV FRQVHTXHQWO\ NQRZQ DV WKH µ4 ORRS¶
(Dueweket and Gennis 1991; Matsumoto et al. 2006; Mogi et al. 2006). Site-directed 
mutagenesis has revealed that two residues within the Q loop, Lysine-252 and 
Glutamate-257, are required for cytochrome bd-I oxidase activity (Mogi et al. 2006) and 
DUHWKRXJKWWRSOD\DUROHLQTXLQROELQGLQJ6KLIWVLQµUHGXFHGminus R[LGLVHG¶VSHFWUD
following Glu257 mutation indicate a close proximity of this residue to haem b558, 
suggesting that Glu257 not only binds to quinol but also participates in electron transfer 
from quinol to haem b558 (Mogi et al. 2006). 
 Three haems are associated with the oxidase in a 1:1:1 stoichiometry per 
oxidase complex. Two of the haems are in a high-spin state (d and b595) and are thought 
to form a di-haem active site where oxygen is reduced (Hill, Alben and Gennist 1993; 
Vos et al. 2000; Arutyunyan et al. 2008; Rappaport et al. 2010; Borisov and 
Verkhovsky 2013), and modelling of the excitonic interaction between haems d and b595 
35 
 
has led to an estimated intermolecular distance of 10 Å (Arutyunyan et al. 2008). 
Despite the proximity and evidence for functional cooperation (Vos et al. 2000), doubt 
has been cast upon the existence of a di-haem active site as no spin coupling has been 
observed between the haems (Junemann 1997). The third haem cofactor is a 
hexacoordinate low-spin haem b558 located within subunit I that is responsible for quinol 
oxidation that supplies electrons to the di-haem site for the reduction of molecular 
oxygen to water. 
In the absence of CydB, CydA is still integrated into the cytoplasmic membrane, 
and haem b558 is still incorporated  but the high spin haems d and b595 are absent from 
the cytochrome subunits (Newton and Gennis 1991). In an attempt to explain this loss 
of haem groups, it has been suggested that the two high-spin haems are located at the 
interface between CydA and CydB subunits. Loss of cydDC abolishes haem cofactor 
incorporation into cytochrome bd-I but the CydAB polypeptides are still inserted into 
the membrane (Georgiou, Hong and Gennis 1987). Synthesis of this apo-cytochrome 
bd-I is also observed in haem-deficient cells (Calhoun, Newton and Gennis 1991), 
implying that haem insertion is the last step of cytochrome bd-I assembly. 
Site-directed mutagenesis studies have been used alongside spectroscopic 
methods to reveal that highly-conserved histidine-186 and methionine-393 of CydA are 
axial ligands of b558 (Fang, Lin and Gennis 1989; Kaysser et al. 1995; Spinner et al. 
1995). The positive charge of the conserved arginine-391 residue has a role in 
stabilising the reduced form of haem b558 and is required for oxidase activity (Zhang et 
al. 2004). Histidine-19 of CydA provides the essential axial ligand for b595 (Sun et al. 
1996). Furthermore, an E99L mutation within CydA abolishes the haem d spectral 
signals (Bloch et al. 2009), supporting the idea that glutamate-99 could be the axial 
ligand to haem d  (Mogi, Endou and Akimoto 2006).  
Cytochrome bd-I contributes to the proton motive force (PMF) via the vectorial 
translocation of protons that is linked to quinol reduction and oxidation (Calhoun et al. 
1993), but unlike cytochrome boƍ is unable to directly pump protons (Puustinen, Finel 
and Haltia 1991) and is therefore considered, in bioenergetic terms, less efficient (H+:e- 
ratio = 1). All three haem cofactors appear to be located on the periplasmic side of 
cytochrome bd-I (Zhang et al. 2004), which poses the question of how protons are 
translocated across the membrane from the cytoplasm to the site of oxygen reduction 
that occurs on the periplasmic side. As the translocation of protons is unlikely to involve 
inter-haem transfer, conserved amino acid residues that can be reversibly protonated 
have been implicated, so far glutamates 99 and 107 within transmembrane helix III of 
36 
 
CydA have been suggested to partake in proton translocation (Osborne and Gennis 
1999). 
Despite having a reduced contribution to the PMF, cytochrome bd-I does 
facilitate aerobic respiration under conditions of low oxygen due to a very high affinity 
for oxygen: bd-I has a Km of 3 ± 8 nM '¶PHOOR+LOODQG3RROH compared to Km 
values in the range of 0.016-0.35 µM for cytochrome boƍ '¶0HOOR +LOO DQG 3RROH
1995). It is likely that the di-haem active site plays a role in this high affinity for oxygen 
(Borisov, Liebl and Rappaport 2002), promoting growth in microaerobic environments. 
 
1.5.2.1 The cydABX genes 
Until recently, cytochrome bd-I was generally believed to be comprised of two subunits 
encoded by cydA (subunit I) and cydB (subunit II) (Kranz and Gennis 1983; Green et al. 
1988; Calhoun, Newton and Gennis 1991) located at 16.6 minutes on the E. coli genetic 
map (Bachmann 1990; Calhoun, Newton and Gennis 1991). The molecular weights of 
subunits I (57kDa) and II (43kDa) determined by sodium dodecyl sulphate-
polyacrylamide-gel electrophoresis (SDS-PAGE) (Miller and Gennis 1983) are 
consistent with predicted masses calculated from the protein sequences (Green et al. 
1988). 
Two open reading frames, ybgE and ybgT are found at the 3¶ end of the cydAB 
genes which together are thought to form an operon (Figure 1-7) (Muller and Webster 
1997). The 4 kDa YbgT protein was shown to co-purify with CydAB and is believed to 
be a part of the complex (VanOrsdel et al. 2013);  ybgT has since been renamed cydX. 
Cells lacking CydX exhibit diminished oxidase activity which can be restored by the 
addition of cydX on a plasmid (VanOrsdel et al. 2013). Silver staining shows that CydX 
is present in stoichiometric amounts with CydA and CydB (Hoeser et al. 2014), 
confirming CydX as a third subunit of cytochrome bd-I. CydX is thought to be required 
for either the insertion or the stability of haem d and b595 that make up the di-haem 
active site of cytochrome bd-I; UV/visible difference spectroscopy revealed that the 
signals of haem d and b595 are lost when CydA and CydB are not accompanied by 
CydX. No role in cytochrome bd-I assembly/function has been identified for ybgE, with 
its deletion having no effect on phenotypes typically observed for cydA or cydB mutants 








Figure 1-7. The cydABX locus of E. coli 
 
The cytochrome bd-I terminal oxidase is encoded by the cydABX genes. ybgE is thought 
to also form part of the operon but as of yet no role in cytochrome bd-I 
assembly/function has been identified.  
 
 
Beyond cydABX, the two genes encoding CydDC are essential for assembly of 
functional cytochrome bd-I (Georgiou, Hong and Gennis 1987; Bebbington and 
Williams 1993; Poole et al. 1993; Poole, Gibson and Wu 1994). In its absence, CydA 
and CydB are still synthesised and inserted into the membrane, but the oxidase lacks 
haem groups essential for function (Georgiou, Hong and Gennis 1987).  As discussed 
previously CydDC exports two low-molecular weight thiols, glutathione and cysteine, 
from the cytoplasm to the periplasmic space (Pittman et al. 2002; Pittman, Robinson 
and Poole 2005). However, exogenous addition of either of these thiols to a strain 
lacking CydDC does not restore cytochrome bd-I assembly, so the molecular 
mechanism via which CydDC contributes to cytochrome bd-I assembly remains 
unclear. 
 
1.5.3 Cytochrome bd-II  
Dassa et al. 1991 discovered an operon comprised of three genes upstream of appA, an 
acid phosphatase gene that is regulated positively in response to oxygen deprivation by 
AppR (KatF). The genes named appC, appB and appX are co-transcribed at a promoter, 
P2, just upstream of appC, whereas a second minor promoter P1 controls appA (Figure 
1-8). The appCBX genes are regulated by oxygen in exactly the same way as appA. 
Support for the idea that AppC and AppB are implicated in oxygen metabolism was 
provided by the increased sensitivity to dioxygen phenotype of a cyo cyd app triple 
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Figure 1-8. The appCBX locus of E. coli 
 
The cytochrome bd-II terminal oxidase is encoded by the appCBX genes, downstream 
appA encodes an acid phosphatase enzyme. The appCBX genes are co-transcribed at a 
promoter, P2, whereas a second minor promoter P1 controls appA. 
 
 
The newly discovered appCB genes were predicted to encode integral membrane 
proteins with striking sequence homology to CydA (60% similarity) and CydB (57% 
similarity) and with similar hydrophobicity profiles (Figure 1-9). To our knowledge, no 
CydD and CydC homologues with functions allied specifically to AppB and AppC 
assembly have been identified. The appCB gene products are also known as CbdAB 
(Sturr, Krulwich and Hicks 1996), AppBC, CyxAB or, most commonly now, 
cytochrome bd-II. 
The cytochrome bd-II oxidase was at first considered to be nonelectrogenic 
(Bekker et al. 2009), but the ability of cytochrome bd-II to generate a proton motive 
force was later re-examined. It was shown via absorption and fluorescence spectroscopy 
along with oxygen pulse methods that in the steady-state, cytochrome bd-II can generate 
a proton motive force via a molecular mechanism identical to that in cytochrome bd-I 
(Borisov et al. 2011). With an estimated H+»eí ratio of 0.94 ± 0.18, the proton motive 
force generated by cytochrome bd-II is expected to be sufficient to drive ATP synthesis 







Figure 1-9. Predicted secondary structures of AppC, AppB, and AppX  
 
Secondary structure prediction was performed using the Protter online tool (v1.0) (Omasits et al. 2014). Transmembrane helices are numbered 
sequentially, the haem b595 ligand (His19) is shown in blue, the haem b558 ligands (His186 and Met393) are shown in red, and the likely sites of quinol 
binding (Lys252 and Glu257) are shown in green. 
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1.5.4  Regulation of terminal oxidase expression 
The respiratory chain of Escherichia coli is a complex branched array of modular 
components that are able to oxidise a wide variety of substrates, permitting bacteria to 
grow in a range of aerobic environments. The expression of cytochromes boƍ and bd-I 
are controlled by different transcriptional regulators, and these complexes are expressed 
under different conditions. The regulation of cytochrome bd-II is lesser-studied, 
although the appCB operon is known to be induced under conditions of carbon and 
phosphate starvation and is under the control of RpoS and AppY (Atlung et al. 1997). 
The differential regulation of cyo and cydAB operons provides an insight into the roles 
of cytochromes boƍ and bd-I in E. coli: cytochrome boƍ has so far been shown to be 
more energetically efficient than cytochrome bd-I, but has a lower affinity for oxygen 
and is therefore less efficient than cytochrome bd-I in low oxygen environments. The 
regulatory mechanisms discussed below act to optimise the expression of the boƍ and 
bd-I oxidases in response to changing respiratory requirements under varying oxygen 
tensions.  
 
1.5.4.1 Regulation of the cyo and cydAB operons 
LacZ-fusion experiments with cytochrome boƍ and cytochrome bd-I revealed that in 
cells grown aerobically there are an estimated 304 molecules of cytochrome boƍ and 204 
molecules of cytochrome bd-I per cell compared to only two molecules of cytochrome 
boƍ and 606 molecules of cytochrome bd-I per cell when grown anaerobically (Cotter et 
al. 1990).  This difference in oxidase composition within the membrane illustrates the 
differential regulation of cytochrome bd-I and cytochrome boƍ in response to oxygen 
tension.  
Cytochrome boƍ and cytochrome bd-I of E. coli are regulated by the combined 
action of FNR and the two-component system ArcAB (Gunsalus 1992). The fumarate 
and nitrate reductase regulator, FNR, is a global transcriptional regulator that 
orchestrates changes from aerobic to anaerobic metabolism at the transcriptional level 
(Unden et al. 1995; Becker et al. 1996; Beinert and Kiley 1999). FNR contains an 
oxygen-labile [4Fe-4S]2+ cluster that controls protein dimerisation and site specific 
DNA binding. Oxygen is sensed via the assembly and disassembly of the [4Fe-4S]2+ 
cluster (Green et al. 1996; Lazazzera and Beinert 1996; Beinert and Kiley 1999). When 
cells encounter a change from aerobic to anaerobic growth conditions, FNR is activated, 
41 
 
and subsequently binds to DNA at consensus sequences resulting in the modulation of 
gene expression (Lazazzera and Beinert 1996). In contrast, ArcAB is a two-component 
regulatory system comprised of a transmembrane sensor kinase (ArcB) and a cytosolic 
response regulator (ArcA). ArcB is activated by falling oxygen tensions and in turn 
phosphorylates ArcA, which functions at the transcriptional level, to activate the 
expression of cydAB and repress the expression of cyoABCDE (Iuchi et al. 1990; Fu, 
Iuchi and Lin 1991; Iuchi and Lin 1992).  Expression of both aerobic and anaerobic 
respiratory pathway genes are controlled under microaerophilic conditions, ensuring a 
hierarchical pattern of gene expression in response to changes in oxygen availability 
(Tseng et al. 1996).  Expression of cytochrome bd-I reaches a peak at an oxygen tension 
of approximately 2% (Tseng et al. 1996).  At oxygen tensions lower than this FNR 
becomes activated and represses the cyoABCDE and cydAB operons, with the genes of 
the anaerobic respiratory pathway becoming activated (Cotter et al. 1990; Tseng et al. 
1996).  Repression of the cydAB genes by FNR is dependent upon ArcA (Cotter et al. 
1990; Tseng et al. 1996; Cotter et al. 1997; Govantes et al. 2000), suggesting that FNR 
functions as an anti-activator by counteracting ArcA-mediated activation as opposed to 
direct repression of transcription (Tseng et al. 1996; Cotter et al. 1997; Govantes et al. 
2000). Consequently, cydAB expression increases with falling oxygen tensions via 
ArcAB, until oxygen tension is low enough for FNR to suppress the effects of ArcAB.  
It has also been found that during shifts to anaerobic conditions or upon entry into 
stationary phase, changes in DNA supercoiling play a role in the induction of cydAB 
expression which is independent of ArcAB or FNR (Bebbington and Williams 2001).  
The mechanisms above account for how cytochrome bd-I expression is 
regulated at lowering oxygen tensions, but does not fully explain how cytochrome boƍ 
levels are higher than cytochrome bd-I at higher oxygen tensions. In highly aerobic 
conditions, the abundant histone-like protein, H-NS, represses cydAB expression 
resulting in diminished expression of cydAB under aerobic conditions (Govantes et al. 
2000). H-NS is thought to decrease gene expression by causing localised changes to 
DNA that prevent RNA polymerase binding (Ueguchil and Mizuno 1993). 
As well as adapting to low oxygen conditions, expression and membrane content 
of cytochrome bd-I has been shown to increase in response to a variety of stresses, 
including high temperature (Wall et al. 1992; Delaney et al. 1993), high pH (Avetisyan 
et al. 1991), high pressure (Tamegai et al. 2005) and the presence of protonophore-
uncouplers (Armine V Avetisyan, Pavel A Dibrov, Anna L Semeykina, Vladimir P 
Skulachev 1991; Bogachev, Murtazina and Skulachev 1993; Bogachev et al. 1995). 
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Also, induction of cytochrome bd-I by heat shock and loss of PMF is dependent upon 
the ArcAB two-component system (Wall et al. 1992).  In response to exposure of nitric 
oxide, anaerobically grown cells see a preferential induction of the cytochrome bd-I 
genes, but not of genes encoding cytochrome boƍ; cydA and cydB were shown to be up-
regulated by 3.9-fold and 3.2-fold, respectively. Similar results were seen in response to 
nitric oxide (NO) for cells growing aerobically, with the cydA and cydB genes being 
induced by 2.4-fold and 2.5-fold, respectively. This study reported an accompanying 
up-regulation of other FNR-repressed genes, suggesting that this response is likely due 
to an interaction between NO and the iron-sulphur cluster within FNR  (Pullan et al. 
2007): the iron-sulphur cluster is required for DNA binding and is inactivated upon NO 
exposure (Cruz-Ramos et al. 2002). 
 
1.6 Nitric oxide stress in E. coli 
Nitric oxide (NO) is a key signalling and defence molecule in biological systems which 
Escherichia coli encounters both as part of its own metabolism and during host 
infection. NO is produced by E. coli as an obligate intermediate of anaerobic 
denitrification; during which nitrate is reduced to nitrite, which is subsequently reduced 
to ammonia via a NO intermediate (Zumft 1997; Watmough et al. 1999). In eukaryotic 
cells and certain bacteria, nitric oxide is also produced via the oxidation of L-arginine 
by NO synthases (NOS) including inducible nitric oxide synthase (iNOS) (Cutruzzola 
1999; Stuehr 1999; Elfering, Sarkela and Giulivi 2002). Host defence mechanisms such 
as neutrophils and activated macrophages (Fang 2004; Lundberg et al. 2004; Poole and 
Hughes 2000) utilise NO and associated reactive nitrogen species (RNS) as protection 
against invading bacteria. Nitric oxide has been shown to inhibit E. coli growth and 
respiration (Yu et al. 1997). The toxicity of NO and RNS in biological systems is due to 
their ability to react with a variety of cellular targets. Reactive nitrogen species are 
capable of causing damage to bacterial proteins, DNA and lipids. NO can affect 
terminal oxidases, thiol groups and metal centres such as iron sulphur clusters. To 
survive exposure to NO-mediated nitrosative stress, E. coli has evolved mechanisms to 
circumvent the harmful effects of NO. Various bacterial NO-detoxifying enzymes are 
contained within E. coli including the enzymes cytochrome c nitrite reductase (NrfA), 
flavohemoglobin (Hmp), and a flavorubredoxin (NorV). Alongside these enzymes, 
there are proteins that work to reverse the damage caused by NO such as the iron-
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sulphur repair protein YtfE. These four NO protection mechanisms will now be 
discussed in more detail.  
 
1.6.1. E. coli tolerance mechanisms against NO: Hmp 
Flavohaemoglobins are comprised of two domains, a globin domain containing haem b 
and a ferredoxin-NADP reductase (FNR)-like domain that converts the globin into an 
NAD(P)H-oxidising protein with diverse reductase activities. In E. coli, hmp encodes a 
flavohemoglobin that is involved in the response to nitric oxide (NO) and nitrosative 
stress; The hmp gene is inducible under both aerobic and anaerobic conditions by 
nitrate, but is induced more efficiently by nitrite and NO (Poole et al. 1996). 
 
The non-covalently bound haem of the globin domain has been shown to avidly 
bind NO in vitro. Sequential electron transfer from NAD(P)H to bound nitric oxide 
results in the reduction of NO to either nitrate under aerobic conditions or nitrous oxide 
under anaerobic conditions (Figure 1-10). Being one of the best-studied NO-defence 
mechanisms, the role of Hmp in NO detoxification was demonstrated by the finding that 
strains lacking Hmp are hypersensitive to NO and nitrosative stress. Hmp has been 
shown to be a virulence factor in Salmonella and other pathogens (Bang et al. 2006). 
Interestingly protection provided by Hmp appears to be more profound when grown 
aerobically than anaerobically (Gardner et al. 1998).  
 
1.6.2. NorRVW 
The nitric oxide reduction modulon norRVW is involved in the anaerobic or 
microaerobic reduction of NO to nitrous oxide (N2O) (Gomes et al. 2002). The norV 
gene encodes a non-haem flavorubredoxin (Gomes et al. 2000; Vicente and Teixeira 
2005; Gardner, Helmick and Gardner 2002) that has a di-iron centre and exhibits 
submicromolar affinity for NO 7XFNHUDQG'¶DXWUHDX[. NorV is associated with 
an NADH:(flavo)Rb oxidoreductase encoded by norW (Gardner, Helmick and Gardner 
2002), which is rapidly reduced by NADH (but not NADPH) and transfers an electron 
to oxidised NorV to support multiple turnovers of NorV-mediated NO reduction (Figure 







Figure 1-10. Electron transfer within Hmp leading to the reduction of NO 
 
Hmp is depicted with the globin domain containing the haem prosthetic group at the left 
of the protein. Electrons are transferred from NAD(P)H to FAD and then to the haem 
group. A Under aerobic conditions O2 is reduced to form a superoxide anion, 
subsequent oxygenation of NO leads to the formation of NO3- presumably via a 
peroxynitrite intermediate that is not shown. B Under anaerobic conditions the ferrous 
haem reacts directly with NO to form a nitrosyl species, electron transfer to NO results 






Figure 1-11. NorVW couples NADH oxidation to NO reduction 
The flavorubredoxin NorV reduces nitric oxide to nitrous oxide. The flavorubredoxin 
reductase (FlRd-reductase) NorW then re-reduces NorV using NADH as an electron 
donor. NorV of E. coli contains three domains: a metallo-ȕ-lactamase-like domain 
which contains the non-haem di-iron centre (Fe-Fe), a flavodoxin-like domain, 
containing one FMN moiety and a C-terminal module with a rubredoxin-like centre. 




The norVW genes are regulated by an NO-responsive transcription factor NorR. NorR is 
formed of three domains, a GAF domain which contains a mononuclear non-haem iron 
that binds nitric oxide, a central AAA domain with ATPase activity and a DNA binding 
domain at the C-terminal of the protein (Gardner, Gessner and Gardner 2003; Justino et 
al. '¶$XWUpDX[et al. 2005). NorR is thought to respond only to NO (Spiro 2006), 
becoming activated by the reversible formation of a mononitrosyl complex which 
consequently stimulates the ATPase activity to initiate transcription of norV (Figure 1-
12) '¶$XWUpDX[et al. 2005). 
       Deletion of norV elicits a sensitivity to NO under anaerobic conditions 
(Gardner, Helmick and Gardner 2002). Despite this, the rate of NO reduction remains 
similar to the parental strain. Deletion of hmp alongside norV however results in a clear 
defect in anaerobic metabolism of NO (Justino et al. 2005; Vine and Cole 2011). NorV 
has been shown to contribute to the survival of EHEC within macrophages, and is 
considered a virulence factor of EHEC (Shimizu et al. 2012). This finding reinforces the 
identity of the flavorubredoxin and its accompanying reductase as a factor used by E. 
coli in the protection from host-derived NO. Baptista et al. (2012) used electron 
paramagnetic resonance (EPR) experiments to show that exposure to oxidative stress at 
the same time as nitrosative stress inhibits NorR, by preventing NO binding, a 
requirement for flavorubredoxin activation. This is of importance in the context of 
infection as macrophage cells use a combination of nitrosative and oxidative stress to 
combat pathogenic bacteria. Survival of E. coli was studied within activated murine 
macrophages; this showed that the contribution of NorV to survival within macrophages 
depends upon the stage of macrophage infection. An initial oxidative burst inhibits 
NorR as revealed by the lack of protection observed at the early stage of macrophage 












Figure 1-12. Schematic of NorR and the proposed mechanism of transcriptional 
activation 
 
The schematic includes the three domains of NorR; the C-terminal helix-turn-helix 
(HTH) DNA binding domain, the ATPase domain and the N-terminal GAF domain 
containing a non-haem LURQFHQWUH ,QWKHµRIIVWDWH¶NorR contains a ferrous iron ion, 
but in the presence of nitric oxide a mononitrosyl complex is formed which activates 
1RU5 WR DQ µRQ VWDWH¶ ZLWK $73DVH DFWLYLW\ WKDW LV FRXSOHG WR WKH DFWLYDWLRQ RI norV 
transcription. For the purpose of clarity NorR is depicted as a monomer. Figure adapted 
IURP'¶$XWUéaux et al. 2005.  
   
1.6.3. NrfA and the detoxification of NO  
The periplasmic cytochrome c nitrite reductase, NrfA, of E. coli is a homodimer of 
approximately 110 kDa that contains ten c-type haems; five per monomer. This 
respiratory enzyme is expressed under anoxic or microaerobic growth conditions in the 
presence of nitrate and nitrite (Darwin et al. 1993; Rabin and Stewart 1993). NrfA 
(Nitrite Reduction by Formate) catalyses the respiratory six electron reduction of nitrite 
to ammonium (Poock et al. 2002) but importantly can also catalyse the five electron 
reduction of nitric oxide to ammonia (van Wonderen et al. 2008). The reduction and 
therefore detoxification of NO by NrfA suggests a protective role against NO. 
Consistently, under anaerobic conditions strains lacking NrfA have been shown to have 
a much greater sensitivity to NO (Poock et al. 2002). 
  The consumption of NO by NrfA under anaerobic conditions was demonstrated 
in vivo by Poock et al. using a Clarke-type oxygen electrode polarised to detect nitric 
oxide. To prevent complications in studying the contribution of NrfA to NO metabolism 
Poock et al. used a mutant strain of E. coli with a deletion of nirA which encodes a 
cytoplasmic sirohaem nitrite reductase (Harborne et al. 1992). This enzyme also reduces 
nitrite to ammonium and would also be switched on under anaerobic or microaerobic 
conditions. NO consumption was compared between a nrfA mutant and its parental 
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strain (nirA-). The parental strain reduced NO at maximum rate of 300 nmol NO mg 
protein-1 min-1. However, nitric oxide consumption could not be detected when 
measured in a nrf- nirA- strain (Poock et al. 2002). Taken together this demonstrates a 
role for NrfA in tolerance to nitrosative conditions.   
         E. coli has multiple routes for detoxifying nitric oxide. In changeable 
environments E. coli can be exposed to, particularly for pathogenic E. coli, it is likely 
that these different mechanisms, rather than being functionally redundant will be 
important for different conditions faced by bacteria. NrfA, for example, is particularly 
well suited to NO removal as it is located in the periplasm and so can detoxify NO 
before reaching targets within the cytoplasm. Also as NrfA is expressed under anoxic or 
micro-oxic growth conditions, NrfA is likely to be active in the oxygen limiting 
conditions experienced within the host. 
 
1.6.4 Iron-sulphur cluster repair 
Among cellular targets of nitric oxide cytotoxicity are a group of proteins that contain 
iron±sulphur clusters. Iron-sulphur (Fe-S) clusters are a ubiquitous prosthetic group that 
underpin a diverse range of protein functions and fundamental life processes including 
electron transfer (Cooper 1999). NO can bind to the iron of iron-sulphur clusters to form 
an iron-sulphur nitrosyl complex and thus inhibit the catalytic role they play in proteins 
(Butler, Glidewell and Li 1988). Some propose that nitrosative stress limits activity of 
Fe-S proteins by the release of iron from clusters, however more research is needed to 
prove this (Drapier 1997). 
        Also known as RIC (Repair of Iron Centres), Escherichia coli YtfE is a di-iron 
protein that has been shown to enable E. coli to cope with nitrosative and oxidative 
stress by repair of iron sulphur clusters (Todorovic et al. 2008; Justino et al. 2006; 
Justino et al. 2005). YtfE was first associated with nitrosative stress protection when a 
DNA microarray experiment showed a 55-fold increase in ytfE mRNA when treated 
with NO (Justino et al. 2005). Mutation of ytfE was later shown to elicit a sensitivity to 
nitric oxide (Justino et al. 2005), and to reduce activity of iron-sulphur cluster proteins 
under nitrosative stress (Justino et al. 2006).  Furthermore in the absence of YtfE, 
nitrosative damage to Fe-S clusters is accelerated (Justino et al. 2007). 
In wild type E. coli, once sources of nitrosative or oxidative stress are eliminated, a 
recovery in activity of iron-sulphur cluster proteins, aconitase B and fumarase A is seen. 
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Strains lacking ytfE however do not demonstrate this recovery of activity. Furthermore, 
addition of purified holo-YtfE to ytfE mutant extracts, has been shown to restore the 
activity of fumarase and aconitase to rates similar to wild type.  This demonstrates that 
YtfE is able to repair nitrosative damage to Fe-S clusters.  
 
 
1.6.5 Role for cytochrome bd-I in NO tolerance 
Alongside protein thiol groups and iron sulphur clusters, NO can bind to haem proteins 
including cytochromes boƍ and bd-I of E. coli. In response to NO exposure, a 
transcriptomic study reported elevated expression of the cydAB operon encoding 
cytochrome bd-I, which suggested that this terminal oxidase may have a role in 
tolerance to nitrosative stress (Pullan et al. 2007). Gene knockouts were performed in E. 
coli so that cells lacked either the genes encoding cytochrome boƍ or cytochrome bd-I; 
growth and respiratory rates were then assessed for these respiratory mutants in 
response to NO (Mason et al. 2009). Cells that possessed cytochrome bd-I were shown 
to have a higher IC50 (half maximal inhibitory concentration) value for NO than cells 
with cytochrome boƍ, revealing a reduced sensitivity of cytochrome bd-I to NO. 
Recovery rates of respiration were also studied by inhibition with NO, which was 
subsequently removed by the fast-reacting NO scavenger cPTIO. The recovery rate is 
thought to be equivalent to the rate of NO dissociation from the oxidases (Sarti et al. 
2000), so a fast rate of recovery for cytochrome bd-I (cells in which cytochrome boƍ was 
not present) suggested a rapid koff(NO) for this terminal oxidase, complementing 
previous in vitro work (Borisov et al. 2004). The cytochrome bd-I recovery rate 
translated to an NO dissociation rate of 0.163 s-1, similar to that of fully reduced 
purified cytochrome bd-I (Borisov et al. 2007). This rate of dissociation is faster than 
that observed for the majority of haem-proteins (Cooper 1999), and more than five 
times faster than for cytochrome boƍ (Mason et al. 2009), which explains how 
cytochrome bd-I is able to support aerobic respiration in the presence of NO. 
NO is thought to bind at the haem d cofactor, as absorption spectroscopy 
revealed that addition of NO to reduced cytochrome bd-I of E. coli or Azotobacter 
vinelandii shifts the absorption peak of ferrous haem d from 629nm to 641nm, yielding 
a ferrous iron±NO adduct (Borisov et al. 2004). Also a linear relationship between 
oxygen concentration and IC50 of NO (Mason et al. 2009) shows that the two gases are 
in competition with each other, implying that they have the same binding site. If NO-
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mediated inhibition of cytochrome bd-I is due to binding at haem d, a faster rate of NO 
dissociation will facilitate competing oxygen to bind to haem d, so that aerobic 
respiration can continue in the presence of NO.  
 
The superoxide anion generated by macrophages can combine with nitric oxide 
to produce peroxynitrite (ONOOí), which is thought to be at high concentrations within 
the host. Production of ONOOí is particularly prominent in phagosomes once microbes 
have been engulfed. Peroxynitrite is a strong nucleophilic oxidant, which can cause 
damage to DNA, lipid oxidation, protein modifications and ultimately cell death 
(Pacher, Beckman and Liaudet 2007). Cytochrome bd-I in turnover with oxygen has 
been shown to not only resist ONOOí damage, but to be capable of rapidly 
metabolising ONOOí (Borisov et al. 2015), and is thought to be the first example of an 
enzyme that can metabolise ONOOí within E. coli. A temporary inhibition of 
cytochrome bd-I oxidase after ONOOí addition has been attributed to generated nitric 
oxide, as oxygen consumption levels were comparable to those observed when cells 
were treated with nitric oxide.  
 
1.7  bd-type oxidases in the context of bacterial pathogenicity 
With a high affinity for oxygen, expression of bd-type oxidases is advantageous to 
bacteria that colonise microaerobic niches at the sites of infection.  The host immune 
system imposes oxidative and nitrosative stresses to combat microbial infections. 
Cytochrome bd-I expression is induced in E. coli in the presence of nitrosating species, 
which suggests a protective role especially in the context of pathogenesis. Indeed, bd-
type oxidases are expressed in a number of bacterial pathogens such as Listeria 
monocytogenes (Larsen et al. 2006), and even anaerobic pathogens such as Bacteroides 
fragilis (Baughn and Malamy 2004). For some pathogens the bd-type terminal oxidase 
is so vital for survival GXULQJ KRVW FRORQLVDWLRQ WKDW LW¶V ORVV has been shown to 
attenuate virulence, this is the case for both Salmonella (Turner et al. 2003) and group B 
Streptococcus (Yamamoto et al. 2005). 
Brucella abortus (B. abortus) is a Gram-negative species that can multiply 
within macrophage cells and subsequently spread throughout the host. This intracellular 
pathogen modifies gene expression rapidly to adapt to the hostile environment of 
macrophage cells. B. abortus preferentially utilises a bd-type oxidase during 
intracellular replication (Loisel-Meyer et al. 2005). A transposon mutant of cydB was 
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found to have attenuated survival within murine macrophages. Subsequently, Brucella 
cells lacking the oxidase were also shown to be highly attenuated in the mouse model of 
infection (Endley, Murray and Ficht 2001). The diminished survival of this pathogen is 
likely to be connected to an inability to cope with the oxidative stress; presented both by 
the macrophage and due to a build-up of oxidative radicals from the disrupted electron 
transport chain  (Endley, Murray and Ficht 2001). The oxygen-scavenging nature of bd-
type cytochromes is thought to not only support bacterial survival within low oxygen 
conditions of phagocytes (James et al. 1995), but also doubles up to provide an anti-
oxidant function by reducing intracellular oxygen levels (Rezaïki et al. 2004). As 
previously discussed, the role of cytochrome bd-I in NO tolerance, as shown for E. coli 
(Mason et al. 2009), is also a likely contributing factor to Brucella survival through 
resistance to macrophage-derived nitrosative stress. Other intracellular pathogens, such 
as Shigella flexneri (S. flexneri), exhibit a positive correlation between expression of a 
bd-type oxidase and virulence (Way et al. 1999), and Mycobacterium tuberculosis (M. 
tuberculosis) displays a transient up-regulation of a bd-type oxidase during the 
transition from acute to chronic infection of mouse lungs (Shi et al. 2005). With a clear 
role in virulence of human pathogens, a notable observation is that bd-type oxidases are 
restricted to the prokaryotic world and these respiratory complexes are therefore 
potential drug targets: in fact studies to find inhibitors have already begun (Mogi and 
Kita 2009; Mogi et al. 2009). 
 
1.8 CydDC in the context of bacterial pathogenicity 
The export of reduced low-molecular weight thiols by CydDC plays a role in 
periplasmic redox balance, and so, is likely to impact upon bacterial virulence. Loss of 
CydDC in E. coli creates a pleiotropic phenotype, including an inability to synthesise 
functional cytochrome bd-I. As discussed above, cytochrome bd-I plays a key role in 
the adaptation of pathogenic strains within the host. It is not known whether deletion of 
cydDC elicits the loss of bd-type oxidase assembly in all Gram-negative species, but the 
major focus of non- E. coli research on CydDC has been on a general contribution to 
bacterial virulence.  
The intracellular pathogen, S. flexneri depends upon survival within host cells 
during pathogenesis (Sansonetti et al. 1991). Cellular infection, intracellular survival 
and spread of S. flexneri can be studied in vitro by infecting confluent monolayers of 
mammalian cells and comparing the size of resulting bacterial plaques within this cell 
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monolayer. Disruption of cydC was shown to result in impaired pathogenesis as 
demonstrated by a reduced plaque size when compared to wild type cells (Way, 
Borczuk and Goldberg 1999). Survival within the monolayer was then determined by 
counts of bacterial cells recovered from the monolayer, after six hours a reduction in 
cell count was observed for cydC mutant cells, suggesting that a reduction in cell 
viability is, at least in part, accountable for the small plaque size in the absence of 
CydDC (Way, Borczuk and Goldberg 1999). In a mouse intranasal model, the lethal 
dose was 100-fold higher for a cydC mutant when compared to that required of wild 
type cells. As a cydC mutant was shown to have only a baseline level of cytochrome d, 
which corresponds to minimal levels of a bd-type oxidase, the authors of this study 
suggest that the reason for reduced virulence of a cydC mutant in S. flexneri is a lack of 
cytochrome bd-I (Way, Borczuk and Goldberg 1999).    
CydDC is also thought to play a role in the virulence of M. tuberculosis and has 
been studied by using a mouse model of infection: bacteria are introduced to the mouse 
lung, resulting in an acute phase of infection followed by a chronic phase. Expression of 
the cydC gene transiently increases during M. tuberculosis infection of a mouse lung, 
which is thought to correspond to the transition from the acute to chronic phase that is 
observed in the mouse model. However, up-regulation of the cydB gene is even more 
dramatic than cydC, suggesting that CydDC and bd-type oxidase structural genes are 
both up-regulated to enhance oxidase assembly required for pathogen adaptation (Shi et 
al. 2005). Disruption of cydC results in a decreased survival in mice during the 
transition to chronic infection, providing evidence that CydDC is required for 
adaptation to conditions within the host (Shi et al. 2005).    
Virulence of B. abortus was found to be significantly attenuated in mice when 
cydC was disrupted by a transposon insertion (Truong et al. 2014). The same mutant 
also displayed heightened sensitivity to respiratory inhibitors and a reduced ability to 
survive and replicate within murine macrophage and HeLa cells. These findings indicate 
that CydDC confers upon B. abortus an ability to cope with the low oxygen availability 
and environmental stresses associated with intracellular growth. Although one might 
assume that the role of CydDC during B. abortus pathogenesis is to permit synthesis of 
cytochrome bd-I, it is interesting to note that a B. abortus cydB mutant can survive up to 
8 weeks in a mouse model, compared to only 3 weeks for a cydC strain. This work 
supports a role for CydDC beyond the synthesis of bd-type oxidases that can facilitate 




1.9 Hypotheses and project aims 
The overarching goal for this work is to gain a deeper understanding of the role of 
CydDC in E. coli. This includes analysing the changes that occur in the cell when 
CydDC is absent, with particular attention to one of the most important phenotypes of a 
cydDC mutant; the loss of functional cytochrome bd-I.  
Since cytochrome bd-I contributes to NO tolerance by virtue of a fast 
dissociation rate, it was hypothesised that CydDC would also have a role in NO 
tolerance due to the requirement of CydDC for cytochrome bd-I functionality. In 
addition to this, the CydDC substrates GSH and cysteine are thiols that can react with 
incoming NO, so it was also anticipated that CydDC might provide a greater 
contribution to NO tolerance than cytochrome bd-I alone. A major aim was to assess the 
relative contribution of CydDC and cytochrome bd-I to NO tolerance. 
The majority of cydDC mutant phenotypes can be restored by one of the two 
known substrates of CydDC, reduced glutathione or cysteine. Phenotypes that can be 
complemented in this way include loss of motility, the sensitivity to dithiothreitol and 
benzylpenicillin as well as the absence of holocytochrome c and periplasmic 
cytochrome b562. The restoration of cytochrome bd-I, however, has not been shown in 
the presence of either reduced glutathione or cysteine at a range of concentrations. Due 
to the promiscuous nature of ABC-type transporters, it was hypothesised that additional 
unknown substrates may exist for CydDC that are required for cytochrome bd-I 
assembly. Alternatively, it was hypothesised that the export of both cysteine and 
glutathione is required for cytochrome bd-I assembly. A major aim was to identify 
conditions that could complement the loss of cytochrome bd-I in a cydDC mutant, and 
then, to gain insights into the physiological changes induced under these conditions via 
performing transcriptomic analyses. 
If CydDC is indeed important for tolerance to NO, one would expect that this 
transporter would have a substantial role in bacterial pathogenesis as loss of CydDC 
would not only elicit NO sensitivity, but would also perturb the redox environment of 
the periplasm leading to a detrimental effect on the folding of extracytoplasmic 
virulence factors. It was therefore hypothesised that CydDC would be important for 
colonisation of the host by pathogenic strains. Hence, another major aim of this work 
was to evaluate the role of CydDC during in vivo survival of clinical isolates using 




Materials and Methods  
 
2.1 Bacteriological methods 
 
2.1.1 Bacterial strains, plasmids and oligoncleotides 
E. coli strains and plasmids as used in this study are listed in Table 2-1. 




Characteristics  Reference or source 
AAEC554 MG1655 fimB+ fimE+ fimL1; 
invertible element locked on 
McClain & Blomfield, 1993 
BGEC487 MG1655 'fim 'lac ȍ>sacB -KanR]; 
Afim 
Kulasekara & Blomfield, 
1999 
MS2 MG1655; Escherichia coli K-12 Bachmann 1996 
MS1 CFT073; UPEC wild type 
pyelonephritis strain 
Welch et al. 2002 
MS5 CFT073 but harbouring pKD46 MS1180 from Prof. Mark 
Schembri 
MS10 EC958; UPEC wild type belonging to 
clonal group sequence type 131, 
CTX-M-15, CMY-23 
Totsika et al. 2011 
MS13 MG1655 cydAB::Km MS3666 from Prof. Mark 
Schembri 
MS14 MG1655 cydDC::Cm MS3671 from Prof. Mark 
Schembri 
MS15 MG1655 cydAB::Cm 
 




MS16 ST131 EC958 cydAB::Cm MS3673 from Prof. Mark 
Schembri 
MS17 CFT073 cydAB::Cm MS3684 from Prof. Mark 
Schembri 
MS52 BW25113 F-, '(araD-araB)567, 
'lacZ4787(del)::rrnB-3, LAM-, rph-
1, '(rhaD-rhaB)568, hsdR514 
Keio collection- Baba et al. 
2006 
MS53 BW25113 cydBȍ.P Keio collection- Baba et al. 
2006 
MS54 BW25113 cydDȍ.P Keio collection- Baba et al. 
2006 
MS115 CFT073 cydDC::Cm This work 
MS271 ST131 EC958 cydDC::Cm. MS19 
with pKOBEG removed 
MS3924 from Prof. Mark 
Schembri 
MS336 MG1655 cydAB- cydDC::Cm This work 
MS3899 EC958 type 1 enriched Prof. Mark Schembri 
MS3907 EC958cydAB::Gm type 1 enriched Prof. Mark Schembri 
MS6016 EC958lac::mkate-Cm type 1 enriched Prof. Mark Schembri 
MS6110 EC958cydDC::Gm type 1 enriched Prof. Mark Schembri 
 
  
Plasmids   
pCP20 FLP+, Ts replicon, AmpR, CmR Cherepanov and Wackernagel 
1995 
pKD3 CmR flanked by FRT sites Datsenko and Wanner 2000 
pKD4 KmR flanked by FRT sites, AmpR Datsenko and Wanner 2000 
pKD46 O-Red recombinase plasmid Ts 
replicon; Ampr 
Datsenko and Wanner 2000 
pKOBEG O-Red recombinase, Ts replicon, 
araC, arabinose-inducible, GmR 
Chaveroche, Ghigo and 
'¶(QIHUW 
 














Name  5' - 3' Sequence  Use Direction 
P1 TCGTTTTGCCGGATTATG
GG 











Mutagenesis primer for cydDC, 
anneals 500bp upstream of 





Mutagenesis primer for cydDC, 
anneals 500bp downstream of 





cydDC fwd screening primer, 
anneals 200 bp upstream of 





cydDC rev screening primer, 
anneals 200 bp downstream of 




cydAB fwd screening primer, 
anneals 200 bp upstream of 




cydAB rev screening primer, 
anneals 200 bp downstream of 




2.1.2 Chemicals and water 
Reagents were purchased from Sigma or Melford (unless otherwise stated).  Nutrient 
agar, yeast extract and tryptone were purchased from Oxoid. Distilled-deionised water 
was used throughout this work.  Milli-Q water was used wherever a greater level of 
purity was necessary.  For RNA work milli-Q water was used, however, it was essential 
that it had been treated with diethyl pyrocarbonate (DEPC) prior to use. 
Media and solutions of a volume in excess of 50 ml were sterilised by autoclaving at 
121oC at 15 psi (pound-force per square inch) for 15 minutes.  Antibiotic stock solutions 
and solutions with a volume of less than 50 ml were filter-sterilised using Millipore 
filters with a pore size of 0.22 Pm. 
 
2.1.4 Oligonucleotide sequences 
Oligonucleotides (Table 2-2) were designed and then checked using OligoCalc: 
Oligonucleotide properties calculator to ensure no secondary structure is present within 
each oligonucleotide and that G/C content is appropriate. Oligonucleotides were 
produced by MWG-biotech.   
 
2.1.5 Media and buffer solutions 
2.1.5.1 Acetonitrile buffer extraction solution  
For metabolite extraction, an extraction solution was made. Acetonitrile and Na+K+ 
buffer (pH 7.4) were mixed together in equal volumes. Na+K+ buffer was made by 
mixing 10 ml 0.1 M NaH2PO4 with 40 ml 0.1 M K2HPO4 and pH was checked.   
2.1.5.2 Defined medium 
Defined media (Flatley et al. 2005) contained 4g K2HPO4, 1g KH2PO4, 1g NH4Cl, 
0.01g CaCl2, 2.6g K2SO4, 5g glycerol per litre (52 mM) supplemented with 0.1% (w/v) 
casamino acids and 10ml trace elements.  
 
Trace elements solution was prepared by dissolving 5g Na2EDTA in 800ml milli-Q 
water, the pH was adjusted to between pH7.0- 8.0. The following were then added; 0.5g 
FeCl2.6H2O, 0.05g ZnO, 0.01g CaCl2.2H2O, 0.01g CoNO3.6H2O, 0.01g H3BO3 and 
0.01g ammonium molybdate. Milli-Q water was used to make up to 1 litre before filter 




1 M MgCl2 stock was added just before use of the media at a final concentration of 1 
mM/ml.  
 
2.1.5.3 Luria Bertani medium  
Luria Bertani medium (LB) medium contained 10g tryptone, 5g yeast extract and 10g 
NaCl per litre. pH was adjusted to 7.0 using NaOH (Sambrook and Russel, 2001). 
 
2.1.5.4 MOPS (3-(N-morpholino)-propanesulphonic acid) buffer 
To prepare a 50x stock solution one litre of DEPC water contained 0.2 M MOPS (pH 
7.0), 20 mM sodium acetate anhydrous and 10 mM EDTA (pH 8.0).  The MOPS was 
first added to 700 ml DEPC-H2O and pH adjusted to 7.0.  The sodium acetate was then 
added to this solution, followed by EDTA which had been dissolved in a small volume 
of DEPC-H2O and adjusted to pH 8.0.  The total volume was then made up to 1l before 
filter sterilising using a Millipore 0.45 Pm filter and stored away from light due to the 
light sensitive nature of MOPS. 
 
2.1.5.5 MOPS minimal media (Neidhardt, Bloch and Smith 1974) 
A 10x stock of MOPS was made by mixing 83.72g MOPS and 7.17g tricine in 300 ml 
milli-Q water, to this 10 M KOH was added dropwise until a pH of 7.4 was reached. 
Water was added to make a volume of 440 ml before the addition of 10 ml 0.01M 
FeSO4.7H2O. The following were then added; 50 ml 1.9 M NH4Cl, 10 ml 0.276 M 
K2SO4, 0.25 ml 0.02 M CaCl2.2H2O, 2.1 ml 2.5 M MgCl2, 100 ml 5 M NaCl, 0.2 ml 
micronutrient stock and 387 ml autoclaved milli-Q water. The 10x stock of MOPS was 
then filter sterilised and aliquoted into flacon tubes as 50 ml portions.  
The micronutrient stock used to make 10x MOPS was made by adding 0.009g 
ammonium molybdate, 0.062 H3BO3, 0.018g CoCl2, 0.006g CuSO4, 0.040g MnCl2, 
0.007g ZnSO4 to 50ml milli-Q water.  
MOPS minimal media was made by mixing 5 ml 10x MOPS stock with 0.132M 
K2HPO4 in 50 ml milli-Q water. pH was adjusted to 7.4 by adding 10 M NaOH 
dropwise. The resulting solution was filter sterilised and stored at 4oC for up to one 







2.1.5.6 M9 minimal media 
1 litre of 5x stock of M9 salts contained; 80.24g Na2HPO4.2H2O, 15g KH2PO4, 2.5g 
NaCl and 5g NH4Cl. M9 media contained 200 ml 5 x M9 salts, 2 ml filter sterilised 1 M 
MgSO4, 100 µL filter sterilised 1M CaCl2, 20 ml filter sterilised 20% glucose and 778 
ml autoclaved water. 
 
2.1.5.7 Potassium phosphate buffer (pH7.4) 
0.1M potassium phosphate buffer (pH7.4) was made by mixing 802 ml of 0.1 M 
K2HPO4 and 198 ml of 0.1M KH2PO4 and checking final pH.  
2.1.5.8 SOB media 
To make SOB media, 20g tryptone, 5g yeast extract, 0.584g NaCl and 0.186g KCl were 
added to 990ml milli-Q water and autoclaved. Once cooled 10ml filter sterilised 2M 
Mg2+ stock was added.  
 
2.1.5.9 SOC media 
To prepare SOC media, 20g tryptone, 5g yeast extract, 0.584g NaCl and 0.186g KCl 
were added to 970ml milli-Q water and autoclaved. Once cooled 10ml filter sterilised 
2M Mg2+ stock was added and 20ml 1M glucose stock.  
 
2.1.5.10 Yeast extract-peptone-glycerol media (YPG) 
YPG media contained per litre milli-Q water; 10g bacto yeast extract (Difco), 20g bacto 
peptone (Difco), and 30 ml glycerol. 
 
2.1.6 Media supplements 
2.1.6.1 Antibiotics 
Media were supplemented, where indicated, with ampicillin (125 Pg/ml), kanamycin 





2.1.6.2 Casamino acid solution 
A 10% (w/v) stock solution of casamino acid solution was prepared by the addition of 
dried casamino acids to water and was then filter sterilised using a 0.22Pm Millipore 
filter.  
 
2.1.6.4 Nutrient agar  
One litre of medium contained 15g dried nutrient agar. 
 
2.1.6.5 Tris buffers 
All Tris buffers contain Trizma base and the resulting buffer was adjusted to the desired 
pH using 1M HCl.   
 
2.1.7 Culture conditions 
Cultures were typically grown at 37oC in LB at an initial pH of 7.0 (Sambrook and 
Russel, 2001).  Cultures were inoculated with 1% (v/v) using an overnight starter 
culture.  Agar plates were inverted and incubated overnight at 37oC. 
Aerated cultures were grown by shaking at 180 rpm in conical flasks containing one-
tenth of their own volume of medium. 
 
2.1.7.1 Measuring culture optical density 
Culture optical density at 600 nm was measured using a Shimadzu UV-1800 
spectrophotometer in cells with a 1 cm path length. 
 
2.1.7.2 Preparing E. coli glycerol stocks 
0.75 ml 50% autoclaved glycerol was pipetted up and down within a fresh cryotube vial 
to make the glycerol more viscous, 0.75 ml stationary phase culture was then added and 







2.1.8 NOC-12 growth curves 
2.1.8.1 NOC-12 Preparation 
Growth curves were carried out using NOC-12 (Calibochem), a donor of nitric oxide. 
NOC compounds are relatively stable NO-amine complexes that spontaneously release 
NO. NOC-12 is a relatively slow releaser of NO with a half-life of 100 minutes at 37oC, 
pH 7.4. In this work NOC-12 was dissolved in 80 mM sodium phosphate buffer (pH 
8.0) and prepared immediately before use. The 80 mM phosphate buffer (pH 8), was 
made by mixing 46.6 ml 80 mM Na2HPO4 with 3.4 ml 80 mM NaH2PO4.H20. The 
buffer was pH checked before being filter sterilised, aliquoted and stored at 4oC. A 
range of NOC-12 concentrations between 0.1 mM and 0.75 mM were used to ensure an 
effect on growth would be observed.  
2.1.8.2 Bacterial growth in the presence of NOC-12 
Initially bacterial strains used were from the Keio collection (Datsenko and Wanner 
2000). Stationary phase cultures grown in defined medium (Flatley et al. 2005) as 
described in Section 2.1.5.2 and supplemented with 0.1 % casamino acids and 
antibiotics where appropriate were used to inoculate fresh defined medium (Flatley et 
al. 2005) which was aliquoted as vROXPHV RI  ȝO LQWR -well plates. Cells were 
grown at 37oC, 200 rpm in a plate reader (SPECTROstar nano) with growth measured 
every 30 minutes at OD600 for 25 hours. Freshly prepared NOC-12 at a volume to give 
the desired final concentration was added to wells after an hour and a half of growth. In 
control wells where NOC-12 was not added, 80 mM sodium phosphate buffer (pH 8.0) 
was added to compensate for the reduction in OD600 of test wells and to ensure no 
growth affect by the buffer. 
 
2.1.9 Yeast Agglutination assay 
A quick method for investigating the expression of Type 1 fimbriae. Yeast strain 
BY4741 (Flatley et al. 2005) was grown at 30oC 180 rpm to stationary phase in 10 ml 
YPG media in a 50 ml falcon tube. The culture was then pelleted at 3500 rpm for 5 
minutes at 4oC and re-suspended in 1ml MOPS, aliquoted in 100 Pl and stored at 4oC 
until needed.  
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For the assay 10 Pl yeast solution was mixed with 10 Pl of E. coli sample (in stationary 
phase after growing at 37oC overnight) on a microscope slide and left for 5 minutes. 
The mixture was analysed using a light microscope (Leica MZ 75). A consistent zoom 
was used to collect all samples. Images were saved at maximum resolution.   
 
2.2 Genetic methods 
 
2.2.1 Isolation of plasmid DNA 
3ODVPLG '1$ ZDV LVRODWHG IURP EDFWHULDO VWUDLQV XVLQJ D :L]DUG3OXV 69 µPLQLSUHS¶
'1$SXULILFDWLRQNLW3URPHJD7KHPDQXIDFWXUHUV¶LQVWUXFWLRQVZHUHIROORZHGIRUXVH
with a centrifugation.  All centrifugation and filtrations were carried out at room 
temperature.  Following the initial pelleting of overnight cultures in an Eppendorf 
centrifuge 5418 at 6,000 x g for 10 minutes, all centrifugation steps were carried out in 
an Eppendorf 5415R microcentrifuge at 13,000 rpm (maximum speed). 
 
2.2.2 Polymerase chain reaction (PCR) 
For colony PCR, a colony was diluted in 50 µl sterile water, and 1 µl of this was used as 
a DNA template in the reaction. A typical reaction contained within a 50 µl volume; 
300 nM (1.5 µl of a 10 µM stock) of each primer (forward and reverse), 1 µl of ready 
mixed 10 mM dNTPs, 5 Pl 10x PCR buffer, and sterile distilled water (roughly 39.5 µl) 
was used to make the end volume 50 Pl. Finally 0.5 Pl Taq polymerase was added to the 
mix and PCR tubes were transferred to a Techne progene PCR machine. The PCR 
programme used was one cycle of 94oC for 4 minutes, then 35 cycles of 94oC for 15 
seconds, 55oC for 30 seconds and 72oC with a time depending on the length of PCR 
product required and polymerase enzyme used. A final elongation at 72oC for 7 minutes 
for one cycle finished the PCR reaction.   
 
2.2.3 DNA electrophoresis on agarose gels 
Electrophoresis was performed in a gel apparatus at a constant voltage of 120 V in 1 x 
TAE buffer (a 1:50 dilution of a 50 x TAE stock solution consisting of 242g Trizma 
base, 57.1 ml glacial acetic acid and 100 ml 0.5M NaEDTA (pH 8.0) per litre giving 
final concentrations of 40 mM Tris-acetate and 1 mM NaEDTA as described in 
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Sambrook and Russell (2001)).  Gels were composed of 1 % agarose dissolved in 1 x 
TAE buffer, and 1 µl of 6x loading dye (New England Biolabs) was mixed with 5 µl of 
sample before being added to gel wells. A 1 kb ladder (Promega) was resolved on each 
gel to determine the size of sample DNA fragments. When the concentration of samples 
was also required, hyperladder 1 (Bioline) was used instead. Gels were stained in 100 
ml water with 5 Pl ethidium bromide, rocking for 30 minutes before visualising bands 
on a UV box.    
 
2.2.4 Ȝ-Red mutagenesis  
The procedure described by Datsenko and Wanner in 2000 was used to replace the 
cydDC operon of E. coli CFT073 with an antibiotic resistance cassette. Recombination 
between the genome and a PCR product was achieved using the phage Ȝ-Red 
recombinase system, which is synthesised under the control of an arabinose inducible 
promoter on an easily curable, low copy number plasmid pKD46. 
 
2.2.4.1 cydDC gene knockout in CFT073 background 
A PCR product was amplified using primers pMS35 and pMS36 with a K-12 
cydDC::Cm strain used as a template to produce a fragment consisting of the 
chloramphenicol cassette flanked either side by 500 bp of the sequences before and after 
the cydDC operon. This PCR product was then concentrated and purified by excision on 





Figure 2-1. Ȝ-Red mutagenesis  
Strategy used to disrupt gene VHTXHQFHXVLQJȜ-Red recombinase expression. 1. Primers 
(pMS35 and pMS36, Table 2-2) were designed to produce, via PCR, a DNA fragment 
encoding the chloramphenicol resistance cassette flanked by 500 bp regions 
homologous to areas flanking gene X (orange). 2. DNA fragment was transformed into 
FHOOV H[SUHVVLQJ Ȝ-Red recombinase to encourage recombination between the DNA 
fragment and the genome. 3. Transformants were selected on antibiotic plates. 4. The 
resistance cassette of transformants was excised by the plasmid-encoded FLP 
recombinase which acts upon the FRT (FLP recognition target) repeats that flank the 
resistance gene. 
 
2.2.4.2 Preparation of electro-competent cells 
Competent cells were made using a recipient strain (MS5) containing the temperature 
sensitive plasmid pKD46 (AmpR) that comprises the O-Red recombinase to enhance 
recombination between the PCR product and the genome. In a 250 ml conical flask 
containing 50 ml SOB media supplemented with ampicillin and 20 mM arabinose, 
recipient strain cells were grown at 28oC, 180 rpm until an OD600 between 0.4- 0.8 was 
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reached. From this point on the cells were kept cold. Cells were transferred to chilled 50 
ml falcon tubes and spun at 3000 x g at 4oC for 10 minutes. Supernatant was removed 
and the pellet was re-suspended in 5 ml ice-cold 10% glycerol by gently pipetting up 
and down with cut 1ml pipette tips. Cells were washed in 10% ice-cold glycerol in this 
way three more times before being re-suspended in a final volume of 200 µl 10% ice-
cold glycerol, this was kept on ice until it was used in electroporation.   
2.2.4.3 Transformation by electroporation 
The concentration of PCR product was measured via nanodrop to determine the volume 
needed to add 1000 ng of DNA. This calculated volume was then placed into a chilled 2 
mm electroporation cuvette. Then 50 µl of competent cells were added and the cuvette 
tapped to ensure the mix moved to the bottom of the cuvette. The electroporator was set 
WR N9 ZLWK D UHVLVWDQFH RI  ȍ DQG D FDSDFLW\ RI  ) WKH FXYHWWH ZDV WKHQ
placed into shocking chamber for pulsing.   
1 ml SOC media was added immediately to aid cell recovery and cell mix was 
transferred to a 1.5 ml Eppendorf tube and incubated at 37oC 180 rpm for one hour. 
Cells were then plated onto chloramphenicol LB plates to select for transformants. 
Resulting colonies were checked by colony PCR using primers pMS3 and pMS4. 
2.2.5 Sequencing of DNA 
DNA samples were sequenced by Source Bioscience and were then examined and 
aligned using the sequence analysis program BioEdit (7.2.5).  
 
2.2.6 Curing of Chlorampenicol resistance cassette  
To create the cydDC cydAB double mutant used in microarray experiments, a single 
mutant needed to be cured of the resistance cassette so that a second deletion could be 
detected.  
This process required the pCP20 plasmid (Table 2-1) which encodes a flippase enzyme 
(FLP) for removal of the antibiotic resistance cassette. pCP20 is ampicillin and 
chloramphenicol resistant and also shows temperature-sensitive replication and thermal 






2.2.6.1 Preparation of competent cells (Brachmann et al. 1998). 
Cells were grown in 10ml LB overnight at 37oC, 28 µl of this culture was then used to 
inoculate 28 ml pre-warmed LB (37oC) and then incubated shaking at 37oC until an 
OD600 of ~0.48 was reached. A volume of 3.75 ml warm sterile 100% glycerol was 
added drop-wise to cells while swirling to aid mixing. Cells were then chilled on ice for 
10 minutes before pelleting at 4oC 4000 rpm. The supernatant was removed and the 
pellet was re-suspended in 25 ml ice-cold magnesium chloride solution (freshly made 
before use from 2.5 ml 1M MgCl2, 3.75 ml sterile 100% glycerol made up to 25 ml with 
milli-Q water). Cells were pelleted again for 8 minutes at 4oC 3800 rpm before being re-
suspended in 6.25 ml ice-cold T-salts solution (freshly made before use by mixing 1.5 
ml sterile 100% glycerol, 0.75 ml 1M CaCl2, 0.06 ml 1M MgCl2, made up to 10 ml with 
milli-Q water). Cells were pelleted one last time for 6 minutes 4oC 3600 rpm before 
being re-suspended in 1.25 ml ice-cold T-salt solution. Cells were aliquoted into 100 µl 
volumes into pre-cooled Eppendorf tubes and stored immediately at -80oC. Cells were 
left at -80oC overnight before being used.  
2.2.6.2 Transformation with plasmid 
100 µl of competent cells were mixed with 2 µl plasmid solution, this mixture was then 
incubated on ice for 30 minutes before being heat shocked at 42oC for 30-60 seconds in 
a heat block.  A volume of 1 ml SOC medium was then added immediately to cells to 
aid recovery, before incubating for a further one hour, shaking (180 rpm) in a water bath 
at 28oC. A volume of 200 µl was plated onto ampicillin Luria Bertani (LB) plates to 
select for pCP20. Ampicillin resistant colonies were then grown for 3 hours in LB at 
42oC, plated out onto plain LB plates and further grown overnight at 42oC to ensure 
removal of the pCP20 plasmid. Colonies were picked and streaked onto LB, LB-
ampicillin and LB-kanamycin plates. Colonies that could only grow on LB plates were 
expected to be cured of the kanamycin resistance cassette as well as the pCP20 plasmid, 
and so were grown and glycerol stocked. The removal of the cassette was then checked 
by PCR.  
 
2.2.7 Microarray analysis 
All reagents were prepared using milli-Q water treated with 0.1% DEPC stirring 
overnight to remove RNases that may degrade RNA. After overnight treatment, DEPC 
milli-Q water was autoclaved to eliminate toxicity. The microarrays detailed in this 
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work were cDUULHGRXWXVLQJDµ7ZR-Colour Microarray-%DVHG3URNDU\RWH$QDO\VLV´E\
Agilent Technologies, Inc. 2009. All solutions described in Section 2.2.7.6 were 
obtained from Agilent Technologies, unless otherwise stated. 
 
2.2.7.1 Growth conditions 
Strains used in the microarrays had an MG1655 background. Starter cultures (10 ml) 
were grown to stationary phase in LB with chloramphenicol (25 µg/ml), 0.5 ml was 
used to inoculate 50 ml of defined chemostat medium supplemented with 0.1% (w/v) 
casamino acids. Cells were grown in triplicate in 250 ml conical flasks at 37oC 180 rpm.  
2.2.7.2 Sampling and RNA stabilisation  
Once an OD600 of 0.4 was reached, 30 ml of culture was removed and added to 187.5 µl 
chilled phenol and 3.56 ml chilled ethanol and immediately mixed by vortex for 5 
seconds. After incubating on ice for 5 minutes, samples underwent centrifugation at 
5500 x g (7000 rpm) for 5 minutes at 4oC. Supernatant was removed and remaining 
pellet was stored at -80oC. 
 
2.2.7.3 RNA isolation 
RNA was isolated from pelleWV XVLQJ D 4LDJHQ µ51HDV\ 0LQL .LW¶ DFFRUGLQJ WR WKH
PDQXIDFWXUHU¶V LQVWUXFWLRQV 6DPSOH SHOOHWV ZHUH WKDZHG RQ LFH WKHQ UH-suspended in 
200 µl of TE buffer containing lysozyme (1mg/ml) and vortexed for 10 seconds 
followed by an incubation at 25oC  shaking (180 rpm) for 5 minutes. RLT buffer (700 
µOFRQWDLQLQJȕ-mercaptoethanol (10 µl/ml) was added before vigorous vortexing and 
the addition of 0.5ml 100% ethanol. Mixed by pipetting, the lysates were applied to 
RNeasy Mini columns placed in a 2ml collection tube, then centrifuged for 15 seconds 
at 10,000 rpm and the flow through was discarded. Buffer RW1 (350 µl) was added to 
the column, followed by centrifugation for 15 seconds at 10,000 rpm, the flow through 
was discarded. To remove DNA a mixture of 10 µl DNaseI and 70 µl buffer RDD was 
added directly onto the RNeasy silica gel membrane and incubated at room temperature 
for 15 minutes. After digest, buffer RW1 (350 µl) was added to the column and a 
further 5 minute room temperature incubation before centrifugation for 15 seconds at 
10,000rpm. Both the flow through and collection tube were discarded. Transferred to a 
fresh 2ml collection tube, the column was washed twice with 500 µl buffer RPE. The 
column was transferred to a fresh, RNase free 1.5 ml Eppendorf tube, 30 µl of RNase 
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free water was pipetted directed onto the RNeasy silica gel membrane before 
centrifugation at 10,000 rpm for 1 minute. To increase RNA yield, the eluate was 
replaced onto the membrane with a 1 minute pause before repeating the centrifugation 
at 10,000 rpm for 1 minute. A volume of 2 µl of the RNA was aliquoted while the rest 
was stored at -80oC.  
 
2.2.7.4 RNA determination 
The concentration of RNA was determined using a Nanodrop ND-1000 UV-VIS 
spectrophotometer accompanied with programme ND-1000 version 3.1.2. After 
blanking the instrument with 2 µl nuclease free water, 2 µl of RNA sample was added 
to the pedestal, and its concentration and purity measured.  The ratio of OD260 /OD280 
should be around 2, if lower, this may suggest contamination from protein and the 
sample would have been discarded, this however was not necessary. 
 
2.2.7.5 Complementary DNA (cDNA) synthesis 
For each sample, 12.3 µl RNA (16 µg) was incubated in a PCR block with random 
primers (5 µg) at 72oC for 10 minutes and then chilled on ice for a further 10 minutes. 
For cDNA synthesis, primed RNA was added to a reaction mix consisting of 6 µl 5x 
first strand buffer (Invitrogen), 3 µl 0.1M DTT (Invitrogen) 0.6 µl 50x dNTP master 
mix (0.1 mM dATP, dGTP, dTTP and 0.05 mM dCTP) (Roche) and 2.9 µl nuclease free 
water (Qiagen). Samples were then taken into a dark room, and treated with 2 µl of 
either Cy3 or Cy5 dye (with a technical repeat for each, where the dyes were swapped.) 
Superscript III (1.5 µl 200U µl-1) was added to each sample followed by 5 minutes 
incubation at 25oC. Samples were then taken from dark room for an overnight 
incubation in a PCR machine at 50oC. RNA was hydrolysed by addition of 15 µl freshly 
prepared 0.1M NaOH and incubation at 72oC for 10 minutes. To neutralise samples, 
freshly prepared 15 µl 0.1M HCl was added. The labelling reactions were clean up 
using a QIAquicN 3&5 SXULILFDWLRQ NLW 4LDJHQ DFFRUGLQJ WR PDQXIDFWXUHU¶V
instructions. Buffer PB (without pH indicator) was added to samples at a volume ratio 
of 5:1 and inverted to mix. The mix was then transferred to a spin column in a 2 ml 
collection tube and centrifuged for 1 minute at 10,000 rpm. The flow through was 
discarded and the column was washed twice with 750 µl buffer PE. To ensure the 
removal of all liquid, the column was replaced into the same collection tube and 
centrifuged for a further 1 minute at 10,000 rpm. For cDNA elution, the column was 
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transferred into a fresh nuclease free 1.5 ml Eppendorf, 50 µl of nuclease free water was 
applied to the centre of the membrane and centrifuged for 1 minute at 10,000 rpm. To 
measure concentration of single stranded cDNA, 1.5 µl of labelled cDNA was 
denatured by heating to 95oC for 5 minutes. cDNA was quantified by using a Nanodrop 
ND-1000 UV-VIS spectrophotometer version 3.2.1 against a nuclease-free water blank. 
Samples were suitable for hybridisation if the yield was over 400 ng.  
 
2.2.7.6 Hybridisation of labelled cDNA to array slides 
An appropriate volume of each cDNA was calculated to give a final concentration of 
400 ng. 400 ng of Cy3- labelled cDNA was added to 400 ng of Cy5-labelled cDNA for 
each dye swap, the total volume was then made up to 20 µl using nuclease free water. 
Samples were boiled at 100oC for 2 minutes, then placed onto ice for 2 minutes before 
being placed at room temperature for a further 2 minutes. Samples were centrifuged 
briefly to collect condensation from around the edge of the tubes. Ensuring that no air 
bubbles were introduced to the mixture, 5 µl 10x blocking agent and 25 µl GEx 
hybridisation buffer were added to make a final volume of 50 µl. The samples were 
centrifuged for 1 minute at 13000 rpm before loading onto slides.  
A clean gasket slide was placed into the Agilent SureHyb chamber base with the 
µ$JLOHQW¶ ODEHO IDFLQJ XSZDUGV  O RI K\EULGLVDWLRQ VDPSOH ZDV VORZO\ GLVSHQVHG
onto the gasket, ensuring that the tip of the pipette did not directly touch the slide. The 
arUD\ZDVWKHQSODFHGµDFWLYHVLGH¶GRZQRQWRWKH6XUH+\EJDVNHWVOLGHVRWKDWWKHslide 
went over the gaskets flat, preferably with no air bubbles as this would hinder 
hybridisation. The SureHyb chamber cover was then placed onto the sandwiched slides 
and clamped together. The assembled chamber was then placed into a hybridisation 
oven set to 65oC, rotating at 10 rpm for 17 hours.  
The array-gasket sandwich was removed from the hybridisation chamber and 
submerged in wash buffer 1 at room temperature. The sandwich was prised open. The 
exposed array slide was then transferred to fresh buffer 1 in a dish with a magnetic 
stirrer to stir the buffer for 1 minute. The array slide was then transferred to a dish 
containing pre-warmed buffer 2 (37°C), and the buffer was stirred for 1 minute. The 
slide was then scanned immediately (to minimise the impact of environmental oxidants 
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on signal intensities) in an Agilent DNA microarray scanner. Data was extracted using 
Agilent software ready for analysis in GeneSpring (v13.1).    
2.2.7.7 Data analysis of Microarrays  
The average signal intensity and local background correction were obtained using 
GeneSpring software (v13.1). The mean values from each channel were transformed 
and normalised using the Lowess method to remove intensity-dependent effects in the 
log2 (ratios) values.  The Cy3/Cy5 fluorescent ratios were calculated from the 
normalised values.  Biological experiments, were carried out twice and dye-swap 
analysis performed on each experiment providing four technical repeats, two from each 
biological experiment. Genes differentially regulated t2 fold and exhibiting P-values of 
d0.05 (by means of t-test) were defined as being statistically and differentially 
transcribed. 
2.2.7.8 Modelling changes in transcription factor activities that result from 
exogenous addition of GSH and cysteine 
Mathematical modelling of the microarray data was carried out using TFinfer version 
2.0 (Shahzad Asif et al. 2010). This open access programme is based on a state space 
model and enables the activity of transcription factors to be inferred from gene 
expression data obtained from microarray experiments. The complete transcriptomic 
data-sets obtained from GeneSpring were used for the analysis; therefore no limitations 
with regard to gene expression level were enforced prior to the application of TFinfer.  
Data was input alongside a null hypothesis consisting of zeros, the output data 
from TFinfer was then compared to thiV QXOO K\SRWKHVLV µGDWD¶ 7UDQVFULSWLRQ IDFWRUV
with a difference between the null data set larger than 2 were considered significant.  
TFinfer cannot assign whether activity of transcription factors is up or down, so this has 
to be corrected manually. To do this information on transcription factor function was 
obtained from Ecocyc and RegulonDB, this involved looking at the genes with each TF 
regulon and finding out if the TF acts as a repressor or activator of transcription. Fold-
changes of genes within the regulons of significant transcription factors were looked at 
in the raw data to see if fold-changes were positive or negative, and depending upon 
whether the TF is an activator or repressor, activity signs could be determined, for 
example; if a transcription factor acts as a repressor to genes with a positive fold-
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change, it can be concluded that the transcription factor activity is reduced, and a 
negative sign is manually placed in front of the change in activity value.  
 
2.3 Biochemical methods 
2.3.1 CO difference spectra 
10 ml LB cultures (with appropriate antibiotics) were grown at 37oC and 180 rpm 
overnight. Overnight cultures were then used to inoculate 100 ml LB in 250 ml conical 
flasks. Cells were grown to stationary phase at 150 rpm 37oC. Two 45 ml samples were 
taken from each conical flask and cells were harvested at 4000 rpm for 10 minutes at 
4oC before being re-suspended in 1 ml 0.1 M potassium phosphate buffer (pH 7.4). 
Further dilutions were made where required to generate appropriate cell densities for 
ZKROH FHOO µ&2 UHGXFHG¶ minus µUHGXFHG¶ VSHFWUD LH &2 GLIIHUHQFH VSHFWUD WR EH
recorded. 
A custom-built SDB4 dual wavelength scanning spectrophotometer was used 
(Sambrook, Fritsch and Maniatis. 1989) to obtain CO minus reduced difference spectra 
(400nm- 700nm) at room temperature. The whole cell samples were first reduced with 
sodium dithionite and scanned, then bubbled with CO gas for five minutes before being 
VFDQQHGDJDLQ(DFKUHGXFHGUHDGLQJZDVWKHQVXEWUDFWHGIURPWKHFRUUHVSRQGLQJµ&2
UHGXFHG¶UHDGLQJ to give a CO difference spectrum. 
 
2.4 1H NMR metabolomics  
2.4.1 Growth of cells  
4 ml of stationary phase culture was used to inoculate 400 ml defined medium (Flatley 
et al. 2005) supplemented with 0.1 % casamino acids in 2 litre flasks. Six flasks for wild 
type, six flasks for cydD. Cells were grown at 37oC 180 rpm to emulate the microarray 
growth conditions. 
2.4.2 Metabolite extraction  
Cells were harvested at an OD600 of 0.4 by centrifugation (6000 rpm 5 minutes 4°C) and 
the supernatant was decanted. The cell pellet was washed three times with 1 ml of ice-
cold phosphate buffered saline (PBS), and cells were then snap frozen with liquid 
nitrogen and stored at -80oC until metabolite extraction. Frozen samples were 
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homogenised in 600 µl ice-cold acetonitrile buffer extraction solution (Section 2.1.5.1). 
Homogenates were then snap frozen in liquid nitrogen and subjected to three rounds of 
freeze-thaw cycles with vigorous pipetting and vortexing. Samples were then sonicated 
on ice with two seconds pulse/two seconds rest for 99 cycles. Sonicated samples were 
centrifuged for 10 minutes at 12000 rpm 4oC, and the supernatant collected. The 
remaining pellet was re-suspended in 500 µl acetonitrile extraction solution and 
vortexed for further metabolite extraction, and the resultant supernatant was pooled with 
that from the first extraction. The supernatants were condensed using a vacuum 
desiccator to remove acetonitrile, and samples were then stored at -80oC until NMR 
analysis.  
2.4.3 Proton NMR data collection 
Samples were dissolved in a mixture of 590 µl deuterated water (D20) and 10 µl 6 mM 
DSS (4,4-dimethyl-4-silapentane-1-sulfonic acid) (added as an internal standard to 
calibrate the chemical shift). After centrifugation for 2 minutes at 14000 rpm to clear 
any debris, 550 µl of this mixture was pipetted into NMR tubes (5 mm outer diameter) 
for 1D (one dimensional) proton NMR spectroscopy. 
All spectra were recorded at 37°C on a UnityINOVA 600 MHz NMR 
spectrometer (Varian Inc, Palo Alto, CA, USA). All spectra were referenced to DSS at 
0.00 ppm. Spectra were recorded over 32768 points, 512 transients and a spectral width 
of 8004.8 Hz. An acquisition time of 2.047 seconds and a relaxation delay of 1.5 
seconds were used. This produced a total experimental time of 31 minutes that enabled 
efficient and fast data acquisition with minimal effects resulting from relaxation. Areas 





2.5 In vivo methods 
2.5.1 Mouse UTI studies  
Mouse infection experiments (Roos et al. 2006) were performed as competition 
experiments; wild type and mutant bacteria were mixed in equal cell numbers before 
introducing into the bladders of mice transurethrally. This allowed the virulence of 
cydDC mutants to be directly compared with the wild type cells. For this experiment 15 
mice were used.  
Urine was collected from female C57BL/6 mice (aged between 8-10 weeks) 24 
hours prior to microbial infection to identify mice with pre-existing conditions. Mice 
found to have a combination of 5x102 CFU bacteria and 2x105 white blood cells/ml 
were excluded from the study.  
Strains EC958lac::mkate-Cm type 1 enriched (MS6016, wild type) and 
EC958cydDC::Gm type 1 enriched (MS6110, Table 2-1) were cultured statically at 
37°C overnight in 100 ml LB broth in 500 ml flasks, (two flasks for each strain). 
Stationary phase cells were harvested in 50 ml falcon tubes and were centrifuged at 
9,000 x g for 6 minutes at 20°C, washed twice with 30 ml phosphate-buffered saline 
(PBS), re-suspended in 25 ml PBS and samples of the same strains were combined, 
harvested and finally re-suspended in approximately 1 ml of PBS. Strains were 
diluted/concentrated so that 1 ml concentrated cell suspension had an OD600 =100 (10 
µl/ 990 µl dilution has an OD600 of 1). A 400 µl volume of wild type cells was mixed 
with 400 µl of the mutant strain cells in an Eppendorf with 8 µl Indian ink at a final 
concentration of 1%.  From this mix, 200 µl was taken to perform colony counts on and 
the remaining bacterial sample was supplied for mouse infection. 
 
To document exact numbers of CFU in the inoculum supplied for mouse 
infection, a 10-fold dilution series of the bacterial suspension was performed in PBS. 
Dilutions down to 10-9 were plated out; 10-9 dilution was spotted in triplicate of 20 µl 
and 10-8 and 10-7 dilutions were spotted in triplicate of 5 µl volumes. Colony counts 
were performed the next day  
 
For mouse infection; mice were anaesthetised by brief inhalation exposure to isoflurane, 
and the periurethral area was sterilised by swabbing with 10% povidone-iodine solution, 
this was then subsequently removed with PBS. Mice were catheterised by inserting a 
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sterile Teflon catheter device directly into the bladder through the urethra, 30-40 µl PBS 
containing a mixture of wild type and mutant E. coli with 1% India ink (to visualise 
inocula at autopsy) was instilled transurethrally into the bladder using a 1 ml syringe 
attached to the catheter. The catheter was removed after inoculation and the mice were 
then returned to cages for recovery. At 24 hours post-infection urine samples were 
collected and mice were euthanised, bladders and kidneys were removed aseptically to 
be weighed and homogenised in PBS using sterile ball bearings and a tissue lyser. 
Serial 10-fold dilutions to 10-9 were made (in PBS) of urine and homogenised 
tissue samples (bladder and kidney), and 5 µl volumes were spotted in triplicate onto 
LB, LB- chlorampenicol and MacConkey agar plates. Plates were incubated overnight 
to allow bacterial growth. The next day bacterial colonies were counted including the 
number of white (EC958lac::mkate-Cm type 1 enriched) and red colonies 
(EC958cydDC::Gm type 1 enriched) on MacConkey plates and the results analysed 
using Prism software. 
 
2.5.2 Macrophage survival assay 
Hemapoietic stem cells were harvested from C57BL/6 mice as previously described by 
Tushinski et al. 1982 with 1 x 104 U/ml recombinant human CSF-1 (colony stimulating 
factor-1) to promote differentiation into bone marrow-derived macrophage (BMM) 
cells. BMMs were maintained in RPMI 1640 (Roswell Park Memorial Institute 1640 
medium) (Invitrogen, Carlsbad CA, USA) supplemented with GlutaMAX-I 
(Invitrogen), 10% heat inactivated foetal calf serum (Invitrogen), 20 U/ml penicillin and 
20 µg/ml streptomycin (Invitrogen). Once differentiated into macrophages, cells were 
harvested, and using a haemocytometer, cell counts were performed to achieve 
approximately 200,000 BMM cells per well in three 24-well plates. The three plates 
were set up in tandem as shown in Figure 2-2, and the macrophage cells they contained 
were harvested at different times post infection to allow for three time point 
measurements of infection. Cells were left to adhere to wells overnight in antibiotic-free 
RPMI 1640 medium at 37oC 5% CO2. The next day, BMMs were infected at a 
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Figure 2-2. Layout of 24-well plate used for macrophage survival assay 
The layout used to fill three 24-well plates used per macrophage survival assay. Control 
well contained BMMs cells without bacteria. Other wells contained wild type EC958 
(3899), EC958cydAB (MS3907) mutant and EC958cydDC (MS6110) mutant cells as 
depicted.  
 
All three plates were taken out of the incubator after 30 minutes of the BMMs being 
infected, any bacteria which had not been taken up by macrophages were killed by 
washing and replacing media with gentamycin-containing (200 µg/ml) media. To 
determine the uptake of bacteria into macrophage cells at this time, one of the three 24 
well platHV NQRZQ DV WKH µXSWDNH¶ SODWH KDG WKH DQWLELRWLF PHGLD UHPRYHG DQG FHOOV
were washed with antibiotic free media. Macrophage cells were lysed open by replacing 
WKH PHGLD ZLWK  ȝO  WULWRQ ;-100, left to incubate for 5 minutes at room 
temperature, then pipetted with vigour. This released the bacteria from within the 
macrophage cells. Only the macrophage cells were disrupted at this concentration of 
triton X-100 as prokaryotic E. coli cells which have two membranes surrounding the 
cells are more robust. Bacterial loads (CFU/ml) were then quantified via serial dilution 
(10-1 to 10-7) and spotting in triplicate onto Luria Bertani (LB) agar plates. Plates were 
then incubated overnight. The survival of intra-macrophage bacteria were determined 
by counting cell colonies released from macrophage cells.  
After two hours the number of bacterial cells were counted from one of the 
remaining 24-ZHOOSODWHV7KHVHWZRSODWHVDUHFDOOHGµVXUYLYDO¶Slates, as they allow the 
number of intra-macrophage bacterial cells to be counted once uptake into macrophages 
has been stopped by the addition of antibiotics to the media which kills extra-
macrophage cells. After 24 hours of infection, the third 24-well plate was taken from the 




2.5.2.1 Type 1 fimbrial phase switch promoter PCR  
 
When the fim VZLWFKLQYHUWLEOHHOHPHQWLVLQWKHµRQ¶RULHQWDWLRQfimA is transcribed and 
fimbriae are produced by cells. This PCR reaction is a diagnostic tool to determine 
which orientation the fim switch is in. Each PCR is run in duplicate. 1 µl of stationary 
phase culture is used as template and added to 2.5 µl 10x NEB Taq buffer, 1 µl 5 mM 
dNTP, 0.25 µl 25 µM primer P1 (Table 2-2), 0.25 µl 25 µM primer P2 (Table 2-2), 
20.88 µl milli-Q water and finally 0.125 µl NEB Taq polymerase. PCR reactions were 
incubated at 94oC for 2 minutes followed by 35 thermal cycles of 94°C (1 minute), 55oC 
(1 minute), 72oC (1 minute).  Samples of each PCR reaction were digested with HinfI in 
NE buffer overnight at 37oC. Digested and undigested samples were then resolved on a 
2% agarose gel.  
 
As shown in Figure 2-3A, HinfI-digested PCR products produce bands of 130 bp and 
ESZKHQWKHVZLWFKLVLQWKHµRQ¶RULHQWDWLRQDQGEDQGVRIESDQGESZKHQ
LQWKHµRII¶RULHQWDWLRQ$FRPELQDtion of the four bands seen in Figure 2-3B, shows that 
WKHUH LV D PL[WXUH RI FHOOV LQ WKH µRQ¶ DQG µRII¶ RULHQWDWLRQ ZLWKLQ D SRSXODWLRQ )RU
mouse and macrophage assays, this PCR and subsequent digest were used to check that 




































Figure 2-3. Digestion of PCR product indicates orientation of fim switch  
A schematic diagram of PCR-amplified fim switch (fimS GHSLFWV WKDW LQ WKH µRQ¶
orientation Hinfl digestion produces DNA of 130 bp and 511 bp but when the switch is 
inverted (i.e. off), products of the Hinfl digest are changed to 411 bp and 230 bp. B 
Visualisation of bands produced after digestion with Hinfl on an agarose gel. Lane 1 
shows an uncut DNA fragment and lane 2 shows HinfI digested fragments, displaying a 
PL[WXUHRIµRQ¶ DQGµRII¶RULHQWDWHGfim switches as indicated by the presence of all four 











Characterisation of the cydDC 
phenotype: NO tolerance, cytochrome 






Consistent with previously reported data, the work herein demonstrates that loss of 
cytochrome bd-I elicits sensitivity to NO. As CydDC is required for the assembly of this 
respiratory oxidase it was expected that a mutant of CydDC would be as sensitive to NO 
as a cytochrome bd-I mutant. A cydD mutant was not only sensitive to NO but was 
more sensitive than a cytochrome bd-I (cydB) mutant, suggesting that CydDC provides 
additional NO tolerance beyond the role of cytochrome bd-I. It was then hypothesised 
that additional CydDC-mediated protection against NO toxicity was provided by the 
presence of cysteine and glutathione in the periplasm which are exported by this 
transporter: these thiols are known targets of NO that could hinder the diffusion of this 
toxic radical into the cytoplasm. To test this hypothesis, exogenous glutathione and 
cysteine were added to the growth medium of cydDC cells, which alleviated the level of 
NO-sensitivity to a level resembling that of a cytochrome bd-I mutant. This suggests 
that CydDC-mediated reductant export contributes to protection against NO toxicity 
both by permitting the assembly of cytochrome bd-I and by a more direct mechanism 
(i.e. by reacting with incoming NO).  
It is intriguing that many of the phenotypes of a cydDC mutant can be corrected 
by the addition of cysteine or glutathione to the growth medium (Pittman et al. 2002; 
Pittman, Robinson and Poole 2005), except cytochrome bd-I synthesis, that cannot be 
restored by the addition of glutathione or cysteine alone. Herein, it is demonstrated for 
the first time that addition of both glutathione and cysteine is necessary to restore the 
assembly of cytochrome bd-I. To further investigate the pleiotropic cydDC phenotype, 
the metabolome of wild type cells was compared to that of cydD cells through 1D-1H 
NMR analysis. This showed that loss of CydDC leads to changes in metabolite levels 
including; the elevation of L-methionine and fumarate along with the reduction of 
succinate, D-mannitol, acetate and NAD. The only metabolite with peak intensities that 
are significantly different between the two strains above the 99% level after an unpaired 
t-test was performed was betaine, with an increase in cydD cells. These data 
complement existing cydD vs. wild type microarray data, and provide molecular 





To combat infection, the mammalian immune system releases NO, a free radical that is 
toxic to invading bacteria (Fang 2004; Lundberg et al. 2004; Poole and Hughes 2000). 
E. coli has two well-characterised terminal oxidases of aerobic respiration; cytochromes 
boƍ and bd-I. Both catalyse the two-electron oxidation of ubiquinol by molecular oxygen 
within the cytoplasmic membrane but differ with respect to the efficiency of proton 
translocation and pattern of expression (Ingledew and Poole 1984). Mason et al. (2009) 
have also shown that these respiratory oxidases differ in their tolerance to NO; 
cytochrome bd-I activity is more resistant to nitric oxide than cytochrome boƍ due to a 
fast NO dissociation rate, permitting oxygen reduction to continue in the presence of 
NO. As cytochrome bd-I has a very high affinity for oxygen '¶PHOOR+LOODQG3RROH
1996) and is maximally expressed under microaerobic conditions (Tseng et al. 1996), it 
is expected that pathogenic bacteria rely upon this terminal oxidase for respiration 
within the oxygen limiting environment of the host. This role as oxygen scavenger, 
taken together with the tolerance to NO, cytochrome bd±I has been linked to the 
virulence of certain bacterial pathogens. In fact, a range of bacterial pathogens have 
been shown to express bd-type oxidases including Listeria monocytogenes (Larsen et al. 
2006), B. abortus (Loisel-Meyer et al. 2005), Bacteroides fragilis (Baughn and Malamy 
2004) and S. flexneri. Furthermore, bd-type terminal oxidases have been observed to be 
so vital to pathogen survival during host colonisation that the loss of this oxidase results 
in attenuation of virulence of some pathogens including Salmonella (Turner et al. 2003) 
and group B Streptococcus (Y. Yamamoto et al. 2005). The connection between 
virulence and cytochrome bd-I is discussed further in section 1.6.5. 
 
A significant phenotype of cydDC mutants is their inability to assemble 
cytochrome bd-I (Bebbington and Williams 1993; Georgiou, Hong and Gennis 1987; 
Poole, Gibson and Wu 1994; Poole et al. 1993). Given that the deletion of cytochrome 
bd-I has been shown to elicit sensitivity to NO (Mason et al. 2009), it is expected that 
cydDC mutants will also be sensitive to NO due to an inability to assemble functional 
cytochrome bd-I. The experimental approaches in this chapter are designed to test this 
hypothesis by using the NO-donor molecule NOC-12 to impose nitrosative stress upon 
a series of E. coli knockout strains. In addition, spectroscopic tools and metabolomics 




3.1.1 Nitric oxide releasing compound NOC-12  
NOC-12 is a nitric oxide-amine complex that can spontaneously release nitric oxide 
under physiological conditions without the need for a cofactor. Decomposition of NOC-
12 is elicited by protonation of the oxygen of the NO group and results in the release of 
two molecules of NO per molecule of NOC-12 (Hrabie et al. 1993), the release rate of 
the second NO molecule is much slower than that of the first (Figure 3-1). NOC-12 has 
a similar structure to two other NO releasing compounds; NOC-5 and NOC-7 but with a 
much longer half-life of NO release. The benefits of using NOC compounds is that their 
NO generation is simpler than other classical NO donors, such as GSNO, and the by-
products are thought not to interfere with cell physiology. Decomposition of NOC 
compounds is faster in acidic solutions (Aga and Hughes 2008); stock solutions were 
therefore prepared in an 80mM sodium phosphate buffer (pH 8). Temperature also 
affects the half-life of NOC-12, at pH7 37°C the half-life of NOC-12 is 100 minutes, 
reducing the temperature to 22°C extends the half-life to 327 minutes (Hrabie et al. 






Figure 3-1. Nitric oxide release from NOC-12  
The reaction scheme above shows how the protonation of NOC-12 leads to the release 
of two nitric oxide molecules. It is thought that the release rate of the second NO 
molecule is much slower than the first. 
 
  
         
         H H+ 




3.2.1 Loss of functional CydDC elicits sensitivity to nitric oxide 
To investigate whether the loss of CydDC would elicit sensitivity to nitric oxide, growth 
curves for wild type (MS52), cydD (MS54), and cydB (MS53) K-12 Keio strains (Table 
2-1) were performed using a plate reader as described in section 2.1.8. Following the 
addition of NOC-12, growth was inhibited for a finite period after which growth 
resumed, probably due to adaptation of the cells and/or depletion of the NOC-12 
(Figure 3-2 $V H[SHFWHG WKLV µODJ WLPH¶ DSSHDUV to be dependent upon the 
concentration of NOC-12 used. One way to directly compare the inhibition by NOC-12 
across the three strains is to look at the time taken to reach a particular OD600 value (e.g. 
an OD600 of 0.1 is used in Figure 3-3). Since normal growth rates are observed 
following the lag time, it was not sensible to calculate doubling times as a measure of 
NO sensitivity. After the addition of 0.1 mM and 0.2 mM NOC-12 the difference in 
time taken for wild type cultures to reach an OD600 of 0.1 is very small. Wild type 
growth remained unaffected in the presence of 0.1 mM NOC-12, with growth 
comparable to that in the absence of NOC-12. This indicates that wild type cells are able 
to adapt to this level of nitrosative stress. However, addition of NOC-12 in the absence 
of cytochrome bd-I or CydDC increases the time taken to reach an OD600 of 0.1 by one 
hour or 3 hours, respectively. This suggests that the protection from NO in wild type 
cells is compromised in the absence of these two protein complexes. Growth of wild 
type cells is inhibited when the concentration of NOC-12 is increased to 0.5 mM, 
suggesting that at this concentration, CydDC and cytochrome bd-I of wild type cells are 
not able to completely protect against the detrimental effects of NO. 
The loss of cytochrome bd-I has previously been shown to elicit sensitivity to 
NO (Mason et al. 2009), and consistently with this, mutation of cydB in the Keio strain 
elicits sensitivity to NO. Since the assembly of cytochrome bd-I requires CydDC 
(Georgiou, Hong and Gennis 1987), mutation of cydD would be expected to also elicit 
NO sensitivity, which the current work clearly demonstrates (Figures 3-2 and 3-3). 
When the growth inhibition at equivalent NOC-12 concentrations is compared between 
the cydB and cydD mutants, growth of the cydD mutant is more sensitive than the cydB 
mutant. This result demonstrates that CydDC provides protection against NO, and 
furthermore, suggests an additional CydDC-mediated NO-tolerance mechanism beyond 




Figure 3-2. Mutation of cydB and cydD elicits sensitivity to NO in E. coli  
 
Cultures of wild type (MS52)(A), cydB (MS53)(B) and cydD (MS54)(C) E. coli Keio 
strains were grown under aerobic conditions, and various concentrations of NOC-12 
were added after 1.5 h: black, no NOC-12 control; red, 0.1 mM; blue, 0.2 mM; purple, 












































































Figure 3-3. Change in time taken to reach an OD600 of 0.1 in the presence of the 
NO donor NOC-12 
Cultures of wild type (grey), cydB (blue) and cydD (orange) E. coli Keio strains were 
grown under aerobic conditions. Various concentrations of NOC-12 were added after 
1.5 h of growth. The time taken for cultures to reach an OD600 of 0.1 was determined, 
and data are expressed as the increase in time due to NOC-12 inhibtion (relative to the 
no NOC-12 control). Error bars represent standard deviations of three technical repeats. 
 
 
3.2.2 Periplasmic cysteine and glutathione provide additional protection from NO 
The finding that a cydD mutant is more sensitive to NOC-12 than a cydB mutant is 
interesting, as one might expect that these strains would exhibit a similar level of 
elevated NO sensitivity (due to loss of cytochrome bd-I assembly (Mason et al. 2009)). 
Given that both the known substrates for CydDC contain thiol groups that can react 
with incoming NO, it was then hypothesised that CydDC-exported thiols can provide 
additional protection to E. coli from NO, beyond the involvement of cytochrome bd-I. 
With a reduction in periplasmic thiols to react with incoming NO, it is likely that a cydD 
mutant is confronted with a larger concentration of NO within the cytoplasm than 
strains with functional CydDC. To test this hypothesis, reduced glutathione and cysteine 
were added to growth media during further NOC-12 growth experiments.   
As before, the growth of cydB and cydD Keio mutants was inhibited using the 
nitric oxide donor NOC-12 at a concentration of 0.75mM. The extent of NO-mediated 















































Strain and [NOC-12] (mM)
Change in time taken to reach OD600 0.1
    cydD      cydB    wild type  
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mM cysteine and 2.4 mM GSH. The outer membrane porins allow the diffusion of 
molecules ~600 Da from the extracellular fluid to the periplasm (Decad and Nikaido 
1976). Hence, it is reasonable to assume that extracellular glutathione and cysteine are 
at equilibrium with the periplasmic space. As before, a plate reader was used to measure 
OD readings. Defined medium (Flatley et al. 2005) with and without additional cysteine 
and glutathione was inoculated with bacteria and then aliquoted as 200 µl volumes into 
the wells of 96 well plates. Cells were grown in a plate reader at 37oC and 200 rpm for 
an hour and a half before being challenged with 0.75 mM NOC-12. It has previously 
been shown (Figure 3-2) that addition of NOC-12 at a concentration of 0.75 mM has a 
large affect upon growth of both cydB and cydD E. coli Keio strains; this relatively large 
concentration of NOC-12 (0.75 mM) was used in this experiment as it was assumed that 
as targets of NO, additional cysteine and glutathione in the media would react with 
NOC-12 and dampen the observed affects upon growth. Growth curves are shown in 
Figure 3-4, and the level of inhibition was defined by the time taken to resume growth 
and reach an OD600 of 0.25 (Figure 3-5), which was diminished for the cydD mutant 
when additional cysteine and glutathione was present. This supports the hypothesis that 
a lack of NO-reactive thiols in the periplasm causes cydD mutants to be more sensitive 






Figure 3-4. Effect of exogenous glutathione and cysteine to NO tolerance of cydB 
and cydD mutants 
 
cydB (MS53)(blue) and cydD (MS54)(orange) E. coli Keio mutants were grown in the 
presence (B) or absence (A) of 0.75 mM NOC-12 to determine if exogenous addition of 
cysteine and GSH alleviated NOC-12 growth inhibition. Error bars represent standard 










































Figure 3-5. Exogenous glutathione and cysteine reduces the inhibitory effects of 
NOC-12 on a cydD mutant 
Aerobic growth of E. coli Keio strains in a 96 well plate was measured using a plate 
reader. The time taken for strains to reach OD600 0.25 in the presence of NOC-12 was 
measured to determine level of growth inhibition. Some of the wells contained medium 
supplemented with the low-molecular weight thiols cysteine (1.2 mM) and glutathione 
(2.4 mM). The effect the added thiols have on nitrosative stress can be determined by 
comparing the time taken to reach OD600 of 0.25. Error bars show standard deviation of 
five technical repeats. 
 
One would expect that addition of GSH and cysteine in general would aid tolerance to 
NO. It is intriguing that supplementing media with GSH and cysteine does not, 
however, alleviate NO sensitivity of a cydB mutant and actually produces a slight 
hindrance to growth, possibly due to the toxic effect of cysteine. 
 
3.2.3 Addition of reduced glutathione is more effective at relieving the NO induced 
growth inhibition of a cydD mutant than cysteine 
To assess the individual contribution of the two thiols to NO tolerance, growth curves 
were performed (using a plate reader) with an equal concentration of either cysteine (1 
mM) or GSH (1 mM) added separately to the growth medium. As described above, the 
growth of cydB and cydD strains is inhibited by addition of NOC-12. The magnitude of 
this growth inhibition was compared when cultures were grown in defined medium 







cysteine or 1 mM GSH. Cells were grown in a plate reader at 37oC 200 rpm for an hour 
and a half before being challenged with 0.5 mM NOC-12. A relatively large 
concentration of NOC-12 was used as it was assumed that as targets of NO, additional 
cysteine or glutathione in the media would react with NOC-12. Growth curves are 
shown in Figure 3-6. As seen by the little difference in time taken to reach an OD600 of 
0.25 (Figure 3-7), adding cysteine at a concentration of 1 mM to the media had very 
little effect on the NOC-12-mediated growth inhibition of a cydD strain. However 
addition of glutathione (1 mM) noticeably alleviates the growth inhibition of the cydD 
strain caused by NOC-12. The NOC-12-mediated growth inhibition of the cydB strain is 
also diminished by the addition of glutathione. 
 
 
Figure 3-6. Effect of exogenous glutathione or cysteine to NO tolerance of cydB and 
cydD mutants 
 
cydB (blue) and cydD (red) mutants were grown in the presence of NOC-12 (circles), to 
determine if exogenous addition of GSH (A) or cysteine (B) alleviated growth 














































Figure 3-7. Exogenous glutathione is more effective than cysteine at alleviating 
NO-mediated growth inhibition 
 
Aerobic growth of E. coli Keio strains in a 96 well plate was measured using a plate 
reader. Strains were grown in the presence of 0.5 mM NOC-12 with or without 
exogenous cysteine (1 mM) or glutathione (1 mM). The effect the added thiols have on 
nitrosative stress was defined by the time taken to reach an OD600 of 0.25. Error bars 
show standard deviation of five technical repeats. 
 
 
3.2.4 Exogenous glutathione and cysteine restores cytochrome bd-I assembly in a 
cydDC mutant 
One of the most important phenotypes of a cydDC mutant, is a lack of functional 
cytochrome bd-I (Poole et al. 1993; Poole, Gibson and Wu 1994; Bebbington and 
Williams 1993; Georgiou, Hong and Gennis 1987). In a strain lacking CydDC it has 
been shown that cytochrome bd-I protein polypeptides CydA and CydB are still 
synthesised and inserted into the cytoplasmic membrane but that the haem cofactors, 
essential to cytochrome functional are not incorporated within these subunits 
(Bebbington and Williams 1993). Some phenotypes of a cydD mutant such as the loss 
of motility, the sensitivity to dithiothreitol and benzylpenicillin along with the absence 
of holocytochrome c and periplasmic cytochrome b562 can be corrected with the addition 











Robinson and Poole 2005). However, the restoration of cytochrome bd-I has not been 
observed by the addition of GSH or cysteine alone, so it was of interest to determine 
whether both CydDC substrates are needed in the periplasm for cytochrome bd-I 
assembly.  
As CO binds to different haem groups, giving characteristic spectra, it is possible to use 
µ&2UHGXFHG¶minus µUHGXFHG¶VSHFWUD (i.e. CO difference spectra) to detect the presence 
of fully assembled cytochrome bd-I. CO difference spectra of whole wild type cells 
expressing functional cytochrome bd-I have peaks at 420 nm and 642 nm with a trough 
at 442 nm and 622 nm as seen in the wild type trace (black in Figure 3-8)7KHĮ-band 
peak at 642 nm corresponds to the CO-ligated form of cytochrome d. The trough at 622 
nm is assigned to the loss of absorbance of the reduced un-ligated cytochrome d on 
binding CO. In the Ȗ (soret) region, the absorption maximum of cytochrome bd-I is at 
420 nm with a trough at 442 nm (Kalnenieks et al. 1998). This is thought to correspond 
to the haem b595 of cytochrome bd-I. CydDC mutants lack haem cofactors within 
cytochrome bd-I, which can be observed in the CO difference spectra of cydD cells 
(Figure 3-8, red trace). Whole cydD cells, which are deficient in cytochrome bd-I 
assembly, produce CO difference spectra that lack the peak and trough at 642nm and 
622nm, respectively. The peak and trough at 420 nm and 442 nm, respectively, are also 
shifted slightly to the left; in the absence of cytochrome bd-I, the CO bound cytochrome 
boƍ appears more prominent with a peak around 416 nm and a trough around 430nm 
(Kita, Konishi and Anraku 1984). This provides a simple assay to detect the presence of 
fully assembled cytochrome bd-I within whole cells. As seen in Figure 3-8 a cydD (red 
line) mutant loses the peaks attributed to cytochrome bd-I when compared to a wild 
type strain (black line). 
For these assays, bacterial strains from the Keio collection were grown 
microaerobically to encourage the production of cytochrome bd-I. As described in 
Section 2.3.1 microaerobic conditions were achieved by increasing the volume within 
250 ml conical flasks to 100ml, and reducing the rpm from 180 to 150, to reduce the 
level of dissolved oxygen. Defined medium as described in Section 2.1.5.2 (Flatley et 
al. 2005) had been used to grow bacteria at first, but when wild type strains were 
assayed no cytochrome bd-I signal could be seen. Growing cells in rich LB media 
permitted cytochrome bd-I to be observed in wild type cells and importantly did not 
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Previous attempts to restore cytochrome bd-I in cydD strains did not employ the 
strategy of adding both CydDC substrates to the growth medium in tandem. CO-
difference spectra of whole cells in Figure 3-8 are consistent with previous results that 
cysteine (green trace) or glutathione (purple trace) alone are unable to restore 
cytochrome bd-I assembly in a cydD mutant. Interestingly, here we show that when 
added together simultaneously cysteine (0.5 mM) and GSH (1 mM) can restore the 
assembly of cytochrome bd-I (blue trace). This spectrum is comparable to that of wild 
type cells in that the peak at 642nm is seen which corresponds to the CO-ligated form of 
cytochrome d, although the features at 416 nm and 430 nm are poorly defined compared 
to the wild type trace. We therefore conclude that addition of glutathione and cysteine 

















Figure 3-8. Glutathione and cysteine restore cytochrome bd-I assembly in a cydD 
mutant 
 
CO difference spectra (400 nm- 700 nm) were collected at room temperature. Whole 
cell samples (E. coli from the Keio collection) were scanned in a custom-built SDB4 
dual wavelength spectrophotometer (Kalnenieks et al. 1998). Each scan is labelled with 
the strain and which low-molecular weight thiols were used to supplement the growth 
medium (LB). Cells were grown microaerobically at 37 oC overnight, then harvested at 
4000 rpm and 4oC before being re-suspended in 1 ml of 0.1 M potassium phosphate 
buffer, pH 7.4. Further dilutions were made where required to enable whole cell CO 
difference spectra to be recorded. The protein concentration of the cydD GSH cysteine 
sample used here was 5.6 mg/ml. Spectra have been normalised to give a common Soret 
peak magnitude and offset to fit onto the same figure.  
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3.2.5 Metabolomic perturbations elicited by loss of CydDC 
Loss of CydDC elicits a pleiotropic phenotype, so it is expected that a lot of changes 
occur within cells in response to the absence of the exporter complex. A cydD vs. WT 
microarray experiment has previously been performed by Dr Stuart Hunt (University of 
Sheffield) and Dr. Mark Shepherd (University of Kent) (Holyoake et al. 2015). As 
expected a large number of genes were shown to be differentially regulated in the 
absence of CydDC-mediated reduced thiol export; 97 genes were shown to be 
significantly up-regulated and 41 genes were shown to be significantly down-regulated. 
Of these, selected genes were mapped onto a metabolic diagram to provide a 
physiological overview of the loss of cydD (Figure 3-9). The diagram highlights the up-
regulation of genes involved in protein degradation, ȕ-oxidation of fatty acids and 
respiration. The authors propose that misfolded proteins and fatty acids are broken 
down to feed into the TCA cycle in order to restore the balance of metabolic flux. Genes 
encoding the NapGH and NapAB complexes were also shown to be up-regulated in the 
cydD mutant. As NapGH channels electrons from ubiquinol to NapAB, an electron 
accepting nitrate reductase the authors suggest that the up-regulation of these genes 
compensates for the loss of cytochrome bd-I assembly. Of the genes that are down-
regulated, many are involved in thiosulphate transport, nucleotide metabolism and 
motility.  
Transcriptomic studies, however, do not provide information on protein 
translation nor do they provide an insight into the concentrations of metabolic 
intermediates in the cell. To complement this microarray data, metabolite extractions 
(Section 2.4.2) of cydD and wild type cells were analysed via 1D-1H NMR spectroscopy 
as detailed in Section 2.4.3. Six metabolite extractions and NMR analyses were 
performed for both wild type and cydD cultures. 
The 1H-NMR spectra were normalised to position the signal for 4,4-dimethyl-4-
disilapentane-1-sulfonic acid (DSS) at 0.00 ppm (Figure 3-10). At first glance the NMR 
spectra of cydD metabolites is similar to the spectrum obtained for metabolites extracted 
from the wild type strain. Indeed, the AMIX global analysis software (Bruker) 
calculated no significant difference overall between cydD and wild type spectra. 
However, manual inspection of the spectra of cydD and wild type cells reveals regions 
in which peak positions and intensities vary between the two strains. To identify the 
metabolites that vary in abundance between the two strains the online resource  µ7KH
Madison Metabolomics &RQVRUWLXP 'DWDEDVH¶ 00&' ZDV XVHG (Cui et al. 2008). 
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Peaks in NMR data collected were assigned to a metabolite by inputting chemical shift 
values with a tolerance of ±0.05 parts per million (ppm) chemical shift variance into an 
NMR-based search of metabolites. Published NMR data of metabolites which create 
peaks at the input chemical shift value were then compared with the peaks in NMR data 
collected. Corrected intensity signals were then used to create averages, standard 






Figure 3-9. Model for the adaptations of a cydD strain (Holyoake et al. 2015). 
The gene transcript levels and transcription factor activities that are up- and down-regulated in the cydD vs. wild type transcriptomics are shown in red 
and blue, respectively. The brown and cyan lines denote processes that are predicted to be up- and down-regulated, respectively. TCA cycle 
intermediates that are also shown outside the cycle are highlighted in purple. Abbreviations: Ac-CoA, Acetyl CoA; GSH, reduced glutathione; Grx, 
Glutaredoxin; LMT, low-molecular weight thiol; Trx, Thioredoxin. 
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3.2.5.1 Deletion of cydD results in depletion of intracellular succinate, D-mannitol 
and NAD 
The spectra of metabolites extracted from wild type cells contains a large peak at a 
chemical shift of 2.4 (Figure 3-10A), but this single peak is missing in the spectra of 
metabolites extracted from cydD cells (Figure 3-10B). To assign this peak to a 
PHWDEROLWHWKHZHEVLWHIRUWKHµ0DGLVRQPHWDEROLWHFRQVRUWLXPGDWDEDVH¶(MMCD) was 
used (Kalnenieks et al. 1998). A chemical shift of 2.4 was entered for an NMR-based 
search of metabolites. NMR data of each possible metabolite was then compared with 
the peak at chemical shift 2.4 in Figure 3-10A. The search concluded that the NMR 
standard for succinate (Appendix A-1) was very similar to the differences in signal 
intensities at a chemical shift of 2.4 (between the wild type and cydD mutant). The 1D-
1H NMR spectra of succinate is one single peak at 2.4 which correlates well with the 
changes seen between wild type and mutant cell derived metabolites. As the peak at 2.4 
is missing in a cydD mutant this shows that a cydD mutant has reduced levels of 
succinate when compared to wild type. The change in levels of succinate were not 
shown however, to be significant at the 95% significance level when unpaired t-tests 
were performed (Figure 3-11).  
Looking at Figure 3-10 a peak with a chemical shift around 3.8 is also less 
prevalent in the cydD metabolic profile than that of wild type cells. The reference NMR 
data of D-mannitol shows a large peak at a chemical shift around 3.75 with other 
smaller peaks surrounding it (Appendix A-2), this is consistent with the changes in 
peaks between the two strains in collected NMR data (Figure 3-10), and thus shows that 
D-mannitol is reduced in the absence of CydDC. The levels of D-mannitol were shown 
to be significant at the 95% significance level (Figure 3-11). 
Peaks at 9.35 and 8.42 match peaks assigned to NAD (Appendix A-3) both these 
peaks are reduced in cydD spectra when compared to wild type spectra, and this 
difference in signal intensities is significant at the 95% level when unpaired t-tests are 
performed.  
  
3.2.5.2 Betaine, fumarate and L-methionine are elevated in a cydD strain 
As seen in Figure 3-10 the spectra of metabolites extracted from cydD cells contains a 
large peak at a chemical shift of around 3.27, the magnitude of this peak is diminished 
in the spectra of metabolites extracted from wild type cells. To assign this peak to a 
95 
 
PHWDEROLWH WKH ZHEVLWH IRU WKH µ0DGLVRQ PHWDEROLWH FRQVRUWLXP GDWDEDVH¶ ZDV DJDLQ
used. A chemical shift of 3.27 was inputted for an NMR-based search of metabolites. 
NMR reference data of each possible metabolite was then compared with the collected 
1D-1H NMR data. For example, although there are alternative metabolites that also 
include peaks at a chemical shift around 3.27 in their NMR reference data (including L-
arginine, L-phenylalanine, coenzyme A, D-Glucuronate and D-cellobiose), the peaks 
that accompany the peak at 3.27 do not correlate with the differences in peaks seen in 
the NMR data collected in this thesis. Comparison of the NMR reference data with the 
data collected (Figure 3-10) showed a good correlation with the NMR reference 
spectrum of betaine (Appendix A-4). The peak at 3.25 is distinct within the spectra of 
cydD metabolites but not in wild type metabolites, furthermore an unpaired t-test 
showed a significant difference at the 99% level and thus it was concluded that betaine 
levels are elevated when cydD is deleted.  
Alongside the peak at 3.27, a peak at chemical shift 2.15 is detected in four of 
the five NMR spectra for cydD cells but only one of the six spectra of wild type 
metabolite extracts. The reference 1D-1H NMR data of L-methionine (Appendix A-5) 
matches the changes in peaks between the two strains. Further analysis showed that the 
level of methionine in the two strains is significantly different at the 95% level. Thus 
methionine is more abundant in cells lacking CydDC. Reference 1D-1H NMR data for 
fumarate produces a single peak at a chemical shift around 6.5 (Appendix A-6). Larger 
peak intensities are seen for cydD spectra than wild type spectra, the differences in peak 






















Figure 3-10. 1D-1H NMR metabolite analysis of wild type or cydD cells 
 Metabolite extractions of wild type (A) and cydD (B) cells were analysed via 1D-1H NMR spectroscopy, where six metabolite extractions and NMR 
analyses were performed for both wild type and cydD cultures, one of the wild type results was anomalous so this has been removed here. Where 














Figure 3-11. Relative abundance of metabolites in cydD and wild type E. coli cells 
 
Red bars show metabolite levels in wild type (MS52) cells (normalised to an arbitrary 
value of 100), and yellow bars show metabolite levels in cydD (MS54) cells: the 
magnitude of the cydD metabolite data has been scaled relative to the wild type data. 
Error bars represent standard deviation. Asterisks denote that an unpaired t-test has been 
performed and a significant difference of 95% or above was observed. Only betaine 






It has previously been shown that cytochrome bd-I contributes to the protection of cells 
against NO (Mason et al. 2009). With a fast NO dissociation rate, cytochrome bd-I is 
less sensitive to NO than the alternative terminal oxidase cytochrome boƍ, thus 
cytochrome bd-I permits aerobic respiration to continue in the presence of NO. Since 
CydDC is required for the assembly of cytochrome bd-I, it was at first anticipated that 
cells lacking CydDC would exhibit a similar level of NO-mediated growth inhibition to 
that of cells lacking cytochrome bd-I only. To test this hypothesis, NOC-12 was used as 
a nitric oxide donor and growth was monitored after its addition. This approach 
demonstrated that growth of a cydD Keio mutant is more sensitive than a cytochrome 
bd-I mutant, which indicates an additional contribution to NO tolerance for the exporter 
complex. We hypothesised that the difference in sensitivity between the two strains is 
due to the export of thiols to the periplasm. As thiol groups are targets of NO (Ignarro 
1989; Stamler et al. 1992; Stamler, Singel and Loscalzo 1992), we estimated that loss of 
export of these thiols to the periplasm would result in a higher concentration of NO 
being allowed to enter into the cytoplasm, in which NO can reach vunerable targets. To 
test this hypothesis, glutathione and cysteine were added to the growth medium and 
then a short time later the cells were challenged with NOC-12. The aim was to replace 
cysteine and GSH in the periplasm of cydD mutant cells to determine the sensitivity to 
NO. The results showed that exogenous addition of thiols reduces the NO-mediated 
growth inhibition of the cydD strain to a level comparable to a cytochrome bd-I mutant. 
These data are consistent with the hypothesis that CydDC contributes to the protection 
from NO both by permitting the assembly of cytochrome bd-I and via the export of low-
molecular weight thiols that react with incoming NO.  
After identifying cysteine (2002) and later glutathione (2005) as substrates of 
CydDC, Pittman et al. assayed the restoration of cytochrome bd-I in the presence of 
exogenous reduced glutathione or cysteine. Cysteine was added to the growth medium 
at final concentrations of 0.2 mM or 2 mM (Pittman et al. 2002). Exogenous glutathione 
was added to the growth medium at concentrations of 0.1, 0.25, 0.5, 1 or 2 mM 
(Pittman, Robinson and Poole 2005). Restoration of cytochrome bd-I assembly was not 
observed for cysteine nor glutathione at these respective concentrations. This lack of 
cytochrome bd-I restoration and the promiscuous nature of ABC-type transporters in 
general have led to a proposal that CydDC has additional substrates that are yet to be 
discovered. In the current study, cytochrome bd-I assembly was examined in the 
presence of both glutathione and cysteine. Since high concentrations of cysteine can be 
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toxic to cells, a low concentration (0.5 mM) was used so that an appropriate OD600 
could be reached after overnight growth. A combination of 0.5 mM cysteine and 1 mM 
reduced glutathione was added to cydD cells for overnight growth. The CO difference 
spectra of these cells displayed spectral characteristics of assembled cytochrome bd-I. 
We therefore concluded that glutathione and cysteine added simultaneously to a cydD 
mutant can restore haem insertion into cytochrome bd-I. This result is interesting as it 
suggests that loss of cytochrome bd-I assembly in a strain lacking CydDC is not merely 
due to loss of a reduced thiol pool in the periplasm, otherwise just one of the thiols 
would have restored cytochrome bd-I assembly. Instead, the requirement of both thiols 
indicates a process in which both thiols play a part.  
 
The metabolomics data suggests that loss of CydDC may result in a slight 
increase in L-methionine and fumarate and reduction of succinate, D-mannitol, acetate 
and NAD (unpaired t-test at the 95% level). However, a large increase in betaine levels 
was observed, and this was the only metabolite detected in cydD cells that could be 
confidently described as having altered abundance: betaine is significantly altered at the 
99% level compared to wild type cells (unpaired t-test). This observation is consistent 
with cydD vs. wild type microarray data (Holyoake et al. 2015, collected by Dr. Mark 
Shepherd & Dr. Stuart Hunt) in which the betaine synthesis genes betA and betB are up-
regulated and the transcription factor BetI, a repressor of these genes has reduced 
activity as supported by modelling of transcription factor activities (Holyoake et al. 
2015). The betAB operon is involved in the biosynthesis of betaine, an osmoprotectant 
also known as glycine betaine. Taken together this would show that in response to loss 
of CydDC, activity of the transcription factor BetI is decreased, resulting in the up-
regulation of betAB operon at the transcriptional level which results in an increase in the 
osmoprotectant betaine (Andresen et al. 1988).  The betA gene encodes a choline 
dehydrogenase (CHD) that utilises FAD and pyrroloquinoline (PQQ) cofactors. 
Intriguingly, BetA has been shown to use ubiquinone as an electron acceptor (Barrett 
and Dawson 1975). It is therefore hypothesised that BetA and BetB permit electrons to 
feed into the ubiquinol pool (Figure 3-12) while simultaneously providing glycine-
betaine to alleviate osmotic perturbations elicited by an accumulation of glutathione and 
cysteine in cydD cells.  
The reduction in levels of NAD+ in the absence of CydDC is likely to be a result 
of the reducing conditions produced by the loss of thiol export and thus the excessive 
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amount of reduced thiols in the cytoplasm. Furthermore, BetB utilises NAD during 
betaine biosynthesis, as levels of this metabolite are significantly increased in cydD 
cells, this could further explain the depletion of NAD. It is unclear why D-mannitol 
levels are also depleted. 
Despite the cydD vs. wild type microaray analysis showing an up-regulation of yjcH 
responsible for acetate import, acetate levels were shown to be depleted in cydD cells. 
Microarray analysis however also led to the conclusion that misfolded proteins and fatty 
acids are broken down in cydD cells to feed into the TCA cycle in order to restore the 
balance of metabolic flux, so it is likely that acetate levels are depleted due to its use in 
fuelling ȕ-oxidation of fatty acids as well as the TCA cycle.  
Succinate and fumarate, intermediates of the TCA cycle are both altered in cydD 
cells: levels of succinate are reduced and fumarate is increased, reflecting a potential 
increase in succinate dehydrogenase activity that catalyses the oxidation of succinate to 
fumarate with the simultaneous reduction of ubiquinone to ubiquinol (Figure 3-12). 
This supports the findings of the cydD vs. wild type microarray which showed that 
genes of the TCA cycle are induced (Figure 3-9). This change in energy metabolism 
may be due, in part, to a requirement for additional electron flux into the quinone pool. 
Metabolites were assigned to chemical shift peaks via the comparison of 
collected NMR data with NMR reference data sets from the µ0DGLVRQ metabolite 
consortium dDWDEDVH¶. The comparison of peaks, however, is problematic for a number 
of reasons, including the presence of metabolites in biological samples that have yet to 
be added to the database, changes in the chemical shift of peaks due to variations in pH 
and salt concentration as well as the crowded nature of the collected 1D-1H data which 
means that there are peak overlaps, this all culminates in the fact that peaks could be 
incorrectly assigned. (Cui et al. 2008). Mass spectrometry to compare the metabolite 
extracts from wild type and cydD cultures could confirm that the metabolites identified 

















Figure 3-12. Succinate dehydrogenase 
 
Succinate and fumarate levels are affected by the loss of cydD; an increase in fumarate 
and a decrease in succinate levels reflect upon the up-regulation of succinate 
dehydrogenase seen in previous cydD vs. WT microarray analysis. Succinate 
dehydrogenase catalyses the oxidation of succinate to fumarate with simultaneous 
reduction of ubiquinone to ubiquinol. An increase in succinate dehydrogenase 
expression and activity is likely to be the reason for the changes in TCA cycle 
intermediates, this would also provide additional reducing power to the quinol pool of 









Global adaptations in response to 
CydDC activity: transcriptomic 
perturbations resulting from variations 






Exogenous cysteine and GSH have previously been shown, to restore cytochrome bd-I 
assembly in a cydD mutant, suggesting that the presence of these thiols in the periplasm 
of cells is crucial for the assembly of cytochrome bd-I. Microarray experiments were 
performed to further probe the role of glutathione and cysteine in the periplasm. In cells 
lacking CydDC, GSH and cysteine will still be present in the cytoplasm, potentially at 
higher concentrations than in wild type cells, the periplasm however, is thought to be 
deficient of these thiols due to a lack of export from the cytoplasm. Exogenous addition 
of GSH and cysteine should restore their presence in the periplasmic space. As a cydD 
vs. wild type microarray experiment had already been perfomed, a microarray 
experiment was designed to compare the regulation of genes of a cydDC mutant when 
GSH and cysteine were added exogenously. As it is likely that addition of GSH and 
cysteine to a cydDC mutant would lead to restoration of cytochrome bd-I, a cydDC 
cydAB mutant was also used in parallel with the aim to study the effects of transcription 
caused by the addition of thiols that are independent of cytochrome bd-I restoration.  
The addition of GSH and cysteine to cydDC cells led to an up-regulation of 163 
genes and a down-regulation of 173 genes compared to cydDC cells alone. Whereas the 
addition of these thiols to cydDC cydAB cells led to an up-regulation of 135 genes and a 
down-regulation of 220 genes when compared to cydDC cydAB cells alone. The large 
number of genes found to have altered expression in response to the addition of GSH 
and cysteine to growth media, both in cydDC and cydDC cydAB cells made it difficult 
to clearly identify the physiological changes taking place. The activities of transcription 
factors were modelled to determine which transcription factors have altered activities in 
response to the exogenous thiols. This gave an insight into the stimuli imposed upon 
cells and the transcriptional mechanisms underpinning changes to gene expression. 
Genes controlled by TFs with altered activities formed a subset of genes for ease of 
interpretation.  
Analysis of this subset of genes showed that independently of cytochrome bd-I 
restoration, the addition of GSH and cysteine to growth media resulted in an up-
regulation of respiratory genes, including those encoding cytochrome bd-II and 
hydrogenase I. An up-regulation in transcription of genes related to molybdenum 
cofactor biosynthesis, ion transport and the regulation of intracellular formate levels was 
also observed. Conversely a down-regulation was simultaneously reported in genes 
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encoding proteins of the tricarboxylic acid (TCA) cycle, motility genes and genes 
involved in the biosynthesis and transport of amino acids.  
By investigating the stimuli of TFs with altered activities in both cydDC and 
cydDC cydAB cells, it was found that cells were potentially responding to changes in the 
demand for amino acids, as well as osmotic stress, low oxygen conditions, phosphate 
starvation, and changes in the levels of copper, H2O2, dihydroxyacetone and sodium.  
In connection with thiol-mediated cytochrome bd-I restoration, an increase in 
expression of genes encoding cytochrome bd-I was observed alongside a down-
regulation of genes of the methylcitrate cycle (in which propanoate is used as a carbon 
source to generate to succinate and pyruvate) which respond to changes in available 






The ABC-type transporter CydDC is known to export reduced glutathione and cysteine 
to the periplasm of E. coli. Loss of CydDC results in an over-oxidising periplasm and a 
pleiotropic phenotype which resembles the phenotypes of dsb mutants. The low- 
molecular weight (LMW) thiols exported by CydDC are therefore thought to participate 
in maintaining the redox environment of the periplasm. Exogenous addition of the 
known allocrites of CydDC has been shown to restore the survival and temperature-
sensitive phenotypes of a cydC mutant (Goldman, Gabbert and Kranz 1996a), and it has 
been shown that exogenous cysteine can also re-establish cell motility, restore resistance 
to benzylpenicillin and DTT and can partially restore the assembly of c-type 
cytochromes (Pittman et al. 2002). In the previous chapter we showed for the first time 
that cytochrome bd-I assembly can be restored in a cydD mutant by the addition of 
cysteine and reduced glutathione to the growth medium. These observations highlight 
the multiple cellular roles played by reduced thiols within the periplasm, and the 
importance of their export by CydDC. Furthermore, considering that the exported thiols 
are thought to help maintain the redox environment of the periplasm, this is of 
consequence to extracytoplasmic proteins that contain disulphide bonds. As discussed in 
Section 1.1, disulphide bonds are essential for protein structure and function. It is 
therefore expected that loss of cydDC would lead to problems with functionality of 
these proteins including proteins related to cell motility, attachment and the secretion of 
extracellular proteins.  
The assembly of cytochrome bd-I in a strain lacking CydDC has not been shown 
to be restored by the addition of glutathione or cysteine alone, but simultaneous addition 
of the two reduced thiols can permit haem insertion into the polypeptide chains of 
cytochrome bd-I (Chapter 3). This finding highlights the lack of understanding around 
the relationship between CydDC and cytochrome bd-I. This chapter seeks to 
characterise the transcriptomic adaptations that result from replenishing the periplasm of 
strains lacking CydDC with glutathione and cysteine, with a view to elucidating 






4.2.1 The role of CydDC-exported GSH and cysteine 
With the discovery that exogenously added GSH and cysteine restores cytochrome bd-I 
assembly in a cydDC mutant (Chapter 3), it was of interest to elucidate the 
transcriptomic adaptations that result from the addition of these low-molecular weight 
thiols to cultures lacking the CydDC complex. As discussed in Chapter 3, it is 
reasonable to assume that extracellular glutathione and cysteine are at equilibrium 
within the periplasmic space  (Decad and Nikaido 1976), so extracellular reductant 
levels are thought to mimic those of the periplasm. A microarray approach was chosen 
to provide insights into how cells respond to the absence/presence of these thiols within 
the periplasm: genome-wide transcriptional analysis with microarray technology is a 
powerful tool for determining how gene expression is affected.  Since transcriptional 
perturbations are usually triggered by changes in the local environment, it was 
hypothesised that this approach would provide insights into how CydDC-mediated thiol 
export influences conditions in the cytoplasm. A cydD vs. wild type microarray had 
been previously performed (as discussed in more detail in Section 3.2.5), in 
consideration of this wild type cells were not included in the following experiments; 
experimental conditions were replicated to allow comparisons between datasets.  
In a cydDC mutant, many of the phenotypes are attributable to the loss of bd-
type oxidase assembly. In a microarray experiment that compares gene expression of a 
cydDC mutant in the presence or absence of GSH and cysteine, one would expect to see 
a lot of gene changes that are primarily due to the restoration of cytochrome bd-I. By 
using a cydDC cydAB double mutant alongside a cydDC mutant, it was hypothesised 
that one could differentiate between transciptomic changes resulting from addition of 
GSH and cysteine (direct effects) and those that result from the restoration cytochrome 
bd-I assembly (indirect effects). Hence, a microarray experiment was designed (Figure 
4-1) in which these thiols would be added exogenously at concentrations to match those 
used in cytochrome bd-I restoration assays (Figure 3-8). Two microarray experiments 
were planned, with one to use a cydDC mutant and the other a cydDC cydAB double 
mutant. Global gene transcription could then be compared between these mutants when 
1 mM GSH and 0.5 mM cysteine were added to the growth medium. It was envisaged 
that this approach would provide insights into the global effects of LMW thiols 







Figure 4-1. Experimental design of the microarray experiment 
 
Example of a microarray experiment designed to investigate the transcriptomic 
adaptations that arise from the presence of GSH and cysteine in the periplasm. cydDC 
cells (MS14) were grown in the presence or absence of exogenous GSH and cysteine. 
mRNA was extracted from bacteria and used as the template for a reverse transcription 
reaction to make labelled complementary DNA (cDNA). A dye swap was utilised to 
ensure no bias due to dye signal strength. This meant that each mRNA sample was 
labelled separately with both cy3 (green) and cy5 (red) dyes as depicted with the arrows 
in the diagram. Dye swaps are seen as technical repeats as they give two sets of results 
from the same two flasks of cells, to obtain accurate results these dye swap experiments 
were repeated with bacteria grown in separate flasks to ensure two biological repeats 
and accumulate a total of four sets of fold-change values for each microarray 
experiment.  As exogenous GSH and cysteine have been shown to restore cytochrome 
bd-I, a cydDC cydAB mutant (MS336) was used for a second microarray experiment 
that is otherwise identical to the experiment shown above. It was envisaged that by 
comparison of these two array datasets one could distinguish between transcriptional 
changes resulting from restoration of cytochrome bd-I assembly and those that are 







4.2.2 Creating an MG1655 cydDC cydAB double mutant 
For one of the two microarray experiments performed in this chapter it was necessary to 
create a cydDC cydAB double mutant. A single mutant needed to be cured of the 
resistance cassette so that the presence of a second deletion could be detected. Removal 
of the resistance cassette utilised the pCP20 plasmid (Table 2-1) which encodes a 
flippase enzyme (FLP) for the removal of DNA between repeat sequences.   
 
4.2.2.1 Removal of the resistance cassette in a cydAB::Cm MG1655 E. coli strain  
MS15 cells (cydAB::Cm)(Table 2.1) were made competent using the method as 
described by Brachmann et al. 1998 (Section 2.2.6.1), cells were then transformed with 
plasmid pCP20 (as described in Section 2.2.6.2). To select for transformation cells were 
spread onto ampicillin Luria Bertani (LB) plates. Ampicillin resistant colonies were 
then grown in LB at 42oC to remove the temperature sensitive pCP20 plasmid. Colonies 
were picked and streaked onto LB, LB-ampicillin and LB-kanamycin plates. Colonies 
that could only grow on LB plates were expected to be cured of the chloramphenicol 
resistance cassette as well as the pCP20 plasmid. TKH Ȝ±Red mutagenesis approach 
(Datsenko and Wanner 2000) was then used to replace the cydDC operon with a 
chloramphenicol resistance cassette, as is described in Section 2.2.4. Briefly, primers 
pMS35 and pMS36 (Table 2-2) anneal 500 bp either side of the cydDC operon, were 
used to amplify the chloramphenicol resistance cassette from a K-12 cydDC::Cm 
mutant, generating 500 bp flanking regions, homologous to the DNA either side of the 
genomic cydDC operon. The amplified DNA fragment was introduced into cells via 
electroporation, and recombination was enhanced between the homologous regions by 
the O-Red recombinase. Following the mutagenesis protocol, colony PCR was 
performed to confirm both the replacement of DNA at the cydDC locus and the absence 






4.2.2.2 PCR verification of MS336 (cydAB- cydDC::Cm) 
As there is no selective pressure to keep the cydAB deletion, a PCR was performed on 
the double mutant liquid culture used in the microarray experiment. This checked both 
that the cydDC operon was replaced by a chloramphenicol cassette (cydDC::Cm) and 
that the cydAB operon was not present.  
To check the cydDC operon, primers pMS3 and pMS4 were used (Table 2-2), when 
these anneal to the original wild type DNA sequence a fragment of 3,862 bp in length is 
produced, this corresponds to the band seen in Figure 4 close to the 4 kb marker band. 
Replacement of the cydDC operon with the chloramphenicol resistance cassette is 
expected to produce DNA fragments of 1,552 bp in length. MS14 (cydDC::Cm) was 
used as a control, and similar bands were seen both for this strain and the newly made 
double mutant next to the 1,500 bp band in the DNA ladder thus indicating that the 
operon had been replaced.    
To check the cydAB locus, primers pMS9 and pMS10 were used (Table 2-2). 
Colonies of strains MS2 (MG1655 WT) and MS15 (cydAB::Cm) were included as 
controls; use of MS2 as a DNA template resulted in a band inbetween the 3 kb and 4 kb 
marker bands (Figure 4-2), this corresponds to the expected size of 3,124 bp which 
includes the cydAB genes and 500 bp flanking regions. Use of MS15 (cydAB::Cm) as 
the DNA template resulted in a band at around 1,500 bp (Figure 4-2), this represents the 
size of the chloramphenicol resistance cassette along with the 500 bp flanking regions; 
the expected band size was 1,552 bp. MS13 (cydAB::Km) was also included in this PCR 
check, the resulting band around 2,000 bp corresponds to the expected band size (2015 
bp). PCR of the cydDC::Cm cydAB double mutant (MS336) resulted in a much smaller 
band compared to the other reactions at around 600 bp (Figure 4-2), the expected 






















































































Figure 4-2. PCR verification of double mutant 
 
Colony PCR was performed to ensure the cydDC operon was replaced by a 
chloramphenicol cassette (cydDC::Cm) and that the cydAB operon was not present. To 
check the cydDC operon primers pMS3 and pMS4 were used (right side of the gel), for 
the cydAB operon, primers pMS9 and pMS10 were used (left side of the gel) (Table 2-
2). Colonies of strains MS13 (cydAB::Km), MS15 (cydAB::Cm) and MS2 (MG1655 
WT) were used as positive controls to test that primers pMS9 and pMS10 are working.  
Colonies of strains MS14 (cydDC::Cm) and MS2 (MG1655 WT) were used as controls 
to test that primers pMS3 and pMS4 are working and to compare band sizes.  
 
PCR of MS336 with primers pMS9 and pMS10 resulted in a band around 600 bp, much 
smaller than the bands seen when using MS2 (WT), MS13 (cydAB::Km) or MS15 
(cydAB::Cm) as the DNA template, this small band correlates with the expected band 
size of 550 bp for the flanking regions of the FRT sites thus indicating the absence of 
the cydAB operon.   
 
Using primers pMS3 and pMS4 with MS336 as the DNA template results in a band 
around 1,500 bp, close to the expect size of 1,552 bp for the chloramphenicol resistance 
cassette along with the 500 bp flanking regions, this is also seen when using MS14 
(cydDC::Cm) suggesting that in both these strains a chloramphenicol resistance cassette 
has replaced the cydDC operon.   
 
 
cydAB Primers cydDC Primers 
111 
 
4.2.3 Global transcriptomic changes that result from exogenous addition of GSH 
and cysteine 
Addition of GSH and cysteine did not affect the rate of growth, so cells were grown in 
batch culture and it was not necessary to limit growth rates using continuous culture. 
MG1655 cydDC::Cm (MS14) and MG1655 cydAB cydDC::Cm (MS336) were grown in 
10 ml LB overnight cultures at 37°C 180 rpm. Of these overnights, 500 µl was used to 
inoculate 50 ml defined media (supplemented with MgCl2 and 10% casamino acids) in 
250 ml conical flasks. Where appropriate, freshly prepared and filter sterilised 250 mM 
GSH and 500 mM cysteine stock solutions were added to give a final concentration of 1 
mM GSH and 0.5 mM cysteine. Cultures were then grown at 37°C 180 rpm until an 
OD600 of 0.4 was reached. At this point, 30 ml of culture was removed from the flasks 
and treated as described in sections 2.2.7.2 and 2.2.7.3. The growth conditions were 
chosen to mimic those of existing microarray data of cydB vs. WT (Shepherd et al. 
2010) and cydD vs. WT (Holyoake et al. 2015).  
 
Dye swap experiments were performed to compensate for differences in signal 
and binding affinities of the two dyes cy3 and cy5 (Figure 4-1). For each microarray 
experiment, two biological and two technical repeats were used to perform two dye 
swap experiments. This gave four separate fold-change values per gene (Figure 4-3) 
which could be averaged. Fold-changes with magnitudes equal to or above 2 (i.e. +/- 2) 
and with p-values equal to or below 0.05 were considered significant. p-values were 
determined using the Benjamini Hochberg FDR (False discovery rate) statistical method 
(Benjamini and Hochberg 1995), which assumes that randomly 5% of the genes will 
have a p-value of 0.05 or lower just by chance. Benjamini Hochberg reduces the number 
of genes that are incorrectly rejected as false discoveries. As shown in the volcano plots 
in Figure 4-4, the spread of the data could be visualised with the aforementioned 
stringencies.  For the cydDC + GSH/cysteine vs. cydDC comparison, a total of 163 
genes were significantly up-regulated, and 173 genes were significantly down-regulated 
(the spread of the data is shown in Figure 4-4A and gene lists are found on the CD that 
accompanies the thesis). For the microarray experiment cydDC cydAB + GSH/cysteine 
vs. cydDC cydAB, a total of 135 genes were significantly up-regulated, and 220 genes 
were significantly down-regulated (the spread of the data is shown in Figure 4-4B and 


















Figure 4-3. Expression profiles showing the magnitude of the effect of reduced glutathione and cysteine on gene regulation 
Graphs were generated in GeneSpring (v13.1). The four points along the X-axis represent four scanned array samples: 1_1 and 1_2 are biological 
repeats, and 2_1 and 2_2 are technical repeats with dyes swapped. Line gradients between 1_1 and 1_2 or 2_1 and 2_2 shows the discrepancy between 
scanned array repeats, ideally these lines will be straight to represent good reproducibility. Line gradients between 1_2 and 2_1 show changes between 
dye-swap pairs. Each coloured line represents a gene, only genes which have a fold-change of over 2 or under -2 with a P-value less than 0.05 are 
shown.  As represented in the colour-bar scale, red indicates genes that are up-regulated and blue represents genes that are down-regulated. A. Data for 





































 cydDC cydAB B. 
 






























Figure 4-4. Volcano plots showing the cut off of significant gene fold-changes  
Figure created in GeneSpring (v13.1) to show the spread of the data and to demonstrate 
WKH QXPEHU RI JHQHV LQFOXGHG LQ WKH µVLJQLILFDQW¶ GDWD VHWV 6LJQLILFDQW GDWD LV
represented by red squares (with both an average log2 fold-change over 2 or under -2, 
and a p-value above 0.05), insignificant data is represented by grey squares. A. Data for 
the cydDC + GSH/cysteine vs. cydDC comparison. B. Data for the cydDC cydAB + 
GSH/cysteine vs. cydDC cydAB comparison.  
 
4.2.3.1 Exogenous GSH/cysteine controls the activities of key transcription factors 
As both microarray experiments identified a large number of differentially regulated 
genes, it was at first difficult to glean meaningful insights into how the addition of 
exogenous thiols altered conditions in the cell. To gain an understanding of the 
physiological changes taking place, activities of transcription factors (TFs) were 
modelled to investigate the underpinning transcriptional mechanisms in operation that 
elicit the transcriptomic responses (i.e. a knowledge of TF activities provides 
information on environmental changes).  
Mathematical modelling of the transcription factor activities was carried out 
using TFinfer version 2.0 (Shahzad Asif et al. 2010). The complete transcriptomic data-
sets obtained from GeneSpring were used for the analysis; therefore no limitations with 
regard to gene expression level were enforced prior to the application of TFinfer. For 
both of the microarray experiments described above, AppY, BirA, ArcA CsgD, GadX, 
NhaR, PepA, RcsB TrpR are predicted to have an increased activity and CueR, DhaR, 
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These changes are predicted in both mutants but at slightly different levels, for example 
the increase in AppY activity is larger for the cydDC cydAB mutant than the increase in 
activity seen in the cydDC mutant. However, major difference in TF activities between 
the two datasets (shown as red bars in Figures 4-5 and 4-6) are that RstA has a 
significant increase in activity and MngR, PutA and PrpR have reduced activity after 
addition of GSH and cysteine only in cydDC cells. Furthermore, OmpR and PspF are 
predicted to have reduced activity only in the cydDC cydAB experiment (Figure 4-6). 
These differences show that the cydDC and cydDC cydAB mutants are reacting to the 
addition of the thiols in a slightly different manner. The most obvious difference 
between the two mutants is the capability for cytochrome bd-I restoration in cydDC but 
not cydDC cydAB cells. It is therefore predicted that the variation between the datasets 
of the two microarray experiments is due to cytochrome bd-I restoration after thiol 
addition to cydDC cells.  
To separate the direct effects of exogenous thiols upon transcription from those 
elicited by cytochrome bd-I restoration, the response of both cydDC and cydDC cydAB 
cells to exogenous thiols were compared. Changes to gene regulation (in the same 
direction) seen in both microarray experiments (Supplementary Table 3) are considered 
independent of cytochrome bd-I, whereas differentially regulated genes found in the 
cydDC strain but not cydDC cydAB strain after thiol addition (Supplementary Table 4) 










Figure 4-5. Theoretical change in transcription factor activities when cysteine and 
reduced glutathione are added to a cydDC mutant 
As determined by TFinfer, changes over 2 are considered significant. All TFs with 
changes above 2 and below -2 were selected and are displayed here.  Red bars denote 
transcription factor activities that were not observed in the cydD CcydAB experiment 




Figure 4-6. Theoretical change in transcription factor activities when cysteine and 
reduced glutathione are added to a cydDC cydAB mutant 
As determined by TFinfer, theoretical changes in transcription factor activity over 2 are 
considered significant, applicable transcription factors are shown here.  Red bars denote 
transcription factor activities that were not observed in the cydDC experiment (Figure 4-





4.2.3.2 Transcriptional changes elicited by GSH/cysteine, that are independent of 
cytochrome bd-I assembly 
To investigate how cells lacking cydDC respond to the addition of GSH and cysteine 
independently of cytochrome bd-I assembly, transcription factors with altered activity 
after the addition of GSH and cysteine in both cydDC and cydD CcydAB cells were 
identified using the data from Figures 4-5 and 4-6. The genes affected by those TFs 
were then compiled to make Table 4-1, which includes a colour scale to aid 
visualisation of average fold-changes. 
 
Table 4-1.  Transcriptional changes resulting from addition of GSH/cysteine that 
are independent of cytochrome bd-I assembly 
Changes to transcription factor activities after the addition of GSH and cysteine to both 
cydDC and cydDC cydAB strains, include a significant increase in the activities of 
AppY, ArcA, BirA, CsgD, GadX, NhaR, PepA, RcsB and TrpR while causing a 
significant decrease in the activities of CueR, DhaR, FlhDC, LeuO and OxyS (Figures 
4-5 and 4-6). The mean fold increase or decrease of individual gene expression after the 
addition of thiols is indicated by the colour scale bar. Functional annotations were taken 
from the Ecogene (http://www.ecogene.org) and RegulonDB 
(http://regulondb.ccg.unam.mx) websites. 
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dps Fe-binding and storage protein 23.34 13.94 oxyS 
osmB lipoprotein 21.31 18.51 RcsB 
ybaS predicted glutaminase 15.51 28.18 GadX 
pflB pyruvate formate lyase I 14.16 6.95 ArcA 
focA formate transporter 12.85 5.05 ArcA 
ybaT predicted transporter 12.25 28.7 GadX 
nhaA sodium-proton antiporter 7.49 8.01 NhaR 
appC "cytochrome bd-II oxidase, subunit I" 6.17 123.91 AppY/ArcA 
appA phosphoanhydride phosphorylase 5.88 94.83 AppY/ArcA 
appB "cytochrome bd-II oxidase, subunit II" 5.49 120.08 AppY/ArcA 




hyaF protein involved in nickel incorporation into hydrogenase-1 proteins 4.34 19.59 AppY/ArcA 
hyaB "hydrogenase 1, large subunit" 4.05 33.67 AppY/ArcA 
moaA molybdopterin biosynthesis protein A 3.91 2.35 CueR 
hyaA "hydrogenase 1, small subunit" 3.82 33.88 AppY/ArcA 
moaC "molybdopterin biosynthesis, protein C" 3.72 2.19 CueR 
rutB predicted enzyme 3.6 2.51 ArcA 
hyaE protein involved in processing of HyaA 
and HyaB proteins 3.37 19.6 AppY/ArcA 
moaE "molybdopterin synthase, large subunit" 3.27 2.67 CueR 
moaD "molybdopterin synthase, small 
subunit" 3.22 2.16 CueR 
copA copper transporter 2.61 2.87 CueR 
yaiA predicted protein 2.38 3.76 TrpR 
yacH predicted protein -2.35 -3.05 ArcA 
gltI glutamate and aspartate transporter 
subunit -2.42 -7.41 FlhDC 
trpD 
fused glutamine amidotransferase 
(component II) of anthranilate 
synthase/anthranilate phosphoribosyl 
transferase 
-2.63 -4.33 TrpR 
flgM anti-sigma factor for FliA (sigma 28) -2.9 -2.57 FlhDC 
flgA assembly protein for flagellar basal-body periplasmic P ring -3.23 -8.24 FlhDC 
sucC "succinyl-CoA synthetase, beta 
subunit" -3.24 -10.69 ArcA 
flgN export chaperone for FlgK and FlgL -3.39 
-8.74 FlhDC 
oppA oligopeptide transporter subunit -3.52 
-4.68 ArcA 
sucD "succinyl-CoA synthetase, NAD(P)-binding, alpha subunit" -3.58 -12.18 ArcA 
oppD oligopeptide transporter subunit -3.6 
-4.25 ArcA 
flgG flagellar component of cell-distal portion of basal-body rod -3.64 -5.61 FlhDC 
sdhB "succinate dehydrogenase, FeS subunit" -3.73 -4.54 ArcA 
oppB oligopeptide transporter subunit -3.9 -5.2 ArcA 
trpA "tryptophan synthase, alpha subunit" -3.94 -3.16 TrpR 
oppC oligopeptide transporter subunit -3.98 -4.99 ArcA 
acnB bifunctional aconitate hydratase 2/2-
methylisocitrate dehydratase -4.56 -6.5 CueR 
icd "e14 prophage; isocitrate dehydrogenase, specific for NADP+" -4.58 -10.33 ArcA 
flgF flagellar component of cell-proximal portion of basal-body rod -4.58 -9.99 FlhDC 
gltL glutamate and aspartate transporter 
subunit -4.61 -5.79 FlhDC 
oppF oligopeptide transporter subunit -4.69 -5.13 ArcA 
flgB flagellar component of cell-proximal portion of basal-body rod -4.82 -18.47 FlhDC 
gltK glutamate and aspartate transporter 
subunit -5.04 -4.08 FlhDC 
flgI predicted flagellar basal body protein -5.23 -10.28 FlhDC 
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gltA citrate synthase -5.61 -7.13 ArcA 
flgE flagellar hook protein -5.76 -23.99 FlhDC 
leuD 3-isopropylmalate isomerase subunit -5.85 -11.03 LeuO 
flgC flagellar component of cell-proximal portion of basal-body rod -6.04 -24.19 FlhDC 
leuC "3-isopropylmalate isomerase subunit, dehydratase component" -6.51 -9.07 LeuO 
flgD flagellar hook assembly protein -6.74 -26.18 FlhDC 
trpB "tryptophan synthase, beta subunit" -7.01 -4.55 TrpR 
flgH flagellar protein of basal-body outer-
membrane L ring -7.13 -23.66 FlhDC 
leuA 2-isopropylmalate synthase -7.69 -10.15 LeuO 
carB carbamoyl-phosphate synthase large 
subunit -9.61 -9.74 PepA 
aldA "aldehyde dehydrogenase A, NAD-linked" -10.55 -10.89 ArcA 
leuB 3-isopropylmalate dehydrogenase -10.58 -14.79 LeuO 
dhaM 
fused predicted dihydroxyacetone-
specific PTS enzymes: HPr 
component/EI component 
-13.29 -10.74 DhaR 
dhaK "dihydroxyacetone kinase, N-terminal domain" -20.68 -21.34 DhaR 
dhaL "dihydroxyacetone kinase, C-terminal domain" -23.37 -23.94 DhaR 
 
Of the genes regulated by the transcription factors with altered activity in both cydDC 
and cydDC cydAB cells when GSH and cysteine are added to the medium, a total of 60 
genes have significantly altered expression. 
Genes that see an increase in transcription include those encoding the acid 
phosphatase (appA) and linked appBC genes encoding cytochrome bd-II that is 
discussed in Section 1.5.3. These genes are significantly more up-regulated in cydDC 
cydAB cells than in cydDC cells. Genes that are required for the synthesis of 
hydrogenase-I (hyaABCDF), and molybdenum cofactor biosynthesis (moaACDE) also 
see an increase in expression. An increase in expression of pflB encoding pyruvate 
formate lyase, is observed, this enzyme is involved in anaerobic metabolism, and 
catalyses the Coenzyme A-dependent, non-oxidative cleavage of pyruvate and 
Coenzyme A to produce acetyl-CoA and formate. An induction of focA, which encodes 
a formate transporter involved in regulating intracellular formate levels by exporting 
formate produced by pyruvate formate lyase from the cytoplasm is also seen. Other 
transporters induced by the addition of LMW thiols include, copA and nhaA; nhaA 
encodes a Na+/H+ antiporter, to expel sodium ions from the cytoplasm to enable 
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adaptation to high salinity at alkaline pH and copA encodes a transmembrane copper 
efflux protein. 
The gene encoding DNA protein from starved cells (dps), is the most induced 
gene of Table 4-1, this protein protects cells from multiple environmental stresses both 
by binding to and protecting DNA, by sequestering iron and via ferroxidase activity 
(Zhao et al. 2002; Martinez and Kolter 1997). osmB is also up-regulated, this gene 
encodes an outer membrane lipoprotein that responds to hyperosmolarity, suggesting 
that thiol addition inflicts osmotic stress upon cells. The function of OsmB is however 
unknown (Jung, Gutierrez and Villarejo 1989). 
Alongside genes involved in flagella biosynthesis (flgABCDEFGHIJMN) listed in Table 
4-1, additional motility genes are also repressed in both cydDC and cydDC cydAB cells 
after the addition of GSH and cysteine to the growth media (Supplementary Table 4), 
this includes chemotaxis and fli genes. The repression of motility related genes is 
stronger in the cydDC cydAB cells than cydDC cells.   
Also repressed are genes of the tricarboxylic acid (TCA) cycle including; acnB, 
gltA, sucA, sucB, sucCD, sdhABCD and icd and genes involved in the biosynthesis and 
transport of amino acids. This includes biosynthesis of tryptophan (trpABD), leucine 
(leuABCD) (Figure 4-7) and arginine (carAB) as well as the transport of glutamate and 
aspartate via an ABC-transporter (gltKL and gltI), and the transport of oligopeptides (of 
a maximum of 5 amino acids in length) via oppABCD encoded ABC-type transporter.  
 
Figure 4-7. Leucine biosynthesis  
Blue represents genes of leucine biosynthesis that are repressed by the addition of thiols 




Repression of aldA is also seen, this gene encodes aldehyde dehydrogenase A which has 
a broad substrate specificity and is therefore involved in a range of metabolic pathways. 
One such pathway is the metabolism/degradation of glycol.  
 
4.2.3.3 Transcriptional changes elicited by restoration of cytochrome bd-I assembly  
To perform a focussed analysis of how the restoration of cytochrome bd-I affects 
transcription, the activity of transcription factors that are only significantly affected by 
GSH/cysteine addition within cydDC cells were listed (i.e. not present in the cydDC 
cydAB array dataset). These were identified by cross-referencing the data in Figures 4-5 
and 4-6. The genes affected by those TFs were then compiled to make Table 4-2, which 
includes a colour scale to aid visualisation of average fold changes. 
 
 Repressed   Induced  
-30 to -20 -20 to -10 -10 to -2 2 to 10 10 to 20 20-30 















prpR DNA-binding transcriptional 
activator 4.52 1.47 PrpR 
mngB alpha-mannosidase 3.04 1.65 MngR 
prpD 2-methylcitrate dehydratase -2.77 -1.12 PrpR 
prpC 2-methylcitrate synthase -2.92 1.08 PrpR 
 
Table 4-2. Transcriptional changes resulting from GSH/cysteine-mediated 
cytochrome bd-I assembly 
Addition of GSH and cysteine to a cydDC strain is hypothesised (via TFinfer) to 
decrease the activity of the transcription factors MngR, PrpR and PutA. An increase in 
the activity of RstA is also seen. These transcription factors are however not 
significantly affected by the addition of GSH and cysteine to a cydDC cydAB mutant, 
suggesting a response to cytochrome bd-I restoration. Significant fold-changes of genes 
controlled by these TFs in a cydDC strain after the addition of thiols is indicated by the 
colour scale bar. Functional annotations were taken from the Ecogene 




TFinfer identified four TFs with activities affected by the addition of thiols to cydDC 
cells that were not affected in cydDC cydAB cells after thiol addition, indicating that the 
change in activity of these transcription factors is due to the restoration of cytochrome 
bd-I assembly. Listing the genes controlled by these transcription factors and reducing 
this list to genes in which a significant change is seen in cydDC but not cydDC cydAB 
cells reduces this list to just four genes. These genes are involved in catabolism of 
propanoate to succinate and pyruvate via the methylcitrate cycle (Brock et al. 2002) and 
the degradation of mannosyl-D-glycerate. 
TF modelling via TFinfer is a great way to produce a more focused subset of data, 
however, genes with large fold changes upon thiol addition are present in the original 
data and have not been included in the analysis so far. Supplementary data in the CD 
attached to this thesis lists all genes changes, here some of the largest fold changes seen 
are for genes involved in acid response, including gadABCE and hdeABD (Table 4-3). 
The gad acid resistance system includes the glutamate decarboxylase enzymes GadA 
and GadB, which catalyse the irreversible decarboxylation of glutamate to 
ȖǦDPLQREXW\UDWH *$%$ *DG& LV DQ DQWLSRUWHU WKDW H[SRUWV ȖǦaminobutyrate in 
exchange for glutamic acid. It is thought that these proteins protect the cell from acid 
stress by consuming one cytoplasmic proton to decarboxylate glutamatic acid into 
ȖǦaminobutyrate, a neutral compound. GadC-mediated export of ȖǦaminobutyrate to the 
outside of the cell would promote neutralisation of the external pH (Capitani et al. 
2003). hdeA and hdeB encode periplasmic chaperone proteins. Under neutral pH these 
proteins are found as dimers that dissociate into monomers at low pH, the monomers 
bind to acid-denatured proteins to prevent acid-induced aggregation of periplasmic 






















gadA glutamate decarboxylase A, PLP-dependent 72.54 98.12 
gadC 
predicted glutamate:gamma-aminobutyric acid 
antiporter 71.57 58.49 
gadB glutamate decarboxylase B, PLP-dependent 67.16 88.67 
gadE DNA-binding transcriptional activator 48.69 41.32 
hdeA acid-resistance protein 45.10 27.66 
hdeB acid-resistance protein 37.79 35.67 
hdeD acid-resistance membrane protein 27.64 41.33 
 
Table 4-3. Transcriptional changes to key genes involved in acid response after the 
addition of GSH and cystiene 
Differential expression of acid tolerance genes resulting from the presence of reduced 
glutathione (1 mM) and cysteine (0.5 mM) in the growth medium. The mean fold 
increase or decrease in individual gene expression is indicated by the colour scale bar. 
Functional annotations were taken from GeneSpring (v13.1) software. 
 
 
Supplementary Table 4 shows the entire list of genes significantly affected in 
cydDC but not cydDC cydAB cells after thiol addition. This list gives more of an insight 
into which genes are affected by the thiol-mediated restoration of cytochrome bd-I. An 
increase in expression of cydABX encoding cytochrome bd-I as well as ybgE within the 
same operon is seen. A down-regulation of genes with a role in the arginine degradation 




The results reported above identify transcriptomic changes that result from the addition 
of GSH and cysteine to the growth media. Herein, the GSH/cysteine-induced 
transcriptional adaptations that are cytochrome bd-I-independent are analysed in the 
context of their potential impact upon metabolic processes, followed by a discussion of 
the cytochrome bd-I-dependent adaptations.  
To further analyse the environmental changes that could elicit the cytochrome bd-I-
independent gene regulation in response to GSH/cysteine, environmental stimuli were 
identified for all the transcription factors (TFs) in Table 4-1 (Table 4-4).  
TF analysis gives an insight into the changes of the local environment; by 
looking at which stimuli TFs respond to, as detailed in Table 4-4. Transcription factors 
that are affected by the addition of GSH and cysteine in both cydDC and cydDC cydAB 
mutants respond to a range of external stimuli which includes; low oxygen and low 
osmolarity, starvation of phosphate and amino acids, changes to the levels of copper, 
H2O2, dihydroxyacetone (Dha) and sodium, as well as a reduction in the demand for 
biotin. This culminates in a down-regulation of genes involved in dihydroxyacetone 
degradation, flagella and amino acid biosynthesis, and genes of the TCA cycle. Changes 
to TF activities also underpin an up-regulation of respiratory genes, including those that 
encode cytochrome bd-II and hydrogenase I, as well as genes related to the regulation of 
intracellular formate levels and genes associated with molybdenum cofactor 
biosynthesis. 
In both cydDC and cydDC cydAB cells, addition of thiols leads to an increase in the 
activities of CsgD (both a repressor and activator) and RcsB (activator), these 
transcription factors are induced under low osmolarity, with osmB, a lipoprotein 
regulated by RcsB, being one of the most up-regulated genes in Table 4-1.   
ArcA and AppY respond to low oxygen levels, their activities are shown to be 
up regulated by the addition of reduced glutathione and cysteine in both cydDC and 
cydDC cydAB cells. ArcA is the response regulator of the Arc (anoxic redox control) 
two-component system ArcAB, a global regulator that acts upon many genes involved 
in respiratory metabolism (Liu and De Wulf, 2004). In the microarrays performed, 
addition of reduced thiols led to an up-regulation of respiratory genes appBC encoding 
cytochrome bd-II and hyaABCDF encoding hydrogenase-I (in cydDC cells, genes of the 
cydABX operon encoding cytochrome bd-I are also up-regulated by these TFs, however 
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as cydDC cydAB cells do not contain the cydAB operon, they are not included in Table 
4-1). ArcA also acts simultaneously as a repressor, genes of the TCA cycle, including 
acnB, gltA, sucA, sucB, sucC, sucD, sdhABCD and icd, were shown to be repressed 
after thiol addition.  
ArcA is transphosphorylated by the sensor kinase ArcB when oxygen is limiting 
or absent, phosphorylated ArcA simultaneously induces expression of cytochrome bd-I 
and represses the expression of cytochrome bo. Membrane anchored ArcB senses 
respiratory growth conditions via the redox state of the quinone pool using a thiol-based 
redox switch (Iuchi and Lin, 1988; Malpica et al., 2004; Alvarez et al., 2013). Under 
aerobic conditions the quinone pool of E. coli is mainly made up of ubiquinone, which 
is maintained in an oxidised stated via the transfer of electrons to oxygen via terminal 
oxidases, thus electrons flow from the redox active cysteine residues of ArcB to 
produce disulphide bonds that silence the kinase activity (Malpica et al., 2004). As 
oxygen becomes limiting the quinone pool becomes more reduced which permits 
electron transfer to cysteine residues of ArcB, reducing disulphide bonds and activating 
the ArcB kinase function. We speculate that reduced thiols in the periplasm may reduce 
the quinone pool and/or the cysteine residues of ArcB directly to cause the observed 
activation of ArcA activity. ArcA has been shown to induce appY gene expression 
under conditions of anaerobiosis, in consideration of this it is possible to further 
speculate that thiol induced reduction of ArcB disulphide bonds is also responsible for 
the increase in AppY TF activity.  
None of the other transcription factors mentioned in Tables 4-4 and 4-5 appear 
to have redox-sensitive cysteines at the cytoplasmic membrane, so it is unlikely that 
sensor kinase mis-folding is the cause of changes to activity of the remaining TFs. A 
large up-regulation of genes involved in the acid response, however does suggest that 









TF  Role Induced by References 
AppY Activator 
Anaerobiosis, stationary phase, 
and phosphate starvation 
(Brøndsted and Atlung 1996; 
Atlung et al. 1997) 
ArcA Both  Low oxygen conditions  
(Georgellis, Lynch and Lin 1997; 
Iuchi and Lin 1988) 
BirA Repressor A reduced demand for biotin 
(Eisenberg, O and Hsiung 1982; 
Adikaram and Beckett 2013) 
CsgD Both  
Low osmolarity and low 
growth temperature (<32°C) 
(Gualdi et al. 2008; Prigent-
Combaret et al. 2001) 
CueR Both  Presence of copper 
(Stoyanov, Magnani and Solioz 
2003; Yamamoto and Ishihama 
2005) 
DhaR Both  Presence of dihydroxyacetone (Bächler et al. 2005) 
FlhDC Both  Inducer unknown  
(Stafford, Ogi and Hughes 2005; 
Claret and Hughes 2002; Lay and 
Gottesman 2012) 
GadX Both  
Inducer unknown- possibly 
Na+ concentration but not 
proven 
(Richard and Foster 2007) 
LeuO Activator Amino acid starvation 
(Chen et al. 2001; Majumder et 
al. 2001) 
NhaR Activator Na+ concentration  
(Rahav-Manor et al. 1992; Padan 
and Schuldiner 1994) 
oxyS Repressor H2O2 
 (Gonzalez-Flecha and Demple 
1999; Altuvia, Weinstein-Fischer 
and Zhang 1997) 
PepA Repressor Inducer unknown (Devroede et al. 2004) 
RcsB Activator 
Changes in temperature, 
overexpression of membrane 
protein, and osmolarity 
(Sledjeski and Gottesman 1996; 
Majdalani and Gottesman 2005; 
Mouslim, Latifi and Groisman 
2003) 
TrpR repressor 
Increase in intracellular levels 
of tryptophan 
 (Squires, Lee and Yanofsky 
1975; Gunsalus and Yanofsky 
1980)  
 
Table 4-4. Identification of GSH/cysteine-mediated environmental changes that are 
independent of cytochrome bd-I assembly 
Transcription factors identified in Table 4-1 are listed with environmental stimuli that 
induce function. It is hypothesised that these environmental changes take place due to 
the presence of CydDC substrates GSH and cysteine in the periplasm, and are 
independent of cytochrome bd-I assembly. 
 
DhaR is an activator of the dhaKLM operon when in the presence of dihydroxyacetone. 
Here, the activity of DhaR is reduced and the dhaKLM genes are the most repressed 
genes in Table 4-1. The dhaKLM genes encode three subunits of the Dha kinase which 
utilises phosphoenolpyruvate (PEP) as a source of phosphate to phosphorylate 
dihydroxyacetone. 
FlhDC controls motility and chemotaxis by activating genes of flagella 
biosynthesis. Activity of FlhDC was found to be reduced by the addition of GSH and 
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cysteine, as the motility genes flgABCDEFGHIJMN are repressed. Unfortunately as no 
inducer of FlhDC has yet been reported, this makes it difficult to understand why these 
genes are repressed by the addition of thiols to the media.  
LeuO (activator) and TrpR (repressor) are induced by changes in the level of 
amino acids and alter the biosynthesis of amino acids accordingly. Here, the addition of 
GSH and cysteine leads to an increase in the repression of tryptophan biosynthesis by 
TrpR and a repression of leucine biosynthesis by a reduction in LeuO activity, implying 
that the demand for amino acids within cells is reduced.  
NhaR (and potentially GadX) respond to changes in sodium ion levels. CueR 
responds to increases in copper levels, as CueR activity is decreased, it is possible that 
intracellular copper levels are diminished. The small RNA oxyS is induced by H2O2, so 
a repression if oxyS activity in the current study indicates a reduction in oxidative stress 
and H2O2 levels. 
To further analyse the environmental changes that could elicit the cytochrome 
bd-I-dependent gene regulation in response to GSH/cysteine, environmental stimuli 
were identified for all the transcription factors in Table 4-2 (Table 4-5).  
 
TF  Role Induced by References 
MngR Repressor Fatty acids levels 
 (Sampaio et al. 2004; Quail, 
Dempsey and Guest 1994) 
PrpR Both  
The absence of glucose or 
glycerol 
 (Lee, Newman and Keasling 
2005) 
PutA Repressor   Absence of proline  





activator Low Mg2+ 
 (Minagawa et al. 2003; K. 
Yamamoto et al. 2005; 
Ogasawara et al. 2007) 
 
Table 4-5. Identification of GSH/cysteine-mediated environmental changes that 
result from cytochrome bd-I assembly 
Transcription factors identified in Table 4-2 are listed with environmental stimuli that 
induce function. It is hypothesised that these environmental changes take place due to 
the presence of CydDC substrates GSH and cysteine in the periplasm, and are 
dependent upon cytochrome bd-I assembly. 
 
Transcription factors that are affected only by the addition of GSH and cysteine in a 
cydDC mutant but not the cydDC cydAB mutant respond to stimuli including, levels of 




The repressor MngR is known to be degraded by fatty acids and is shown here to 
be down-regulated by thiol addition. This suggests that fatty acid levels are increased. 
Interestingly, the mngAB operon, controlled by MngR is found upstream of the cydABX 
operon. 
PutA has two functions that are mutually exclusive of one another. In the 
absence of proline, PutA is cytoplasmic and acts as a repressor of proline degradation 
enzymes. In the presence of proline PutA is associated with the inner membrane and 
catalyses both enzymatic steps in the proline degradative pathway which simultaneously 
reduces ubiquinone to ubiquinol. Transcription factor activity of PutA is reduced when 
cytochrome bd-I is restored by thiol addition, so proline degradation is presumed to be 
up-regulated with an increase in reduction of ubiquinone to ubiquinol. PutA activity has 
also been shown to be reduced by prolonged exposure to osmotic stress, so the 
reduction in transcription factor activity may be due to this reason rather than changes in 
proline levels (Deutch et al. 1989).  
PrpR is an activator of prpBCD, the activity of PrpR is reduced as seen by the 
repression of prpC and prpD. The prpBCDE operon encodes proteins involved in the 
methylcitrate cycle which utilises propionate as a carbon source, this cycle yields 
succinate and pyruvate that can feed into the TCA cycle. 
 
4.3.1 The impact of the CydDC substrates upon E. coli physiology 
In the absence of CydDC, cysteine and GSH are still present in the cytoplasm, but the 
absence of thiol export to the periplasm leads to a pleiotropic phenotype, including loss 
of fully assembled cytochrome bd-I. This microarray experiment aimed to define the 
affects that CydDC-mediated thiol export has on gene expression in E. coli by replacing 
thiols in the periplasm. Two microarray experiments were designed to indicate changes 
in expression of genes caused dependently or independently of cytochrome bd-I 
restoration.  
 These experiments showed that thiol addition affects the expression of many 
genes, both in cydDC and cydDC cydAB cells; which reflects the pleiotropic phenotype 
of CydDC mutants.  
In both cydDC and cydDC cydAB cells, the transcription of genes related to 
central metabolism are affected, with genes of the TCA cycle being repressed alongside 
the biosynthesis and transport of amino acids. Transcription of motility genes were also 
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down-regulated in the presence of the two LMW thiols. Respiratory genes are up-
regulated, including appBC which encodes cytochrome bd-II and hyaABCDF genes that 
encode hydrogenase-I. 
In response to the addition of GSH and cysteine, transcription factors with altered 
activity respond to a variety of stimuli, including; a sufficient level of intracellular 
amino acids, low oxygen, changes in osmolarity, phosphate starvation, over-expression 









Roles of CydDC and cytochrome bd-I in 
the pathogenesis of uropathogenic E. 








In Chapter 3 it was reported that CydDC-mediated reductant export provides tolerance 
to NO independently of cytochrome bd-I. NO is an important tool of the host innate 
immune system armoury and these findings suggest that cytochrome bd-I and CydDC 
may provide a concerted role in survival within the host environment. Given that the 
genetic variation between pathogenic and non-pathogenic strains is considerable, an 
analysis of the gene and protein sequences encoding CydDC and cytochrome bd-I from 
the commensal strain MG1655 were compared with those from two UPEC strains; 
CFT073 and EC958. This data showed that the protein sequences of cytochrome bd-I in 
all these strains were identical. Amino acid substitutions were shown to exist between 
the protein sequences of MG1655 CydD and CydC and the corresponding proteins in 
the pathogenic strains. The location of these amino acids suggests that these variations 
are unlikely to affect the core function of the exporter complex. 
To investigate the contribution of CydDC and cytochrome bd-I to nitric oxide 
tolerance in the context of pathogenic E. coli, NOC-12 growth curves were performed 
using the UPEC strains CFT073 and EC958. Deletion of either CydDC or cytochrome 
bd-I was found to elicit sensitivity to NO in both UPEC strains. When comparing the 
inhibition of the two CFT073 mutants, a similar inhibition was seen for both mutants 
after the addition of 0.5 mM NOC-12, increasing the concentration of NOC-12 to 1 mM 
resulted in a larger growth inhibition for strains lacking CydDC. This suggested that at 
higher concentrations of NOC-12, CydDC plays a more prominent role in NO-tolerance 
for the CFT073 strain. In the EC958 background, however, the cytochrome bd-I mutant 
was more sensitive to NO than the cydDC mutant.  
Prior to infection studies, it seemed prudent to investigate if deletion of 
cytochrome bd-I and CydDC affected the level of type 1 fimbriae (an important adhesin 
and virulence factor). Yeast agglutination assays demonstrated that aerobically-grown 
non-pathogenic and CFT073 cells exhibited a low level of fimbriation, and that type 1 
fimbriae are not expressed by EC958 cells when grown aerobically. Changing the 
culture conditions to static growth selected for type 1 fimbriae expression in all three E. 
coli strains, and deletion of CydDC or cytochrome bd-I was shown to have no effect 
upon the level of  type 1 fimbriae in UPEC strains under these growth conditions.    
The role of cytochrome bd-I and CydDC in UPEC strains was studied in the 
context of the host using a mouse UTI model and macrophage survival assays. The 
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deletion of cytochrome bd-I reduces the survival of UPEC strain EC958 within 
macrophage cells. However, the deletion of cydDC (and consequent loss of functional 
cytochrome bd-I) was shown to have no effect upon the ability of UPEC strain EC958 
to survive within macrophage cells or to colonise the mouse model of UTI. Taken 
together with the observation that the EC958cydDC strain is less sensitive to NO than 
expected (due to previous K-12 data), this intriguing observation highlights how some 
clinical isolates of the same species can respond differently to the loss of highly 






Uropathogenic E. coli (UPEC) are among the most common infectious diseases of 
humans (Harding and Ronald 1994), causing an estimated 150 million infections a year 
globally. A major cause of morbidity and mortality, symptomatic UTIs usually start as 
cystitis, but can ascend into pyelonephritis with potential for bacteria to cross the 
epithelial cells of the proximal tubule and the endothelial cells of the capillary to gain 
access to the bloodstream, causing bacteraemia and occasionally sepsis. With a high rate 
of recurrence and the emergence of antibiotic resistance, it is important to understand 
the mechanisms that promote survival of pathogens that cause UTI. It is well-known 
that E. coli has several resistance mechanisms that provide tolerance to the toxic effects 
of host-derived NO that is encountered during infection, including the NO-tolerant 
cytochrome bd-I terminal respiratory oxidase that permits aerobic respiration under the 
microaerobic conditions encountered during infection (Mason et al. 2009).  This chapter 
explores the importance of cytochrome bd-I and the CydDC ABC transporter (that is 
required for cytochrome bd-I assembly) during UPEC infection. 
We have previously shown (Chapter 3) that deletion of genes encoding 
cytochrome bd-I (cydB) and CydDC (cydD) in non-pathogenic E. coli strains elicits an 
NO-sensitive phenotype. We further showed that growth of the cydD mutant is more 
sensitive to nitric oxide than the cydB mutant. These findings suggest that reductant 
export by CydDC may provide a significant contribution to the survival of UPEC during 
infection. However, large pathogenicity islands carrying virulence genes create genetic 
diversity within UPEC strains (Lloyd et al. 2009; Welch et al. 2002; Groisman and 
Ochman 1996), which may explain why uropathogenic E. coli have been reported to 
display greater resistance to nitrosative stress than non-pathogenic E. coli (Bower and 
Mulvey 2006). Given these profound genetic differences between E. coli K-12 and 
UPEC strains, it is essential to assess the importance of CydDC and cytochrome bd-I in 
UPEC genetic backgrounds before assuming that the role of these proteins in NO 
tolerance remains the same. The well-characterised pyelonephritis-causing CFT073 
strain and the multi-drug resistant EC958 isolate (Lau et al. 2008) of the sepsis-causing 
ST131 clonal group were used. 
 
Pyelonephritis is considered the most serious UTI as it is known to cause 
scarring of the kidneys. E. coli CFT073 was first isolated from the blood and urine of a 
woman being treated for acute pyelonephritis in the USA (Mobley and Green 1990). 
This highly virulent strain is cytotoxic for cultured human renal cells and causes acute 
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pyelonephritis in an ascending UTI mouse model (Mobley and Green 1990; Mobley et 
al. 1993). Like other pyelonephritogenic E. coli strains, CFT073 cells express P 
fimbriae, encoded by the pap (pyelonephritis-associated pili) genes, which allow a firm 
attachment to uroepithelial cells (Källenius et al. 1981).   
The E. coli clonal group sequence type 131 (ST131) has emerged to become a 
globally dominant cause of human infection (Rogers, Sidjabat and Paterson 2011), and 
the success of this pathogen is largely attributed to accumulated antibiotic resistance and 
virulence genes. This multidrug resistant clone carries the CTX-M-15 extended 
spectrum beta-lactamase enzyme and is fluoroquinolone resistant. EC958 is a single 
isolate of the ST131 clonal group that was first isolated in 2005 from the urine of a 
patient with a urinary tract infection in the UK (Woodford et al. 2007). EC958 
represents the most well-characterised ST131 strain, with a genome sequence published 
in 2011 (Totsika et al. 2011) which was followed by a transposon mutagenesis study 
that identified genes required for resistance to human serum (Phan et al. 2013). 
 In this chapter, we assess the sensitivity of cydDC and cydAB mutants of 
UPEC strains CFT073 and EC958 to NO via in vitro growth experiments, then 
analyse the importance of CydDC and cytochrome bd-I in the context of in vivo 





5.2.1 Investigating sequence conservation in CydDC and cytochrome bd-I 
Given the high degree of genetic variability between K-12 and UPEC strains, it was 
deemed prudent to analyse sequence similarities/differences within CydAB and CydDC 
protein complexes from the non-pathogenic MG1655 strain and UPEC strains CFT073 
and EC958.  
5.2.1.1 The sequences of the cydDC operon are similar for MG1655, CFT073 and 
EC958 strains 
The nucleotide sequences of cydDC from different E. coli strains were aligned using 
Bioedit (v7.2.5) to enable a direct comparison of the nucleotide sequences. Despite a 
number of single nucleotide polymorphisms (SNPs), the cydDC nucleotide sequence of 
MG1655 has a 98% identity with the cydDC sequences of CFT073 and EC958. When 
comparing the cydDC nucleotide sequences of CFT073 and EC958 a 99% identity is 
seen.  
5.2.1.2 Variations in amino acid sequences of CydD and CydC  
To determine if the differences in gene sequence were of any significance, the translated 
amino acid sequences were aligned (Appendix C-1), and SNPs were investigated to 
decide if they resulted in a change of amino acid. Those that lead to an amino acid 
change are described in Table 5-1. The majority of amino acid changes seen are shared 
between the two pathogenic groups. Most of the substitutions result in a non-










Table 5-1 Amino acid variations in CydD and CydC in E. coli strains MG1655, 
CFT073 and EC958 
Colours indicate the nature of amino acid side chains: orange, non-polar; green, polar; 
blue, basic; purple acidic. 
 
To investigate how these SNPs might affect protein function, amino acid 
changes were mapped onto their predicted location on membrane topology maps using 
Protter v1.0 (Omasits et al. 2014), an online programme that predicts membrane 
topology. It was found that the large majority of the variable amino acids are located in 
the ATP-binding domains (Figure 5-1). The change from valine to phenylalanine at 
position 70 in CydD maintains a hydrophobic amino acid at that site, which is consistent 
with the predicted location within a membrane spanning helix (Figure 5-1). This 
mutation is unlikely to affect protein structure or function as the amino acid is changed 
to another hydrophobic amino acid side chain. The remaining replacements of amino 
acids are found at the C-terminus of CydD or CydC, where the ATP-binding domains of 
each protein are found. These changes are less conservative in amino side chain 
characteristics, suggesting that they could potentially affect protein function. 








CydD 70 Valine Phenylalanine Phenylalanine 
CydD 457 Alanine Threonine Threonine 
CydD 560 Arginine Glutamine Glutamine 
CydC 323 Glutamate Glutamate Lysine 
CydC 360 Serine Tyrosine Tyrosine 
CydC 385 Glutamine Leucine Leucine 
CydC 447 Serine Alanine Alanine 
CydC 522 Arginine Cysteine Cysteine 
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The highly conserved Walker-A ATP-binding motif G/AxxxxGKT/S (where x is any 
amino acid), and the consensus Walker-B motif, zzzzD or zzzzDE, (where z is a 
hydrophobic amino acid), are integral parts of ATP-binding domains (Hanson and 
Whiteheart 2005). The P-loop of the Walker-A motif directly binds the phosphates of 
ATP and the aspartate residue of the Walker-B motif can coordinate a magnesium ion 
that is required for ATP hydrolysis (Hanson and Whiteheart 2005). Further 
investigation of the variation in amino acid sequences within CydD and CydC (Figure 
5-1) showed that none of the substitutions that differ between pathogenic or non-
pathogenic E. coli strains occur within the Walker-A or B motifs of the ATP-binding 
domains. This implies that the variations seen in UPEC CydD and CydC protein 
sequences are unlikely to affect the core function of CydDC 
To further investigate the spatial organisation of these SNPS, a recent model of the 
structure of CydDC was studied (Shepherd 2015). This model was generated by using a 
structural homolog, Sav1866 (an ABC transporter of Staphylococcus aureus) as a 
template via the memoir modelling tool (Ebejer et al. 2013). The Sav1866 template had 
been created by crystallisation of Sav1866 in the presence of two bound ADP 
molecules, despite this the NBDs exhibit an ATP bound conformation which is 
consistent with the finding that the TMDs are in an outward facing conformation 
(Dawson and Locher 2006). The bound ADP molecules of the Sav1866 model were 
shown to into fit the NBDs of CydDC. Labelling the model with the SNPs listed in 
Table 5-1 identified that these SNPs are dispersed across the dimer complex. None of 
the amino acids seem to be close to the conserved histidine residues or the nucleotide 
binding site in the NBDs, instead appearing at the outer edges of the NBDs (Figure 5-2). 
This further suggests that the core function of CydDC is unlikely to be affected by the 
SNPs found in UPEC strains.   
5.2.1.3 The gene sequences of cydAB are similar for MG1655, CFT073 and EC958 
E. coli strains and lead to no changes in amino acid sequence 
The nucleotide sequences of cydAB from different E. coli strains were aligned using 
Bioedit (v7.2.5) to enable a direct comparison of the nucleotide sequences. The cydAB 
nucleotide sequence of MG1655, despite a number of single nucleotide polymorphisms 
(SNPs), has a 99% identity with the cydAB sequences of CFT073 and EC958. None of 
the SNPs within the sequence of cydAB cause a substitution of amino acids and 
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Figure 5-1. Membrane topology of CydD and CydC showing positions at which amino acids vary between MG1655, CFT073 and EC958 E. 
coli strains 
 
Where amino acids in the CFT073 and/or EC958 sequences are different from the MG1655 sequence, these amino acids are coloured pink. The 
sequences coloured red or blue in the C-terminal ATP-binding domains show the Walker A and B motifs respectively.  Most of the amino acid 
substitutions occur within the ATP-binding domains (an intracellular domain) of CydD and CydC. The conserved histidine residue conserved within 
ABC transporters is shown in green. One substitution occurs within a membrane helix, but this is a conservative change from valine to phenylalanine 




     
Figure 5-2 Spatial organisation of SNPs within CydDC of E. coli 
 
A The CydDC model superimposed on to the structure of Sav1866 by Shepherd, 2015 
was used to determine the spatial position of the SNPs listed in Table 5-1 in a bid to 
determine if SNPs are likely to affect protein function. Conserved histidine residues 
His542 of CydD and His531 of CydC are highlighted in red, these residues form a 
K\GURJHQERQGZLWK WKHȖ-phosphate of ATP. B 90° rotation shows the view from the 
cytoplasm and emphasises the lack of SNPs in the area of nucleotide binding. 
Abbreviations: ICLs, intracytoplasmic loops; TMD, transmembrane domains; NBDs, 
nucleotide binding domains.  
 
5.2.2 Deletion of the cydDC operon in the CFT073 strain 
A CFT073cydAB strain was available in the Shepherd lab collection (MS17), which had 
been kindly provided by Prof. Mark Schembri at the University of Queensland. For this 
chapter it was necessary to generate a CFT073cydDC VWUDLQ06XVLQJWKHȜ±Red 
mutagenesis approach (Datsenko and Wanner 2000) described in Section 2.2.4. Briefly, 
primers pMS35 and pMS36 (Table 2-2) that anneal 500 bp either side of the cydDC 
operon, were used to amplify the chloramphenicol resistance cassette from a K-12 
cydDC::Cm mutant, generating 500 bp flanking regions, homologous to the DNA either 








electroporation, and recombination between the homologous regions was enhanced by 
the O-Red recombinase. Following the mutagenesis protocol, colony PCR was 
performed to confirm that the mutation had been introduced. PCR using primers pMS3 
and pMS4 (Table 2-2) produces fragments of sizes 3,862 bp when the original DNA 
sequence was used as a template and 1,552 bp when the chloramphenicol resistance 
cassette had replaced the cydDC operon (Figure 5-3). These data clearly indicate that 
the cydDC operon had been replaced by the resistance cassette. This was later verified 
via Sanger sequencing, performed as described in Section 2.2.5 and the results are 
















Figure 5-3. PCR verification of electroporation colonies 
 
Colony PCR was performed on colonies resistant to chloramphenicol after 
electroporation of MS5 (CFT073 pKD46) with cydDC::Cm DNA fragment. For the 
PCR, primers pMS3 and pMS4 (Table 2-2) were used. Colonies of strains MS5 and 
MS14 (MG1655 cydDC::Cm) were tested alongside electroporation colonies as 
controls. Use of MS5 as a DNA template resulted in a band at around 4,000 bp 
representing the size of the cydDC operon (expected size 3,862 bp) and MS14 showed a 
band around 1,500 bp representing the size of cydDC::Cm (expected size 1552 bp). 
PCR of the electroporation colonies also resulted in DNA fragments around 1,500 bp in 
length, indicating that the cydDC operon has been replaced by the chloramphenicol 


































5.2.3 Nitric oxide tolerance: The contribution of CydDC and 
cytochrome bd-I in the pathogenic strains EC958 and CFT073 
In Chapter 3 it was shown that cytochrome bd-I and CydDC complexes contribute to 
NO tolerance in non-pathogenic E. coli K-12 strains via growth experiments using 
NOC-12 as an NO donor. It was therefore of interest to investigate if this holds true for 
pathogenic strains. Herein, the contribution of CydDC and cytochrome bd-I to NO 
tolerance is investigated in clinical isolates EC958 and CFT073. 
 
5.2.3.1 Loss of functional cytochrome bd-I and CydDC in EC958 strains elicits 
sensitivity to NO. 
EC958 strains were kindly provided by Prof. Mark Shembri from the University of 
Queensland. Initial growth curves demonstrated that deletion of cydAB and cydDC in 
EC958 and CFT073 strains increases the lag phase. Since NO is a labile molecule and 
changes to cell density can have a profound effect upon NO sensitivity, the addition of 
NOC-12 was performed once cells were no longer in the lag phase at a defined optical 
density of cell culture. Strains were allowed to grow in flasks to an OD600 of 0.5, which 
ensured that cells were no longer in lag phase. Cultures were then diluted to an OD600 of 
0.2 before being placed into microplate wells for growth curves to be performed in a 
plate reader. Higher concentrations of NOC-12 were used than in previous growth 
curves due to the higher starting optical density. Growth in the presence of NOC-12 
shows a similar pattern to that seen using Keio strains (Figure 3-2) Growth is inhibited 
for a period of time that is dependent upon the concentration of NOC-12 added and 
strain used, and then growth resumes once cells have adapted to the NO released and/or 
the level of NO has been depleted (Figure 5-4). The extent of growth inhibition by NO 
could then be assessed by comparing the duration in which growth is inhibited, for 
example by comparing the time taken to reach an OD600 of 0.5.  
In the absence of NOC-12, the growth of all three strains is very similar as 
shown by the similar amount of time taken for these strains to reach an OD600 of 0.5 
(Figure 5-5). When NOC-12 is added at a concentration of 0.5 mM there is a drastic 
difference in growth inhibition when cydDC (MS271) and cydAB (MS16) are deleted 
when compared to wild type (MS10) as shown by the extension of the time taken to 
reach OD600 0.5, wild type growth appears to remain unaffected, with growth 




to adapt to this level of nitrosative stress, however when cells lose these protein 
complexes this protection against growth inhibition is lost. Growth of wild type strains 
is inhibited when the concentration of NOC-12 is increased to 0.75 mM, and the 
difference in growth inhibition of wild type and mutant cells is diminished, suggesting 
that at this concentration, CydDC and cytochrome bd-I are not able to completely 
protect cells from the detrimental effects of NO.    
Comparison of the inhibitory effect of NOC-12 between EC958cydAB and 
EC958cydDC strains indicates that cydAB is slightly more sensitive to NO, taking 
longer to reach an OD600 of 0.5 at equivalent NOC-12 concentrations (Figure 5-5), 
although the cydDC strain is also more sensitive to NO than the isogenic wild type. 
 
 
Figure 5-4. Mutation of cydAB and cydDC in EC958 UPEC strains elicits sensitivity 
to NO 
 
Cultures were grown shaking in 96 well plates. Bacterial growth was measured using a 
plate reader. A without addition of NOC-12 B following the addition of 0.5 mM NOC-
12 C 0.75 mM NOC-12 and D 1 mM NOC-12. All data shown in this figure was 
collected within the same 96 well plate. Each condition was performed with five 
























Figure 5-5. Mutation of cydAB and cydDC in EC958 elicits sensitivity to nitric 
oxide 
 
The time taken to reach an OD600 of 0.5 was used as a measurement of growth 
inhibition between wild type, cydAB and cydDC strains of uropathogenic E. coli EC958. 
The more that a strain was inhibited by NO released from NOC-12 the longer these 
strains took to reach an OD600 of 0.5. NOC-12 was added at concentrations of 0.5 mM, 
0.75 mM and 1 mM. The error bars show the standard deviation of five technical 
repeats.  
 
The extent of growth inhibition by NO was assessed for E. coli CFT073 cydAB 
and cydDC mutants, as previously performed for E. coli EC958 (Section 5.3.1), growth 
curves are shown in Figure 5-6. The extent of inhibition was compared between the 
strains by analysing the length of time in which growth is inhibited after NOC-12 
addition (Figure 5-7). Unlike the EC958 strain, growth of wild type CFT073 (MS1) was 
inhibited by NOC-12 added at a concentration of 0.5 mM, suggesting that CFT073 
strains are more sensitive to nitrosative stress than EC958. Despite this, mutation of 
cydAB (MS17) and cydDC (MS115) did elicit additional sensitivity to 0.5 mM NOC-12 
as shown by the prolonged time taken to reach OD600 0.5. This suggests that CydDC 
and cytochrome bd-I do have a role in protection against nitrosative stress in E. coli 
CFT073. A similar level of growth inhibition is observed for CFT073cydAB (blue) and 
CFT073cydDC (orange) at a NOC-12 concentration of 0.5 mM. Increasing the 
concentration of NOC-12 to 1 mM however, elicits a larger sensitivity of growth for 





strains lacking CydDC than those lacking cytochrome bd-I. This suggests that at higher 





















Figure 5-6. Growth of CFT073 UPEC strains in the presence of NOC-12 
 
Cultures were grown shaking in 96 well plates. Bacterial growth was measured using a 
plate reader. A without addition of NOC-12 B following the addition of 0.5 mM NOC-
12 C 0.75 mM NOC-12 and D 1 mM NOC-12. All data shown in this figure was 
collected within the same 96 well plate. Each condition was performed with five 



























Figure 5-7. Loss of CydDC and cytochrome bd-I leads to NO sensitivity in CFT073 
UPEC 
 
Wild type, cydAB and cydDC mutants of E. coli CFT073 were grown at 37oC, 200 rpm 
in 96 well plates. Following the addition of NOC-12 (0.5 mM and 1 mM) bacterial 
growth was measured at OD600. Growth inhibition after the addition of NOC-12 was 
assessed by comparing the time taken for growth to reach an OD600 of 0.5. Five 
technical repeats were performed for each growth condition and the error bars represent 
standard deviation between these.  
 
5.2.4 Cytochrome bd-I and CydDC influence type 1 fimbriation 
To colonise the urinary tract, UPEC strains need to tightly adhere to uroepithelial cells 
to prevent being flushed out by the shearing force of urine flow. Type 1 (or mannose-
sensitive) fimbriae are one of the few virulence factors shown to satisfy Molecular 
.RFK¶V 3RVWXODWHV LQ DFXWH 87, (Connell and Agace 1996; Bahrani-Mougeot et al. 
2002). It has been demonstrated through use of a fimbrial adhesin inhibitor that type 1 
fimbriae are crucial for E. coli EC958 to establish infection within the bladders of mice 
(Totsika et al. 2013).   
The structural subunits of type 1 fimbriae are homologous proteins sharing an 
invariant disulphide bridge (Crespo et al. 2012), it has been shown in CFT073 cells, that 
functional assembly of type 1 fimbriae can occur independently of the DsbAB and 
DsbLI disulphide folding machineries (Totsika et al. 2009), suggesting an alternative 






and is therefore likely to influence disulphide folding (Pittman et al. 2002; Pittman, 
Robinson and Poole 2005), deletion of cydDC is hypothesised to perturb disulphide 
formation in type 1 fimbriae, preventing these mutants from being able to successfully 
adhere to host cells. To determine the level of type 1 fimbriation, a yeast agglutination 
assay (Section 2.1.9) was used; Saccharomyces cerevisiae cells were mixed with 
bacterial cells and this mixture was viewed under a light microscope. Bacterial fimbriae 
attach to mannoside-containing receptors on the surface of yeast cells which can be 
visualised as agglutination due to yeast cells being larger than bacterial cells. The theory 
is that, the more fimbriae present on each bacterial cell, the more yeast cells are bound 
to the bacterial cell to elicit a larger amount of agglutination. If little or no fimbriae are 
present on the bacterial cells, yeast and bacteria will continue to be freely diffused 
throughout the mixture. This is a quick and easy way of assessing functional fimbriae 
but is limited in sensitivity, as exact fimbriae levels cannot be determined. 
 
5.2.4.1 Loss of CydDC and cytochrome bd-I elicits loss of type 1 fimbriae in 
CFT073 and Keio strains in agitated cultures 
Wild type Keio and CFT073 strains exhibit agglutination (Figure 5-8), indicating the 
presence of type 1 fimbriae on these cells that is manifested as clumping under the light 
microscope. In addition to wild type and cydDC experiments, strains lacking 
cytochrome bd-I were also included as a control, and it was hypothesised that loss of 
this operon would not inhibit fimbrial assembly. All of the EC958 strains appear very 
similar to the afimbriate (Afim) control strain, showing no agglutination when mixed 
with the yeast solution. This is possibly due to a 1,895bp insertion  that was identified in 
the fimB gene of EC958, inactivating a recombinase that activates expression of type 1 
fimbriae (Totsika et al. 2011).  
Mutation of cydAB and cydDC in the Keio and CFT073 background diminishes 
the amount of agglutination seen (Figure 5-8), and suggests that deletion of these genes 
diminishes assembly of type 1 fimbriae. Gene deletions in the Keio background appears 
to completely inhibit agglutination with the yeast cells, whereas the CFT073 mutants 
display a very small amount of agglutination but this is significantly diminished 
compared to the wild type. The lack of resolution in this experimental approach 




CydDC. However, the surprising finding is that loss of cytochrome bd-I assembly 
diminishes the assembly of type 1 fimbriae.  
$ VWUDLQ ZKLFK LV ORFNHG LQ WKH µRQ¶ SRVLWLRQ DW WKH fim switch (AAEC554) 
(McClain et al. 1993) was used as a positive control, and none of the other E. coli 
VWUDLQV WHVWHG VKRZHG WKH VDPH OHYHO RI DJJOXWLQDWLRQ DV WKLV µORFNHG RQ VWUDLQ¶ 7KLV
suggests that the test cultures exhibiting agglutination comprise populations of cells that 
have some fim VZLWFKHVLQWKHµRQ¶SRVLWLRQDQGVRPHLQWKHµRII¶RULHQWDWLRQ 
5.2.4.2 Loss of cytochrome bd-I or CydDC does not diminish type 1 fimbriation in 
static aerated liquid cultures 
Fimbriae are crucial for UPEC to colonise the urinary tract and it is likely that their 
expression will be induced by an environmental cue during host colonisation. Inside the 
urinary tract, bacterial pathogens will encounter oxygen limiting conditions, so it was of 
interest to investigate the impact of CydDC and cytochrome bd-I upon the assembly of 
type 1 fimbriae under conditions found inside the host. 
Expression of functional type 1 fimbriae is known to be enhanced when cultures 
are grown statically (Totsika et al. 2011). Hence, decreasing the dissolved oxygen 
concentrations was undertaken to allow the influence of CydDC and cytochrome bd-I 
on fimbriae levels to be investigated under conditions found during infection. Yeast 
agglutination in all test strains was improved when grown statically (Figure 5-9) 
compared to when cultures are agitated (Figure 5-8), which is consistent with the model 
that static growth strongly selects for type 1 fimbriae expression. Agglutination in 
pathogenic strains CFT073 and EC958 was unaffected by deletion of the cydAB or 
cydDC operons, suggesting that expression of type 1 fimbriae is not influenced by these 
systems under conditions of diminished aeration. 
In the Keio background, mutation of cydB does not completely abolish the expression of 
type 1 fimbriae as agglutination is still observed, however the level of type 1 fimbriae 
appears to be reduced as the amount of agglutination seen after 5 minutes is diminished.  
Interestingly, the cydD mutant, which is also unable to assemble cytochrome bd-I, 










            
Figure 5-8. Loss of type 1 fimbriae is seen in CFT073 and Keio strains lacking 
CydDC or cytochrome bd-I 
Yeast agglutination assay showing the levels of expression of type 1 fimbriae on E. coli 
cells of Keio, CFT073 and EC958 strains when grown in agitated cultures. A strain in 
which the fim VZLWFK LV ORFNHG LQ WKHµRQ¶SRVLWLRQ$$(& (McClain et al. 1993) 
was used as a positive control, and an afimbriate strain (Afim) was used as an 
agglutination negative control (BGEC487) (Kulasekara and Blomfield 1999).  
 
















              
 
 
Figure 5-9. Loss of type 1 fimbriae is not observed in UPEC strains lacking CydDC 
or cytochrome bd-I when grown statically 
Yeast agglutination assay showing the levels of type 1 fimbriae of various E. coli strains 
(Keio, CFT073 and EC958) when grown statically at 37϶C. A strain in which the fim 
VZLWFKLVORFNHGLQWKHµRQ¶orientation (AAEC554) (McClain et al. 1993) was used as a 
positive control, and an afimbriate strain (Afim) was used as an agglutination negative 
control (BGEC487) (Kulasekara and Blomfield 1999).   











5.2.5 Macrophage survival assays 
During infection pathogenic strains of E. coli are engulfed by macrophages, which 
expose the pathogen to nitrosative stress. Previous chapters and sections within this 
chapter have demonstrated the importance of CydDC and cytochrome bd-I for the 
tolerance of E. coli to nitrosative stress. It was therefore of interest to investigate the 
ability of cydDC and cydAB strains to survive exposure to macrophages that have been 
primed to produce NO. 
 It is well-known that innate immunity plays a major role in defence against 
UPEC. In mice, it has been shown that UPEC infection results in the recruitment of 
macrophage cells to the bladder (Ingersoll and Cohen 2008; Engel et al. 2008), 
indicating that macrophages participate in the innate immune response against UPEC. 
Furthermore, given that macrophages utilise nitric oxide as a defence against invading 
bacteria, it was of interest to investigate the contribution of CydDC and cytochrome bd-
I to survival within macrophage cells. The exact role that intra-macrophage survival 
plays in the virulence of UPEC strains is still uncertain but it is thought that intracellular 
bacterial communities (IBCs) within epithelial cells provide a constant supply of 
bacteria for reinfection of macrophage cells, if UPEC are able to survive within 
macrophage cells it is possible that the bacteria may be transported within macrophage 
cells to other sites within the host (Bokil et al. 2011).  
5.2.5.1 Loss of cytochrome bd-I but not CydDC elicits reduced survival of E. coli 
EC958 within murine macrophage.   
Macrophage survival assays were performed as described in Section 2.5.2 at the 
University of Queensland. EC958 has previously shown elevated bacterial loads in bone 
marrow derived macrophage (BMM) at 24 hours post infection when compared to 
CFT073, showing that they are adapted to growth within macrophage cells (Bokil et al. 
2011). Wild type, cydAB and cydDC mutants of EC958 background were used in these 
experiments. As discussed in Section 5.2.4, the virulence of UPEC strains relies heavily 
upon adhesion through type 1 fimbriae. EC958 strains were used in macrophage and 
mouse model experiments, and to ensure that differential fimbriae expression did not 





Once grown to stationary phase, Fim enrichment was confirmed by a quick yeast 
agglutination assay (Section 2.1.9). 
Cultures were diluted to achieve equivalent OD600 readings for all strains and 
were used to infect BMMs in 24-well plates. A multiplicity of infection of 10 was used 
(10 bacterial cells to every 1 macrophage cell) and this was checked by plating out the 
bacteria used to infect macrophage cells and counting the resulting number of CFU 
(Figure 5-10). After 30 minutes of BMM infection, extracellular bacteria were removed 
by washing with 200 ȝg gentamycin, this prevented any more uptake of bacteria in 
macrophage cells. The number of intra-macrophage bacteria after 2 and 24 hours of 
infection of macrophage cells were used as a measure of survival within macrophage 
cells. The results show that the survival of EC958cydAB is dramatically reduced when 
















Figure 5-10. Inoculum check for macrophage survival assay 
The number of bacterial cells added to macrophage cells for each strain of 
uropathogenic E. coli EC958. Error bars are based upon three CFU bacterial counts of 
inoculum added to macrophage cells. 
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Figure 5-11. Loss of cytochrome bd-I reduces UPEC survival within macrophages  
 
A. Intracellular colony counts after 30 min, 2 h and 24 h post-infection. The number of 
bacteria 30 minutes post infection is considered as the number of cells taken up by 
macrophage, two hours post infection is thought of as a good time point to see how well 
bacteria are able to survive within macrophages. At 24 hours post infection it is 
expected that most of the bacteria will be killed. B. The number of bacteria as a 
proportion of the number of bacteria taken up by macrophage cells. C. The number of 
bacterial cells inside macrophage cells 30 minutes, 2 hours and 24 hours post infection, 









5.2.6 Mouse model of UTI  
Previous work has demonstrated that loss of cytochrome bd-I elicits a diminished ability 
to colonise the mouse urinary tract (Dr Mark Shepherd, personal communication). It 
was hypothesised that loss of CydDC would have a dramatic effect on host colonisation, 
so the ability of UPEC to establish infection of the mouse urinary tract was studied. 
Competition experiments (described in Section 2.5.1) were performed to ensure larger, 
more significant datasets. A total of 15 mice were infected with an equal number of wild 
type (MS6016) and EC958cydDC::Gm (MS6110) strains, and colony counts were 
measured from the urine, bladder and kidneys. To permit the enumeration of both wild 
type and mutant strains taken from the same source, the wild type EC958 strain was lac- 
and chloramphenicol resistant. Therefore wild type CFUs could be distinguished from 
those of mutant strains on chloramphenicol plates and MacConkey agar plates. On 
MacConkey agar plates EC958lac::mkate (wild type) colonies would appear white, and 
mutant colonies would appear pink/red.  
As with the macrophage survival experiments, stationary phase cultures to be used in 
the mouse experiments were confirmed positive for expression of type 1 fimbriae by the 
yeast agglutination assay (Section 2.1.9) 
5.2.6.1 Loss of CydDC has no significant effect upon EC958 colonisation of lower 
urinary tract in mice. 
The colony counts from the urine, bladder and kidneys of mice infected with EC958 and 
EC958cydDC were measured (Figure 5-12). In this model of infection and time frame 
we would not expect to see bacteria within the kidneys and this was verified 
experimentally (Appendix C-3). Each circle (EC958) and square (EC958cydDC) 
represents a mouse and indicates the CFUs isolated from each sample. Colonisation of 
the urine and bladder was very similar for both strains, with the mean value for each 
strain appearing to be almost identical. The wilcoxon matched-pairs signed rank test 
shows that there is no significant difference in the number of wild type and mutant 
bacteria isolated from urine and bladder tissue samples.  As a precaution, CFU/ml of the 
inoculum was measured for each infection and used to calculate the fitness index, 















Figure 5-12. Loss of CydDC has no effect upon bacterial load isolated from urine 
or bladder of mice 
Each circle or square represents a mouse and the CFU isolated from A urine or B 
homogenised bladder samples. Lines through the dots shows mean of values.  Figures 





Figure 5-13. Fitness index: Loss of CydDC has no significant affect upon bacterial 
load in the bladder of mice infected with EC958 
Log fitness index of bacterial loads in mouse A urine and B bladder tissue. Fitness 
index takes into account the nature of a competition experiment, the number of wild 
type cells introduced to mice will not be exactly the same as mutant cells. So to remove 
bias a fitness index is determined which compares the ratio of wild type: mutant at the 
start and end of the experiment. A fitness index of 1 means that the number of CFU 
isolated of both strains is equal. The same is true for a log10 fitness value of 0.  
  
WT vs. cydDC WT vs. cydDC 
Bladder Urine 






5. 3 Discussion  
 
This chapter explored the variation in the roles played by CydDC and cytochrome bd-I 
in either non-pathogenic E. coli or UPEC strains. Previous experiments showed that 
non-pathogenic E. coli rely upon cytochrome bd-I and CydDC for protection from NO. 
This finding is of importance in the context of E. coli pathogenesis. However, as 
pathogenic strains vary genetically from laboratory strains, it remained to be determined 
whether NO protection by cytochrome bd-I and CydDC is as significant within strains 
of UPEC. To start with, the gene and protein sequences of both CydDC and cytochrome 
bd-I complexes were compared between the laboratory strain MG1655 and two UPEC 
strains CFT073 and EC958. As no significant differences between cytochrome bd-I 
protein sequences were observed it was assumed that cytochrome bd-I is fully 
functional and should perform the same role as in non-pathogenic E. coli.  
 
Despite UPEC and non-pathogenic strains being of the same species, variations in gene 
content could result in UPEC strains responding differently to NO exposure. Indeed, 
UPEC are thought to be more tolerant of NO, possibly due to the vertical acquirement 
of DNA elements containing multiple genes such as  pathogenicity islands (Groisman 
and Ochman 1996). Hence, it was anticipated that UPEC strains might not rely upon 
cytochrome bd-I or CydDC for NO tolerance as heavily as non-pathogenic strains. To 
test this, NOC-12 experiments previously performed on Keio collection strains (Chapter 
3), were repeated with UPEC strains to determine the contribution of CydDC and 
cytochrome bd-I to the protection against NO in UPEC strains. These experiments 
showed that loss of cytochrome bd-I and CydDC in CFT073 and EC958 UPEC strains 
still elicited sensitivity to NO. The relative sensitivity, however, when compared 
between CydDC and cytochrome bd-1 mutants was inconsistent with data collected on 
the non-pathogenic K-12 strain. For example, in the EC958 background, mutants of 
cytochrome bd-I were more sensitive to NO than an EC958 cydDC mutant. In the 
CFT073 background, cydAB and cydDC mutants showed a very similar level of growth 
inhibition at a concentration of 0.5 mM NOC-12 but a greater sensitivity of strains 
lacking CydDC at a NOC-12 concentration of 1 mM when compared to mutants of 
cytochrome bd-I. The similar level of inhibition elicited by the addition of 0.5 mM 




that the sensitivity of CFT073cydDC may be attributed solely to the loss of cytochrome 
bd-I. It is possible that the presence of exported thiols in the periplasm is not as 
important for defence against a NOC-12 concentration of 0.5 mM: at this concentration 
other NO detoxification systems in the cell (e.g. Hmp), could be sufficient to deal with 
incoming NO. The increase to 1 mM NOC-12 would then require LMW thiols in 
combination with Hmp to diminish the level of NO in the cytoplasm.  
In the EC958 experiments, the data unexpectedly showed that EC958cydDC was 
less sensitive to NO than EC958cydAB but still more sensitive than the isogenic wild 
type. Considering that CydDC is necessary for cytochrome bd-I function this finding 
cannot be easily explained. It was originally thought that a UPEC strain without CydDC 
would not be able to assemble cytochrome bd-I, and that a cydDC mutant would be 
equally or more sensitive to NO than a cytochrome bd-I mutant. As bd-I assembly has 
not been measured in the EC958cydDC strain it could be possible that a small amount 
of cytochrome bd-I in UPEC strains is still functional in the absence of CydDC. The 
EC958 genome could potentially encode more than one copy of CydDC, with the 
release of the EC958 genome in 2014 (Forde et al. 2014), it is now possible to search 
the genome for sequences similar to cydDC. The mega BLAST tool on the NCBI 
website (http://blast.ncbi.nlm.nih.gov) can be used to search for highly similar 
sequences; the gene sequences of cydD and cydC from EC958 were used as a query to 
search the entire E. coli ST131 EC958 genome for closely related sequences, with an 
aim to determine if alternative cydD and cydC genes are encoded by the pathogen. Only 
one hit, the original cydDC operon was found, thus demonstrating that the ST131 
genome encodes only one copy of CydDC.  
Alternaively, it is possible that glutathione and/or cysteine may be exported into 
the periplasm by another route that is independent of CydDC.  Indeed, glutathione has 
previously been shown to be present in the periplasm of a cydDC mutant (Eser et al. 
2009). Another possibility is that additional thioredoxin-like proteins in the periplasm of 
EC958 (as seen in other pathogenic bacteria, (Heras et al. 2009) that are not present in 
lab strains of E. coli may help to maintain the redox environment of the periplasm, 
making the export of thiols by CydDC less important for the assembly of cytochrome 
bd-I. As performed above, the BLAST tool was again used, this time dsbL and dsbI 
gene sequences were used as a query to search the entire E. coli ST131 EC958 genome 
for closely related sequences, highly similar sequences were indeed found within the 




correspond to dsbL and dsbI respectively. The difference in sensitivity between the 
cydDC mutant and isogenic wild type is still relatively large, suggesting that 
cytochrome bd-I assembly in EC958 remains largely reliant upon CydDC, but possibly 
not to the same extent as for Keio E. coli.  
Despite the variation of NO inhibition between cydDC and cytochrome bd-I 
mutants among UPEC strains, it was nevertheless, still shown that cytochrome bd-I and 
CydDC both contribute to the protection of UPEC strains against NO. The results imply 
that these protein complexes have a role in the survival of EC958 and CFT073 UPEC 
strains within the host. In addition to NO tolerance, CydDC may influence survival 
during infection through facilitating the folding of extracytoplasmic virulence factors 
that contain disulphide bonds (as mentioned in Section 1.1 and depicted in Figure 5-14); 
ensuring that conditions are maintained for correct protein folding and assembly. For 
bacteria colonising the urinary tract, it is important to be able to adhere tightly to 
epithelial cells and to resist the shearing force of urine flow. To accomplish this, UPEC 
utilise fimbriae including the mannose-sensitive type 1 fimbriae. It was hypothesised 
that the level of functional type 1 fimbriae would be affected by loss of the CydDC 
exporter complex due to the absence of disulphide bonding. To test this hypothesis the 
yeast agglutination assay was used with cytochrome bd-I mutants as controls. Deletion 
of cytochrome bd-I and CydDC in Keio or CFT073 backgrounds was shown to diminish 
the level of type 1 fimbriae expressed in aerobically grown cells, although type 1 
fimbriae were not expressed by EC958 cells when grown aerobically. Changing the 
culture conditions to static growth selected for type 1 fimbriae expression in all three E. 
coli backgrounds. Static growth relates to pathogenesis, as bacteria experience reduced 
oxygen availability when inside the host. Apart from a slight reduction in the level of 
agglutination seen for the cytochrome bd-I mutant of the Keio collection, under static 
growth conditions, deletion of CydDC or cytochrome bd-I was not shown to have an 
effect upon the expression of type 1 fimbriae. This was unexpected, with the prediction 
being that loss of CydDC would affect redox poise within the periplasm and thus 
prevent disulphide folding of fimbrial proteins. Considering this finding, one would 
expect that adhesion to host cells by type 1 fimbriae would not be affected by the loss of 
CydDC during pathogenesis. UPEC, however, do possess alternative adhesins which 
could be affected by the loss of CydDC, including P fimbriae, that require correct 
disulphide bonding for folding of both pilus subunits and the PapD chaperone (Jacob-






Figure 5-14. Disulphide folding within the E. coli periplasm 
 
The oxidative folding pathway (DsbAB) and disulphide bond isomerisation pathway 
(DsbCD) work to ensure that proteins in the periplasm are correctly folded. Glutathione 
(GSH) and cysteine exported to the periplasm via the ABC transporter CydDC 
collaborate in balancing the redox environment of the periplasm and are thus thought to 
influence disulphide bonding. The bd-type oxidases require CydDC for assembly and 
act as an electron sink for electrons released to form disulphide bonds. Figure adapted 
from Pittman et al. 2005  
 
In vivo experiments allow the interaction between the host and virulence factors 
to be studied. Experiments were performed to directly determine the contribution of 
CydDC and cytochrome bd-I to the survival of EC958 within macrophage cells, and the 
contribution of CydDC to the colonisation of the mouse lower urinary tract.   The 
results of the macrophage survival assay were striking, in that they showed an 
EC958cydDC mutant survives much better than an EC958cydAB mutant. Again, it 
would be expected that bacteria without CydDC would also lack cytochrome bd-I and 
that a similar effect upon survival within mouse macrophages would be observed as for 
the cytochrome bd-I mutant. A similar result was seen in the mouse UTI model, where 
colonisation of the mouse bladder was shown to be unaffected by the loss of CydDC. 
The discrepancy seen between cydDC and cytochrome bd-I mutants in NOC-12 growth 
curves of EC958 was therefore also mirrored in the in vivo experiments, although the 




work. For the mouse UTI experiments, no significant difference was seen between the 
number of wild type and cydDC mutant bacteria harvested from mouse urine and 
bladders after 24 hours. Taken together, these observations suggest that CydDC does 
not facilitate the colonisation of the mouse lower urinary tract nor to survival within 
macrophage cells. It further shows that the results of the yeast agglutination assay, in 
which we concluded that CydDC is not required for correct folding of type 1 fimbriae 
holds true for other extracytoplasmic virulence factors which are used by UPEC to 
colonise the urinary tract within the first 24 hours of infection. This result does not 
however provide information on the role of CydDC during UPEC pathogenesis after 
this time point.  
Messens et al. (2007) demonstrated that loss of periplasmic GSH increases the 
redox potential of the E .coli periplasm from -165 mV to -125 mV, despite this, RNase I 
activity is not affected. As RNase I requires the formation of correct disulphide bonds, 
the group concluded that the role played by DsbA and DsbC in the formation of correct 
disulphide bonds in RNase I is much larger than that of the redox environment of the 
periplasm. The findings shown in this chapter are in agreement with this concept and 
suggest that thiol export by CydDC has less of an affect on disulphide bonding than 














6.1 Background  
Before embarking on this work, CydDC had been shown to export the low-molecular 
weight thiols GSH and cysteine from the cytoplasm to the periplasm of E. coli cells 
(Pittman et al., 2002, 2005). These findings placed CydDC with a role in periplasmic 
redox homeostasis. Mutants of CydDC display a pleiotropic phenotype, with the most 
important phenotype being the loss of cytochrome bd-I assembly. Despite most of the 
phenotypes of cydDC mutants having been shown to be complemented by the 
exogenous addition of either GSH or cysteine, this was not the case with cytochrome 
bd-I assembly which remained elusive, and had led to speculation of additional 
substrates of CydDC. 
In this work, it was shown for the first time, that the simultaneous addition of 
GSH and cysteine to the growth medium of a cydD mutant allows the restoration of 
cytochrome bd-I, despite previous demonstrations that exogenous addition of neither 
cysteine (0.2-2mM) nor GSH (0.1-2mM) could restore assembly. Thus contrasting the 
reasoning behind the search for additional substrates of CydDC. In consideration of 
previous reports of CydDC-independent GSH export to the periplasm (Eser et al., 
2009), this finding demonstrates that any alternative GSH export methods do not 
provide a sufficient rate of GSH export to permit assembly when cysteine alone is 
added exogenously, instead both cysteine and GSH must be provided exogenously for 
cytochrome assembly. This requirement for both reduced thiols raises questions about 
the relationship between CydDC export and cytochrome bd-I assembly. DTT, a strong 
reducing agent was shown to be unable to restore cytochrome bd-I assembly when 
added exogenously to cydD cells, emphasising that loss of cytochrome assembly is not 
merely due to a need for reducing power in the periplasm. Ultimately this finding hints 
at a complex process in which both thiols play a role in cytochrome bd-I assembly.  
 
As discussed is Section 1.1.3 c-type cytochrome maturation requires the reduction of 
both the CXXCH haem binding motif and the haem cofactor. Considering that both c-
type cytochromes and cytochrome bd-I assembly are vulnerable to the loss of CydDC, it 
is possible that cysteine and GSH play a specialised redox role in these processes. It is 
important to note however that c-type cytochrome assembly can be partially restored 




assembly of c-type cytochromes in the presence of both GSH and cysteine, to determine 
if further restoration is observed.   
The di-haem active of cytochrome bd-I is only detectable in the presence of cydX, 
encoding a single transmembrane helix of the quinol oxidase. In the absence of CydDC, 
CydAB polypeptides are still inserted into the membrane, yet it is unknown whether 
CydX would still be incorporated (Georgiou et al., 1987). If the absence of CydDC does 
affect CydX incorporation, haem cofactor stability would be affected and further 
investigation may help to explain the necessity of two different reduced thiols.   
A microarray analysis was performed to investigate the effects of exogenous GSH and 
cysteine upon cells lacking CydDC with the hope of understanding the significance of 
both LMW thiols in the assembly of cytochrome bd-I. Therein activity of the ArcAB 
two-component system was shown to be increased upon the addition of cysteine and 
GSH, ArcB senses the redox status of the quinone pool and ultimately adapts 
transcriptional regulation of respiratory genes. This reflects upon the up-regulation of 
the cydABX genes when thiols were added to the growth medium of the cydDC mutant. 
Taken together with reports of significant cytochrome bd-I restoration in a cydC mutant 
in response to the overexpression of the cydAB genes (Goldman et al., 1996) it is 
possible that changes to gene expression in response to changes of the redox 
environment may have a partial role to play in cytochrome bd-I assembly.  
 
Another key finding was the demonstration that CydDC provides E. coli cells with 
tolerance to nitric oxide and the conclusion that CydDC of K-12 strains provides 
addition NO protection to cells beyond permitting the assembly of cytochrome bd-I. 
This finding, alongside the perceived role of CydDC in periplasmic redox homeostasis 
led to the hypothesis that CydDC plays a role in virulence of pathogenic E. coli. In vivo 
experiments tested the ability of cydDC and cydAB uropathogenic E. coli (UPEC) 
mutants to survive within NO-producing macrophage cells. A mouse model of UTI was 
also used, this tested the ability of cydDC mutants to colonise the lower urinary tract of 
mice. The results of these were disappointing, showing that loss of CydDC had little/no 
affect upon colonisation of the urinary tract or for survival within macrophage cells. 
Herein, these and other findings shown within this work will be examined critically in 




6.1.1 A dual role for CydDC in NO tolerance 
Previous work had shown that cytochrome bd-I contributes to the tolerance of E. coli to 
nitric oxide by virtue of a fast NO dissociate rate, that permits binding of oxygen to the 
terminal oxidase in the presence of NO (Mason et al. 2009). Considering that CydDC is 
required for the assembly of cytochrome bd-I, it was hypothesised that loss of CydDC 
would result in NO sensitivity. In Chapter 3, a donor of NO, NOC-12, was used to test 
the contribution of CydDC to NO tolerance alongside a wild type and cytochrome bd-I 
mutant. The data presented and discussed in Chapter 3 demonstrated that CydDC has a 
role in NO tolerance beyond permitting the assembly of cytochrome bd-I. It was 
predicted that the NO reactive thiols GSH and cysteine exported to the periplasm by 
CydDC could intercept incoming NO at the periplasm, to reduce the concentration of 
reactive NO that reaches vulnerable targets within the cytoplasm. This hypothesis is 
depicted in Figure 6-1. To test this, NOC-12 growth curves were performed, in which 
glutathione and cysteine were added to the growth medium to represent thiols normally 
present in the periplasm of cytochrome bd-I mutant cells; the aim was to show that the 
additional protection provided by CydDC beyond facilitating cytochrome bd-I assembly 
is due to these thiols. The additional thiols reduced the NO sensitivity of cydD cells to a 
level similar to cydB cells and it was thus concluded that CydDC has a dual role in 
tolerance to NO; enabling cytochrome bd-I assembly and export of thiols to shield 
against incoming NO.  
The NO growth curves performed in this thesis were done so under aerobic conditions, 
it would be interesting to have also performed these under microaerobic conditions in 
which cytochrome bd-I is maximally expressed. As discussed in Section 1.5.4.1 the 
ratio of cytochrome bd-I to cytochrome boƍ changes as oxygen tension changes, cells 
become much more reliant upon cytochrome bd-I under microaerobic conditions, 
whether this would affect NO sensitivity of cydB and cydD strains would need to be 
determined. CydDC though not under control of ArcA and FNR like cytochrome bd-I, 
is still shown to be regulated by oxygen concentration, with maximal expression under 
aerobic conditions, expression is 5-fold lower under anaerobic conditions. Anaerobic 
expression of cydD is elevated in the presence of nitrate or nitrite and deletion of 
CydDC results in loss of c-type cytochromes, which includes cytochrome c nitrite 
reductase NrfA. As discussed in Section 1.6.3 periplasmic NrfA consumes NO under 




2002). Considering this, it would be assumed that under anaerobiosis, loss of CydDC 
would also result in an increase in NO sensitivity. However NorV and Hmp would also 











Figure 6-1 Model describing the role of CydDC mediated cysteine/glutathione export: incoming NO is intercepted and cytochrome bd-I 
assembly is enabled 
 
A) Wild type cells express CydDC (green) which exports cysteine and reduced glutathione (depicted as red circles) to the periplasm, there thiols can 
then intercept incoming NO to reduce the affects within the cytoplasm (as signified by a reduced arrow from the periplasm to the cytoplasm). B) 
Deletion of cydDC prevents the export of thiols to the periplasm, so higher levels of NO can reach the cytoplasm (as represented by the larger arrow). 
C) Exogenous addition of cysteine and reduced glutathione re-creates the affect of CydDC export in a mutant lacking CydDC, permitting assembly of 





6.1.2 The impact of CydDC substrates upon E. coli physiology: insights 
from a transcriptomic study 
With an aim to study what happens within cells when the two known thiol substrates of 
CydDC are exogenously added to cells lacking CydDC (as in the cytochrome bd-I 
restoration experiments), transcriptional analysis of cydDC cells were performed with 
the addition of GSH and cysteine to the growth medium. In this situation, cytochrome 
bd-I restoration is expected, and a large number of changes to gene expression are likely 
to be due to a gain of function of the oxidase. For this reason, transcriptional changes in 
a cydDC cydAB mutant with the addition of GSH and cysteine were also studied. 
As a large number of genes were identified, the results of the two microarray 
experiments were processed to produce a more focused subset of genes. This was 
achieved first by using TFinfer to deduce which transcription factors have activities that 
are significantly affected by the thiols. This permitted an understanding of the 
environmental stimuli imposed on cells by thiol addition. A major aim of this study was 
to examine the effects of thiol addition beyond the restoration of cytochrome bd-I, so 
transcription factors were grouped; TFs affected in both cydDC and cydDC cydAB cells 
(considered to be independent of cytochrome bd-I restoration), and TFs that were only 
significantly affected in cydDC cells but not cydDC cydAB cells (considered to be 
cytochrome bd-I restoration dependent). Lists of genes that are controlled by these two 
groups of TFs were listed in Tables 4-1 and 4-2, only genes that were shown to be 
significantly up- or down- regulated were included. These two tables were then used to 
create a metabolic map (Figure 6-2). 
Changes in gene expression that were independent of cytochrome bd-I restoration 
included a repression of genes involved in motility, the TCA cycle, dihydroxyacetone 
degradation, as well as amino acid biosynthesis and transport. An induction of genes 
related to respiration was observed including appBC that encodes cytochrome bd-II and 
hyaABCDF genes that encode hydrogenase-I. Placing these changes in gene expression 
on a metabolic map (Figure 6-2), showed that the repression of genes encoding enzymes 
of the TCA cycle are accompanied by a repression of genes encoding enzymes that feed 
into the TCA cycle too. 
Addition of thiols repressed expression of TCA cycle genes via the ArcA 




microarray, the authors of the latter study proposed that misfolded proteins and fatty 
acids are broken down to feed into the TCA cycle in order to restore the balance of 
metabolic flux (Holyoake et al., 2016). NMR metabolomic data showed that in the 
absence of cydD, levels of succinate were elevated while those of fumarate were 
simultaneously depleted, which suggested an increase in succinate dehydrogenase 
activity. Succinate dehydrogenase catalyses the oxidation of succinate to fumarate and 
simultaneously reduces ubiquinone to ubiquinol (Figure 3-12). Taken together this 
indicates that loss of CydDC-exported thiols affects the redox status of the quinone pool 
and that TCA cycle genes are up-regulated to aid in re-balancing of the redox status. 
This is interesting as ArcB senses respiratory growth conditions via the redox state of 
the quinone pool using a thiol-based redox switch (Iuchi and Lin, 1988; Malpica et al., 
2004; Alvarez et al., 2013) and ArcA, the corresponding response regulator controls 
expression of cydABX genes encoding cytochrome bd-I, it suggests that in wild type 
cells, CydDC-mediated thiol export affects the transcription of the genes encoding 
cytochrome bd-I, adding a new level to the relationship between the two protein 
complexes. Previously it had been shown that the regulation of cydDC and cydABX 
operons are not coordinated (Section 1.2), these results however suggest some form of 
relationship between the level of activity of CydDC and transcription of cydABX.   
 
The repression of motility genes suggests that swarming motility is reduced by the 
addition of thiols. Which is surprising considering that Pittman et al. 2002 showed that 
exogenous cysteine restores motility defects of a cydD mutant, (most likely by 
permitting the correct disulphide folding of FlgI). It had been expected that addition of 
both cysteine and GSH would restore assembly of the flagella suprastructure by 
balancing the redox environment of the periplasm. It is therefore possible that contrary 
to a re-balancing of the periplasmic redox environment, the amount of thiols added is 
surplus to requirement and instead the periplasm is becoming more reduced than is 
observed in wild type cells. It would be of interest to observe the motility of cydDC 
cells in the presence of exogenous thiols to determine the actual effect of both thiols.  
A larger repression of motility genes was observed after the addition of thiols to cydDC 
cydAB cells when compared to cydDC cells. Looking at the previously performed cydB 
vs. wild type microarray data, flagella genes were repressed and accompanied by a 




of motility genes is an energy conserving mechanism in the face of reduced energetic 
efficiency of cytochrome bd-II. It is thus likely that the difference between repression of 
motility genes is due to the lack of cytochrome bd-I restoration in the cydDC cydAB 
double mutant and the larger reliance upon cytochrome bd-II as shown by the increased 
regulation of appBC in the cydDC cydAB background.  
Changes in gene expression that are considered dependent upon the restoration of 
cytochrome bd-I include a repression of genes of the 2-methylcitrate cycle, this cycle 
overlaps with the TCA cycle and utilises propionate to produces pyruvate. Northern-
blot analysis has shown than unlike acnB, prpD is exclusively transcribed during 
growth on propionate  (Brock et al. 2002). This suggests that in the absence of 







































Figure 6-2. Model for the processes influenced by CydDC substrates in the 
periplasm: environmental signals and downstream effects  
 
The gene transcript levels and transcription factor activities that are up- and down-
regulated in the cydDC GSH/cysteine vs. cydDC and cydDC cydAB GSH/cysteine vs. 
cydDC cydAB are shown in red and blue, respectively. The gene transcript levels and 
transcription factor activities that are up- and down-regulated only in the cydDC 
GSH/cysteine vs. cydDC microarray are shown in orange and purple, respectively. The 
green and purple lines denote steps in the 2-methylcitrate cycle and ȕ-oxidative of fatty 
acids. Dotted lines show potential environmental stimuli responded to. Abbreviations: 





6.1.3 In vivo model for CydDC 
The role of cytochrome bd-I (Mason et al. 2009) in NO tolerance of K-12 strains had 
already been shown. Considering that the function of cytochrome bd-I is reliant upon 
CydDC, it was expected that mutants of CydDC would be equally as sensitive as 
cytochrome bd-I mutants. Growth curves utilising the nitric oxide (NO) donor, NOC-12 
showed that CydDC provides protection to cells from NO, beyond the role of 
cytochrome bd-I assembly.  
NO is an important defence in the armoury of the host innate immune system. These 
findings suggested that cytochrome bd-I and CydDC may provide a concerted role in 
survival within the host environment. Therefore, the contribution of CydDC and 
cytochrome bd-I of UPEC strains, CFT073 and EC958, to NO tolerance were tested. 
The results showed that loss of either of the two complexes resulted in NO sensitivity in 
both CFT073 and EC958. Comparisons between the two mutants were however 
inconsistent with non-pathogenic K-12 strain data. For example, an EC958 cytochrome 
bd-I mutant was shown to be more sensitive to NO than the EC958 cydDC mutant. 
CydDC and cytochrome bd-I mutants of CFT073 were shown to have a similar level of 
growth inhibition after the addition of lower concentrations of NOC-12, yet a greater 
sensitivity of cydDC mutants were seen at higher NOC-12 concentrations when 
compared to cytochrome bd-I mutants. Despite this inconsistency, CydDC and 
cytochrome bd-I were still shown to be more sensitive to NO when compared to wild 
type cells. These results were promising, suggesting that loss of CydDC would result in 
a loss of NO tolerance and potentially the loss of other functions requiring disulphide 
bonding in the periplasm as CydDC is known to participate in redox homeostasis of the 
periplasm.  
 
In vivo studies were used to test the ability of EC958 CydDC and cytochrome bd-I 
mutants to colonise the urinary tract via the UTI mouse model, and the ability to survive 
within macrophage cells of the immune system via macrophage survival assays.  
Results of macrophage survival assays were striking, in that they showed that loss of 
CydDC had no effect upon the survival of EC958 cells within macrophage cells. Yet the 
EC958cydAB mutant showed a reduced survival when compared to the isogenic wild 
type and EC958cydDC cells.  Considering that bacteria without CydDC should also lack 




that of EC958cydDC and EC958cydAB cells. The discrepancy between the two mutants 
suggests that cytochrome bd-I assembly is restored in the cydDC mutant, potentially via 
thiols provided by the RPMI medium used to culture the macrophage cells or the 
macrophage cells themselves (Figure 6-3). Taken together macrophage survival assays 
showed that the results of NOC-12 growth curves do not always directly translate into 




Figure 6-3. Mechanism for cytochrome bd-I restoration in cydDC mutant cells 
during macrophage infection assays 
 
A wild type cells express CydDC (green) which permits haem (yellow) insertion into 
cytochrome bd-I (pink). B deletion of cydDC causes a pleiotropic phenotype including 
loss of haem insertion into cytochrome bd-I. C During macrophage infection assays, we 
hypothesise that host derived thiols are imported into the periplasm of cydDC mutant 
cells to permit the assembly of cytochrome bd-I.      
 
In the mouse UTI model wild type/cydDC competition experiment, no significant 
difference was seen between the number of wild type (EC958) and EC958cydDC 
mutant CFU harvested from mouse urine and bladders after 24 hours of infection. Thus 
disappointingly, CydDC was not shown to facilitate the colonisation of the mouse lower 
urinary tract. This finding mirrors the results of the yeast agglutination assay, in which 
it was concluded that CydDC is not required for the correct folding of type 1 fimbriae. 
That the loss of CydDC does not affect colonisation of the mouse urinary tract is 
indicative that other extracytoplasmic virulence factors which UPEC rely upon to 
colonise the urinary tract within the first 24 hours of infection are also unaffected by the 




information on the role of CydDC during UPEC pathogenesis after 24 hours of 
infection.  
 
Previously performed mouse UTI model competition experiments showed that loss of 
cytochrome bd-I was detrimental to the colonisation of the mouse urinary tract (Dr 
Mark Shepherd, personal communication). Therefore a discrepancy between the EC958 
mutants of CydDC and cytochrome bd-I was again observed, suggesting that restoration 
of cytochrome bd-I in the EC958cydDC mutant occurs during the experiment. There is 
no evidence for high concentrations of cysteine and glutathione in mouse urine, 
however, due to the nature of the experiment, in which wild type and cydDC mutants 
were combined before being introduced to the mouse urinary tract, it is possible that 
wild type cells, capable of exporting GSH and cysteine to the periplasm of cells may 
have complemented neighbouring cydDC mutants as porins of the outer membrane 
allow the diffusion of molecules >600 Da from the periplasm to the extracellular fluid 
(Decad and Nikaido 1976).  
 
The differences in results between the cydDC and cytochrome bd-I mutants were much 
more pronounced in the in vivo experiments, whereas NO sensitivity of the two mutants 
had been relatively similar in the NOC-12 growth curve experiments. This could be due 
to static growth imposed upon bacteria to enrich for type 1 fimbriae before use in in vivo 
experiments. Under these conditions we would expect differential expression of cydDC 
and cydAB (cytochrome bd-I); as discussed in Section 1.5.4.1, cydAB of E. coli is 
maximally expressed under microaerobic conditions and at high cell densities, cydAB is 
regulated by FNR and ArcA (Tseng et al. 1996). As discussed in Section 1.2, however, 
CydDC shows a decrease in expression when grown anaerobically or at high cell 
densities, furthermore cydDC shows no significant regulation by FNR or ArcA (Cook, 
Membrillo-hernández and Poole 1997). 
 
In conclusion, despite the importance of CydDC in cytochrome bd-I assembly, in vivo 
findings suggest that CydDC would not be an appropriate target to combat infections 
caused by uropathogenic E. coli. Cytochrome bd-I, however, which was shown to 
contribute to the survival within macrophage cells and has been shown in the work of 
others to reduce the ability of UPEC to colonise the urinary tract, would be a more 




6.1.4 The role of CydDC in Gram-positive organisms 
The role of CydDC appears to be clear in the context of Gram-negative cells. However, 
CydDC is also known to be expressed by some Gram-positive bacteria which vary in 
the structure of their cell wall when compared to Gram-negative strains. The cell 
envelope of Gram-positive organisms is made up of a thick layer of peptidoglycan 
surrounding the cytoplasmic membrane and lacks the outer membrane of Gram-negative 
cells. In the past it has been assumed that Gram-positive organisms do not have a 
periplasmic space. This presents the question of why CydDC, a transporter of reduced 
thiols from the cytoplasm to the periplasm of E. coli and with a role in maintaining the 
periplasmic redox status is still encoded by Gram-positive organisms? It is becoming 
accepted, however, that Gram-positive cells do contain a space between the inner 
membrane and the thick layer of peptidoglycan that resembles the periplasm of Gram-
negatives. The role of CydDC and its expression in Gram-positive bacteria still requires 
investigation, yet it is possible that CydDC plays a role in maintaining redox poise in 
this periplasm-like compartment. Further to this, it would be interesting to determine if 
cytochrome bd-I assembly is still lost in Gram-positive cydDC mutants. Considering 
that cydDC and cydAB operons are separated in the genomes of Gram-negative species, 
yet in Gram-positive bacteria, are arranged as a cydABCD gene cluster, it is intuitive to 
suggest that the two encoded protein complexes would be functionally related.  
 
 
M. tuberculosis has an unusual Gram stain result due to its unusual cell wall which 
possesses features of both Gram-positive and negative bacteria (Fu and Fu-Liu, 2002), 
the cell wall of M. tuberculosis possesses a pseudo-lipid bilayer that resembles the outer 
membrane of Gram-negative cells. Earlier, in Section 1.8, it was mentioned that the 
expression of both cydA and cydC genes transiently increases during Mycobacterium 
tuberculosis infection of the mouse lung and furthermore that mutation of cydC impairs 
growth of M. tuberculosis in mice. The correlation between cydA and cydC gene 
expression suggests that CydDC is involved in cytochrome bd-I assembly yet the exact 
function of CydDC in Mycobacterium tuberculosis infection remains to be determined 





6.2 Further experiments 
In Chapter 5, the results of in vivo studies did not reflect the expectations drawn from 
NOC-12 growth curves. Cells had been grown statically to induce expression of type 1 
fimbriae, this however is not how cells were grown during NOC-12 growth curves. This 
could account for the discrepancy as expression of cydDC and cydAB are affected by 
changes to oxygen availability. For this reason it would be interesting to test the NO 
sensitivity of statically grown cydDC and cytochrome bd-I mutants. 
In the CO difference spectra performed in Chapter 3, growth of a cydD mutant 
in the presence of additional GSH and cysteine was shown to result in cytochrome bd-I 
restoration. The restoration of peaks within the spectral data is however, not a direct 
indication that the oxidase is functional, just that the haems required for function are 
present. This could be tested by growing cydD cells in  a similar way to that of 
restoration assays, with reduced aeration, overnight with additional cysteine and GSH in 
the growth medium before performing a NOC-12 growth curve, if cytochrome bd-I is 
functional, a large decrease in the sensitivity of the cydD mutant would be expected.  
In Chapter 5, the gene and protein sequences of cytochrome bd-I and CydDC 
from non-pathogenic and UPEC strains were compared. This concluded that no amino 
acid changes are present within the UPEC proteins that are likely to affect function. 
Nevertheless, in light of the conflicting cydDC and cytochrome bd-I mutant results in 
the studies using UPEC strains, it would be important to check that cytochrome bd-I 
assembly is in fact prevented in mutants of CydDC, to do this, CO difference 
spectroscopy (as performed in Chapter 3) would be performed on whole cells of 













Abramson, J., Riistama, S., Larsson, G., Jasaitis, A., Svensson-Ek, M., Laakkonen, L., 
Puustinen, A., Iwata, S., Wikström, M. (2000) The structure of the ubiquinol oxidase 
from Escherichia coli and its ubiquinone binding site. Nat Struct Biol 7: 910±917. 
Adikaram, P., and Beckett, D. (2013) Protein:Protein interactions in control of a 
transcriptional switch. J Mol Biol 425: 4584±4594. 
Aga, R.G., and Hughes, M.N. (2008) Globins and other nitric oxide-reactive proteins, 
part a. In Methods in Enzymology. Poole, R.K. (ed.). Academic Press, pp. 35±46. 
Altuvia, S., Weinstein-Fischer, D., and Zhang, A. (1997) A small, stable RNA induced 
by oxidative stress: role as a pleiotropic regulator and antimutator. Cell 90: 43±53. 
Alvarez, A.F., Rodriguez, C., and Georgellis, D. (2013) Ubiquinone and menaquinone 
electron carriers represent the yin and yang in the redox regulation of the ArcB sensor 
kinase. J Bacteriol 195: 3054±61. 
Andresen, P.A., Kaasen, I., Styrvold, O.B., Boulnois, G., and Strøm, A.R. (1988) 
Molecular cloning, physical mapping and expression of the bet genes governing the 
osmoregulatory choline-glycine betaine pathway of Escherichia coli. J Gen Microbiol 
134: 1737±1746. 
Anraku, Y. (1988) Bacterial electron transport chains. Annu Rev Biochem 57: 101±132. 
Armine V Avetisyan, Pavel A Dibrov, Anna L Semeykina, Vladimir P Skulachev, 
M.V.S. (1991) Adaptation of Bacillus FTU and Escherichia coli to alkaline conditions: 
the Na+-motive respiration. Biochim Biophys Acta 1098: 95±104. 
Arutyunyan, A.M., Borisov, V.B., Novoderezhkin, V.I., Ghaim, J., Zhang, J., Gennis, 
R.B., and Konstantinov, A.A. (2008) Strong excitonic interactions in the oxygen-
reducing site of bd-type oxidasH(?WKH)H-to-Fe distance between hemes d and b595 is 10 
Å. Biochemistry 47: 1752±1759. 
Atlung, T., Knudsen, K., Heerfordt, L., and Brøndsted, L. (1997) Effects of sigmaS and 
the transcriptional activator AppY on induction of the Escherichia coli hya and cbdAB-
appA operons in response to carbon and phosphate starvation. J Bacteriol 179: 2141±
2146. 
Aung, H.L., Berney, M., and Cook, M. (2014) Hypoxia-activated cytochrome bd 
expression in Mycobacterium smegmatis s cyclic AMP receptor protein dependent. J 
Bacteriol 196: 3091±3097. 
Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, K. A., 
Tomita, M., Wanner, B. L. Mori, H. (2006) Construction of Escherichia coli K-12 in-
frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2: 1±11. 
Bächler, C., Schneider, P., Bähler, P., Lustig, A., and Erni, B. (2005) Escherichia coli 
dihydroxyacetone kinase controls gene expression by binding to transcription factor 




Bachmann, B.J. (1990) Linkage map of Escherichia coli K-12 , Edition 8. Microbiol 
Rev 54: 130±197. 
Bachmann, B.J. (1996) Derivations and Genotypes of Some Mutant Derivatives of 
Escherichia coli K-12. In Escherichia coli and Salmonella: Cellular and Molecular 
Biology. Neidhardt, F.C., Curtiss, R., Ingraham, J. l., Lin, E.C.C., Low, K.B., 
Magasanik, B., et al. (Eds). ASM Press, pp. 2460±2488. 
Bader, M., Muse, W., Ballou, D.P., Gassner, C., and Bardwell, J.C.A. (1999) Oxidative 
protein folding is driven by the electron transport system. Cell 98: 217±227. 
Bader, M.W., Hiniker, A., Regeimbal, J., Goldstone, D., Haebel, P.W., Riemer, J., 
Metcalf, P., Bardwell, J. C. (2001) Turning a disulfide isomerase into an oxidase: DsbC 
mutants that imitate DsbA. EMBO J 20: 1555±1562. 
Bahrani-Mougeot, F., Buckles, E., Lockatell, C.V., Hebel, J.R., Johnson, D., Tang, C., 
and Donnenberg, M.S. (2002) Type 1 fimbriae and extracellular polysaccharides are 
preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary 
tract. Mol Microbiol 45: 1079±1093. 
Bang, I.-S., Liu, L., Vazquez-Torres, A., Crouch, M.-L., Stamler, J.S., and Fang, F.C. 
(2006) Maintenance of nitric oxide and redox homeostasis by the Salmonella 
flavohemoglobin hmp. J Biol Chem 281: 28039±47. 
Baptista, J.M., Justino, M.C., Melo, A.M.P., Teixeira, M., and Saraiva, L.M. (2012) 
Oxidative stress modulates the nitric oxide defense promoted by Escherichia coli 
flavorubredoxin. J Bacteriol 194: 3611±7. 
Barker, P.D., Nerou, E.P., Freund, S.M. V., and Fearnley, I.M. (1995) Conversion of 
Cytochrome b562 to c-type cytochromes. Biochemistry 34: 15191±15203. 
Barrett, M.C., and Dawson, A.P. (1975) The reaction of choline dehydrogenase with 
some electron acceptors. Biochem J 151: 677±683. 
Baughn, A., and Malamy, M. (2004) The strict anaerobe Bacteroides fragilis grows in 
and benefits from nanomolar concentrations of oxygen. Lett to Nat 427: 162±165. 
Bebbington, K.J., and Williams, H.. (1993) Investigation of the role of the cydD gene 
product in production of a functional cytochrome d oxidase in Escherichia coli. FEMS 
Microbiol Lett 112: 19±24. 
Becker, S., Holighaus, G., Gabrielczyk, T., and Unden, G. (1996) O2 as the regulatory 
signal for FNR-dependent gene regulation in Escherichia coli. J Bacteriol 178: 4515±
4521. 
Beinert, H., and Kiley, P. (1999) Fe-S proteins in sensing and regulatory functions. Curr 
Opin Chem Biol 3: 152±157. 
Bekker, M., Vries, S. de, Beek, A. Ter, Hellingwerf, K.J., and Mattos, M.J.T. de (2009) 
Respiration of Escherichia coli can be fully uncoupled via the nonelectrogenic terminal 
cytochrome bd-II oxidase. J Bacteriol 191: 5510±5517. 
Benjamini, Y., and Hochberg, Y. (1995) Controlling the false discovery rate: a practical 
and powerful approach to multiple testing. J R Stat Soc Ser B 57: 289±300. 
Bloch, D. a, Borisov, V.B., Mogi, T., and Verkhovsky, M.I. (2009) Heme/heme redox 
interaction and resolution of individual optical absorption spectra of the hemes in 
cytochrome bd from Escherichia coli. Biochim Biophys Acta 1787: 1246±53. 




in Escherichia coli growing under unfavorable conditions. FEBS J 336: 75±78. 
Bogachev, A. V., Murtazina, R.A., Shestopalov, A.I., and Vladimir P. Skulachev (1995) 
Induction of the Escherichia coli cytochrome d by low 'PH,+ and by sodium ions. Eur J 
Biochem 232: 304±308. 
Bokil, N.J., Totsika, M., Carey, A.J., Stacey, K.J., Hancock, V., Saunders, B.M., 
Ravasi, T. 
Ulett, G. C., Schembri, M. A., Sweet, M. J. (2011) Intramacrophage survival of 
uropathogenic Escherichia coli: differences between diverse clinical isolates and 
between mouse and human macrophages. Immunobiology 216: 1164±71. 
Borisov, V., Liebl, U., and Rappaport, F. (2002) Interactions between heme d and heme 
b595 in quinol oxidase bd from Escherichia coli: a photoselection study using 
femtosecond spectroscopy. Biochemistry 41: 1654±1662. 
Borisov, V.B., Forte, E., Konstantinov, A. a., Poole, R.K., Sarti, P., and Giuffrè, A. 
(2004) Interaction of the bacterial terminal oxidase cytochrome bd with nitric oxide. 
FEBS Lett 576: 201±204. 
Borisov, V.B., Forte, E., Sarti, P., Brunori, M., Konstantinov, A. a, and Giuffrè, A. 
(2007) Redox control of fast ligand dissociation from Escherichia coli cytochrome bd. 
Biochem Biophys Res Commun 355: 97±102. 
Borisov, V.B., Forte, E., Siletsky, S. a, Sarti, P., and Giuffrè, A. (2015) Cytochrome bd 
from Escherichia coli catalyzes peroxynitrite decomposition. Biochim Biophys Acta 
1847: 182±8. 
Borisov, V.B., Gennis, R.B., Hemp, J., and Verkhovsky, M.I. (2011) The cytochrome 
bd respiratory oxygen reductases. Biochim Biophys Acta 1807: 1398±1413. 
Borisov, V.B., and Verkhovsky, M.I. (2013) Accommodation of CO in the di-heme 
active site of cytochrome bd terminal oxidase from Escherichia coli. J Inorg Biochem 
118: 65±67. 
Bouwman, C.W., Kohli, M., Killoran, A., Touchie, G. a., Kadner, R.J., and Martin, N.L. 
(2003) Characterization of SrgA, a Salmonella enterica serovar Typhimurium virulence 
plasmid-encoded paralogue of the disulfide oxidoreductase DsbA, essential for 
biogenesis of plasmid-encoded fimbriae. J Bacteriol 185: 991±1000. 
Bower, J.M., and Mulvey, M.A. (2006) Polyamine-mediated resistance of 
uropathogenic Escherichia coli to nitrosative stress. J Bacteriol 188: 928±33. 
Brachmann, C., Davies, A., Cost, G., Caputo, E., Li, J., Hieter, P., and Boeke, J. (1998) 
Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of 
strains and plasmids for PCR-mediated gene disruption and other applications. Yeast 14: 
115±132. 
Brock, M., Maerker, C., Schütz, A., Völker, U., and Buckel, W. (2002) Oxidation of 
propionate to pyruvate in Escherichia coli. Eur J Biochem 269: 6184±6194. 
Brøndsted, L., and Atlung, T. (1996) Effect of growth conditions on expression of the 
acid phosphatase (cyx-appA) operon and the appY gene, which encodes a transcriptional 
activator of Escherichia coli. J Bacteriol 178: 1556±1564. 





Himpsl, S. D., Hebel, J. R., Johnson, D. E., Mobley, H. L. T. (2004) Proteus mirabilis 
genes that contribute to pathogenesis of urinary tract infection: identification of 25 
signature-tagged mutants attenuated at least 100-Fold. Infect Immun 72: 2922±2938. 
Butler, A.R., Glidewell, C., and Li, M.S. (1988) Nitrosyl complexes of iron-sulfur 
clusters. Academic London, . 
Calhoun, M., Newton, G., and Gennis, R. (1991) E. coli map. Physical map locations of 
genes encoding components of the aerobic respiratory chain of Escherichia coli. J 
Bacteriol 173: 1569±1570. 
Capitani, G., Biase, D. De, Aurizi, C., Gut, H., Bossa, F., and Grutter, M.G. (2003) 
Crystal structure and functional analysis of Escherichia coli glutamate decarboxylase. 
EMBO J 22: 4027±4037. 
&KDYHURFKH0*KLJR-DQG'¶(QIHUW&$UDSLGPHWKRGIRUHIILFLHQWJHQH
replacement in the filamentous fungus Aspergillus nidulans. Nucleic Acids Res 28: 1±6. 
Chen, C.C., Fang, M., Majumder, A., and Wu, H.Y. (2001) A 72-base pair AT-rich 
DNA sequence element functions as a bacterial gene silencer. J Biol Chem 276: 9478±
85. 
Claret, L., and Hughes, C. (2002) Interaction of the atypical prokaryotic transcription 
activator FlhD2C2 with early promoters of the flagellar gene hierarchy. J Mol Biol 321: 
185±199. 
Collet, J., and Bardwell, J.C.A. (2002) Oxidative protein folding in bacteria. Mol 
Microbiol 44: 1±8. 
Connell, I., and Agace, W. (1996) Type 1 fimbrial expression enhances Escherichia coli 
virulence for the urinary tract. Proc Natl Acad Sci USA 93: 9827±9832. 
Cook, G.M., Cruz-Ramos, H., Moir, A.J.G., and Poole, R.K. (2002) A novel haem 
compound accumulated in Escherichia coli overexpressing the cydDC operon, encoding 
an ABC-type transporter required for cytochrome assembly. Arch Microbiol 178: 358±
69. 
Cook, G.M., Membrillo-hernández, J., and Poole, R.K. (1997) Transcriptional 
regulation of the cydDC operon, encoding a heterodimeric ABC transporter required for 
assembly of cytochromes c and bd in Escherichia coli K-12: regulation by oxygen and 
alternative electron acceptors. J Bacteriol 179: 6525±6530. 
Cooper, C. (1999) Nitric oxide and iron proteins. Biochim Biophys Acta (BBA)-
Bioenergetics 1411: 290±309. 
Cotter, P. a, Chepuri, V., Gennis, R.B., and Gunsalus, R.P. (1990) Cytochrome o 
(cyoABCDE) and d (cydAB) oxidase gene expression in Escherichia coli is regulated by 
oxygen, pH, and the fnr gene product. J Bacteriol 172: 6333±6338. 
Crespo, M.D., Puorger, C., Schärer, M. a, Eidam, O., Grütter, M.G., Capitani, G., and 
Glockshuber, R. (2012) Quality control of disulfide bond formation in pilus subunits by 
the chaperone FimC. Nat Chem Biol 8: 707±13. 
Crooke, H., and Cole, J. (1995) The biogenesis of c-type cytochromes in Escherichia 
coli requires a membrane-bound protein, DipZ, with a protein disulphide isomerase-like 
domain. Mol Microbiol 15: 1139±1150. 
Cruz-Ramos, H., Cook, G.M., Wu, G., Cleeter, M.W., and Poole, R.K. (2004a) 
Membrane topology and mutational analysis of Escherichia coli CydDC, an ABC-type 




Cruz-Ramos, H., Cook, G.M., Wu, G., Cleeter, M.W., and Poole, R.K. (2004b) 
Membrane topology and mutational analysis of Escherichia coli CydDC, an ABC-type 
cysteine exporter required for cytochrome assembly. Microbiology 150: 3415±27. 
Cui, Q., Lewis, I., Hegeman, A., and Anderson, M. (2008) Metabolite identification via 
the madison metabolomics consortium database. Nat Biotechnol 26: 162±165. 
Cutruzzola, F. (1999) Bacterial nitric oxide synthesis. Biochim Biophys Acta 1411: 231±
249. 
'¶$XWUpDX[%7XFNHU13'L[RQ5DQG6SLUR6$QRQ-haem iron centre 
in the transcription factor NorR senses nitric oxide. Nature 437: 769±72. 
'¶0HOOR5+LOO6DQG3RROH5$IILQLW\RIF\WRFKURPHbo¶LQEscherichia 
coli determined by the deoxygenation of oxyleghemoglobin and oxymyoglobin: Km 
values for oxygen are in the submicromolar. J Bacteriol 177: 867±870. 
'¶PHOOR5+LOO6DQG3RROH5.7KHF\WRFKURPHbd quinol oxidase in 
Escherichia coli has an extremely high oxygen affinity and two oxygen-binding haems: 
implications for regulation of activity in vivo by oxygen inhibition. Microbiology 142: 
755±763. 
Daltrop, O., Stevens, J.M., Higham, C.W., and Ferguson, S.J. (2002) The CcmE protein 
of the c-type cytochrome biogenesis system: unusual in vitro heme incorporation into 
apo-CcmE and transfer from holo-CcmE to apocytochrome. Proc Natl Acad Sci U S A 
99: 9703±9708. 
Darby, N.J., and Creighton, T.E. (1995) Catalytic mechanism of DsbA and its 
comparison with that of protein disulfide isomerase. Biochemistry 34: 3576±3587. 
Darwin, A., Hussain, H., Griffiths, L., Grove, J., Sambongi, Y., Busby, S., and Cole, J. 
(1993) Regulation and sequence of the structural gene for cytochrome C552 from 
Escherichia coli: not a hexahaem but a 50kDa tetrahaem nitrite reductase. Mol 
Microbiol 9: 1255±1265. 
Dassa, J., Fsihi, H., Marck, C., Dion, M., Kieffer-Bontemps, M., and Boquet, P.L. 
(1991) A new oxygen-regulated operon in Escherichia coli comprises the genes for a 
putative third cytochrome oxidase and for pH 2.5 acid phosphatase (appA). Mol Gen 
Genet 229: 341±352. 
Daßler, T., Maier, T., Winterhalter, C., and Böck, A. (2000) Identification of a major 
facilitator protein from Escherichia coli involved in efflux of metabolites of the cysteine 
pathway. Mol Microbiol 36: 1101±1112. 
Datsenko, K., and Wanner, B. (2000) One-step inactivation of chromosomal genes in 
Escherichia coli K-12 using PCR products. Proc Natl Acad Sci 97: 6640±6645. 
Dawson, R.J.P., and Locher, K.P. (2006) Structure of a bacterial multidrug ABC 
transporter. Nature 443: 180±185. 
Decad, G., and Nikaido, H. (1976) The outer membrane of Gram-negative bacteria. J 
Bacteriol 128: 325±336. 
Delaney, J.M., Ang, D., and Georgopoulos, C. (1992) Isolation and characterization of 
the Escherichia coli htrD gene, whose product is required for growth at high 
temperatures. J Bacteriol 174: 1240±1247. 
Deutch, C.E., Hasler, J.M., Houston, R., Sharma, M., and Stone, V.J. (1989) 
Nonspecific inhibition of proline dehydrogenase synthesis in Escherichia coli during 




Devroede, N., Thia-Toong, T.-L., Gigot, D., Maes, D., and Charlier, D. (2004) Purine 
and pyrimidine-specific repression of the Escherichia coli carAB operon are 
functionally and structurally coupled. J Mol Biol 336: 25±42. 
Drapier, J.-C. (1997) Interplay between NO and [Fe-S] clusters: relevance to biological 
systems. Methods 11: 319±29. 
Dueweket, T.J., and Gennis, R.B. (1991) Proteolysis of the cytochrome d complex with 
trypsin and chymotrypsin localizes a quinol oxidase domain. Biochemistry 30: 3401±
3406. 
Ebejer, J.P., Hill, J.R., Kelm, S., Shi, J., and Deane, C.M. (2013) Memoir: template-
based structure prediction for membrane proteins. Nucleic Acids Res 41: 379±383. 
Eisenberg, M., O, P., and Hsiung, S. (1982) Purification and properties of the biotin 
repressor. J Biol Chem 257: 15167±15173. 
Elfering, S.L., Sarkela, T.M., and Giulivi, C. (2002) Biochemistry of mitochondrial 
nitric-oxide synthase. J Biol Chem 277: 38079±86. 
Endley, S., Murray, D.M.C., and Ficht, T.A. (2001) Interruption of the cydB locus in 
Brucella abortus attenuates intracellular survival and virulence in the mouse model of 
infection. 183: 2454±2462. 
Engel, D.R., Maurer, J., Tittel,  a. P., Weisheit, C., Cavlar, T., Schumak, B., Limmer, 
A., Van Rooijen, N., Trautwein, C., Tacke, F., Kurts, C.. (2008) CCR2 mediates 
homeostatic and inflammatory release of Gr1 high monocytes from the bone marrow, 
but is dispensable for bladder infiltration in bacterial urinary tract infection. J Immunol 
181: 5579±5586. 
Eser, M., Masip, L., Kadokura, H., Georgiou, G., and Beckwith, J. (2009) Disulfide 
ERQGIRUPDWLRQE\H[SRUWHGJOXWDUHGR[LQLQGLFDWHVJOXWDWKLRQH¶VSUHVHQFHLQWKHE. coli 
periplasm. Proc Natl Acad Sci USA 106: 1572±7. 
Fabianek, R., Huber-Wunderlich, M., Glockshuber, R., Nzler, Kunzler, P., Hennecke, 
H., and Thony-Meyer, L. (1997) Characterization of the Bradyrhizobium japonicum 
CycY protein, a membrane-anchored periplasmic thioredoxin that may play a role as a 
reductant in the biogenesis of c-type cytochromes. J Biol Chem 272: 4467±4473. 
Fabianek, R.A., Hennecke, H., and Thony-PH\HU/3HULSODVPLFSURWHLQWKLRO(?
disulphde oxidoreductases of Escherichia coli. FEMS Microbiol Rev 24: 303±316. 
Fang, F.C. (2004) Antimicrobial reactive oxygen and nitrogen species: concepts and 
controversies. Nat Rev Microbiol 2: 820±32. 
Fang, H., Lin, R., and Gennis, R. (1989) Location of heme axial ligands in the 
cytochrome d terminal oxidase complex of Escherichia coli determined by site-directed 
mutagenesis. J Biol Chem 264: 8026±8032. 
Flatley, J., Barrett, J., Pullan, S.T., Hughes, M.N., Green, J., and Poole, R.K. (2005) 
Transcriptional responses of Escherichia coli to S-nitrosoglutathione under defined 
chemostat conditions reveal major changes in methionine biosynthesis. J Biol Chem 
280: 10065±72. 
Forde, B.M., Zakour, N.L., Stanton-Cook, M., Phan, M.D., Totsika, M., Peters, K.M., 
Chan, K. G., Schembri, M. A., Upton, M., Beatson, S. A. (2014) The complete genome 
sequence of Escherichia coli EC958: A high quality reference sequence for the globally 
disseminated multidrug resistant E. coli O25b:H4-ST131 clone. PLoS One 9. 




coli promotes export of o-acetylserine and cysteine. J Bacteriol 185: 1161±1166. 
Frech, C., Wunderlich, M., Glockshuber, R., and Schmid, F.X. (1996) Preferential 
binding of an unfolded protein to DsbA. EMBO J 15: 392±98. 
Fronzes, R., Remaut, H., and Waksman, G. (2008) Architectures and biogenesis of non-
flagellar protein appendages in Gram-negative bacteria. EMBO J 27: 2271±80. 
Fu, H., Iuchi, S., and Lin, E.C.C. (1991) The requirement of ArcA and Fnr for peak 
expression of the cyd operon in Escherichia coli under microaerobic conditions. Mol 
Gen Genet 226: 209±213. 
Fu, L.M., and Fu-Liu, C.S. (2002) Is Mycobacterium tuberculosis a closer relative to 
Gram-positive or Gram± negative bacterial pathogens? Tuberculosis 82: 85±90. 
Gardner, A.M., Gessner, C.R., and Gardner, P.R. (2003) Regulation of the nitric oxide 
reduction operon (norRVW) in Escherichia coli. Role of NorR and sigma54 in the nitric 
oxide stress response. J Biol Chem 278: 10081±6. 
Gardner, A.M., Helmick, R. a, and Gardner, P.R. (2002) Flavorubredoxin, an inducible 
catalyst for nitric oxide reduction and detoxification in Escherichia coli. J Biol Chem 
277: 8172±7. 
Gardner, P.R., Gardner, A.M., Martin, L.A., and Salzman, A.L. (1998) Nitric oxide 
dioxygenase: an enzymic function for flavohemoglobin. Proc Natl Acad Sci 95: 10378±
10383. 
Georgellis, D., Lynch, A., and Lin, E. (1997) In vitro phosphorylation study of the arc 
two-component signal transduction system of Escherichia coli. J Bacteriol 179: 5429±
5435. 
Georgiou, C.D., Hong, F., and Gennis, R.B. (1987) Identification of the cydC locus 
required for expression of the functional form of the cytochrome d terminal oxidase 
complex in Escherichia coli. J Bacteriol 169: 2107±2112. 
Gohlke, U., Warne, A., and Saraste, M. (1997) Projection structure of the cytochrome 
bo ubiquinol oxidase from Escherichia coli at 6 Å resolution. EMBO J 16: 1181±1188. 
Goldman, B.S., Gabbert, K.K., and Kranz, R.G. (1996a) Use of heme reporters for 
studies of cytochrome biosynthesis and heme transport. J Bacteriol 178: 6338±6347. 
Goldman, B.S., Gabbert, K.K., and Kranz, R.G. (1996b) The temperature-sensitive 
growth and survival phenotypes of Escherichia coli cydDC and cydAB strains are due to 
deficiencies in cytochrome bd and are corrected by exogenous catalase and reducing 
agents. J Bacteriol 178: 6348±6351. 
Gomes, C., Vicente, J., Wasserfallen, A., and Teixeira, M. (2000) Spectroscopic studies 
and characterization of a novel electron-transfer chain from Escherichia coli involving a 
flavorubredoxin and its flavoprotein reductase partner. Biochemistry 39: 16230±16237. 
Gomes, C.M., Giuffrè, A., Forte, E., Vicente, J.B., Saraiva, L.M., Brunori, M., and 
Teixeira, M. (2002) A novel type of nitric-oxide reductase. Escherichia coli 
flavorubredoxin. J Biol Chem 277: 25273±6. 
Gonzalez-Flecha, B., and Demple, B. (1999) Role for the oxyS gene in regulation of 
intracellular hydrogen peroxide in Escherichia coli. J Bacteriol 181: 3833±3836. 
Green, G., Fang, H., Lin, R., Newton, G., Mather, M., Georgious, C., and Gennis, R. 
(1988) The nucleotide sequence of the cyd locus encoding the two subunits of the 





Green, J., Irvine,  a. S., Meng, W., and Guest, J.R. (1996) FNR-DNA interactions at 
natural and semi-synthetic promoters. Mol Microbiol 19: 125±137. 
Grimshaw, J.P. a, Stirnimann, C.U., Brozzo, M.S., Malojcic, G., Grütter, M.G., 
Capitani, G., and Glockshuber, R. (2008) DsbL and DsbI form a specific dithiol oxidase 
system for periplasmic arylsulfate sulfotransferase in uropathogenic Escherichia coli. J 
Mol Biol 380: 667±80. 
Groisman, E., and Ochman, H. (1996) Pathogenicity islands: bacterial evolution in 
quantum leaps. Cell 87: 791±794. 
Gualdi, L., Tagliabue, L., Bertagnoli, S., Ieranò, T., Castro, C. De, and Landini, P. 
(2008) Cellulose modulates biofilm formation by counteracting curli-mediated 
colonization of solid surfaces in Escherichia coli. Microbiology 154: 2017±2024. 
Gunsalus, R. (1992) Control of electron flow in Escherichia coli: coordinated 
transcription of respiratory pathway genes. J Bacteriol 174: 7069±7074. 
Gunsalus, R.P., and Yanofsky, C. (1980) Nucleotide sequence and expression of 
Escherichia coli trpR, the structural gene for the trp aporepressor. Proc Natl Acad Sci 
77: 7117±7121. 
Ha, U.-H., Wang, Y., and Jin, S. (2003) DsbA of Pseudomonas aeruginosa is essential 
for multiple virulence factors. Infect Immun 71: 1590±1595. 
Hanson, P.I., and Whiteheart, S.W. (2005) AAA+ proteins: have engine, will work. Nat 
Rev Mol Cell Biol 6: 519±29. 
Harborne, N.R., Griffiths, L., Busby, S.J., and Cole, J.A. (1992) Transcriptional control, 
translation and function of the products of the five open reading frames of the 
Escherichia coli nir operon. Mol Microbiol 6: 2805±2813. 
Harding, G.K.M., and Ronald, A.R. (1994) The management of urinary infections: what 
have we learned in the past decade? Int J Antimicrob Agents 4: 83±88. 
Heras, B., Shouldice, S.R., Totsika, M., Scanlon, M.J., Schembri, M. a, and Martin, J.L. 
(2009) DSB proteins and bacterial pathogenicity. Nat Rev Microbiol 7: 215±25. 
Hill, J.J., Alben, J., and Gennist, R.B. (1993) Spectroscopic evidence for a heme-heme 
binuclear center in the cytochrome bd ubiquinol oxidase from Escherichia coli. Proc 
Natl Acad Sci 90: 5863±5867. 
Hoeser, J., Hong, S., Gehmann, G., Gennis, R.B., and Friedrich, T. (2014) Subunit 
CydX of Escherichia coli cytochrome bd ubiquinol oxidase is essential for assembly 
and stability of the di-heme active site. FEBS Lett 588: 1537±41. 
Holyoake, L. V., Hunt, S., Sanguinetti, G., Cook, G.M., Howard, M.J., Rowe, M.L., 
Poole, R. K., Shepherd, M., (2016) CydDC-mediated reductant export in Escherichia 
coli controls the transcriptional wiring of energy metabolism and combats nitrosative 
stress. Biochem J 473: 693±701. 
Hong, W., Jiao, W., Hu, J., Zhang, J., Liu, C., Fu, X., Shen, D., Xia, B., Chang, Z. 
(2005) Periplasmic protein HdeA exhibits chaperone-like activity exclusively within 
stomach pH range by transforming into disordered conformation. J Biol Chem 280: 
27029±27034. 
Hosie, A., and Poole, P. (2001) Bacterial ABC transporters of amino acids. Res 




Hrabie, J.A., Klose, J.R., Wink, D.A., and Keefer, L.K. (1993) New nitric oxide-
releasing Zwitterions derived from polyamines. J Org Chem 58: 1472±1476. 
Ignarro, L.J. (1989) Biological actions and properties of endothelium-derived nitric 
oxide formed and released from artery and vein. Circ Res 65: 1±21. 
Inaba, K. (2008) Protein disulfide bond generation in Escherichia coli DsbB-DsbA. J 
Synchrotron Radiat 15: 199±201. 
Ingersoll, K.S., and Cohen, J. (2008) The impact of medication regimen factors on 
adherence to chronic treatment: a review of literature. J Behav Med 31: 213±24. 
Ingledew, W., and Poole, R. (1984) The respiratory chains of Escherichia coli. 
Microbiol Rev 48: 222±271. 
Iuchi, S., Chepuri, V., Fu, H., Gennis, R., and Lin, E. (1990) Requirement for terminal 
cytochromes in generation of the aerobic signal for the arc regulatory system in 
Escherichia coli: study utilizing deletions and lac fusions of. J Bacteriol 172: 6020±
6025. 
Iuchi, S., and Lin, E. (1988) arcA (dye), a global regulatory gene in Escherichia coli 
mediating repression of enzymes in aerobic pathways. Proc Natl Acad Sci 85: 1888±
1892. 
Iuchi, S., and Lin, E. (1992) Purification and phosphorylation of the Arc regulatory 
components of Escherichia coli. J Bacteriol 174: 5617±5623. 
Jacob-dubuisson, F., Pinkner, J., Xu, Z., Striker, R., Padmanhaban, A., and Hultgren, 
S.J. (1994) PapD chaperone function in pilus biogenesis depends on oxidant and 
chaperone-like activities of DsbA. Biochemistry 91: 11552±11556. 
James, P.E., Grinberg, O.Y., Michaels, G., and Harold M. Swartz (1995) 
Intraphagosomal oxygen in stimulated macrophages. J Cell Physiol 163: 241±247. 
Jones, P.M., and George, A.M. (2004) The ABC transporter structure and mechanism: 
Perspectives on recent research. Cell Mol Life Sci 61: 682±699. 
Junemann, S. (1997) Cytochrome bd terminal oxidase. Biochim Biophys Acta 1321: 
107±127. 
Jung, J., Gutierrez, C., and Villarejo, M. (1989) Sequence of an osmotically inducible 
lipoprotein gene. J Bacteriol 171: 511±520. 
Justino, M.C., Almeida, C.C., Gonçalves, V.L., Teixeira, M., and Saraiva, L.M. (2006) 
Escherichia coli YtfE is a di-iron protein with an important function in assembly of 
iron-sulphur clusters. FEMS Microbiol Lett 257: 278±84. 
Justino, M.C., Almeida, C.C., Teixeira, M., and Saraiva, L.M. (2007) Escherichia coli 
di-iron YtfE protein is necessary for the repair of stress-damaged iron-sulfur clusters. J 
Biol Chem 282: 10352±9. 
Justino, M.C., Vicente, J.B., Teixeira, M., and Saraiva, L.M. (2005) New genes 
implicated in the protection of anaerobically grown Escherichia coli against nitric 
oxide. J Biol Chem 280: 2636±43. 
Källenius, G., Svenson, S., Hultberg, H., and Möllby, R. (1981) Occurrence of P-
fimbriated Escherichia coli in urinary tract infections. Lancet 318: 1369±1372. 
Kalnenieks, U., Galinina, N., Bringer-Meyer, S., and Poole, R.K. (1998) Membrane D-
lactate oxidase in Zymomonas mobilis: evidence for a branched respiratory chain. 




Katzen, F., and Beckwith, J. (2000) Transmembrane electron transfer by the membrane 
protein DsbD occurs via a disulfide bond cascade. Cell 103: 769±779. 
Kaysser, T., Ghaim, J., Georgiou, C., and Gennis, R. (1995) Methionine-393 is an axial 
ligand of the heme b558 component of the cytochrome bd ubiquinol oxidase from 
Escherichia coli. Biochemistry 34: 13491±13501. 
Kern, R., Malki, A., Abdallah, J., Tagourti, J., and Richarme, G. (2007) Escherichia coli 
HdeB is an acid stress chaperone. J Bacteriol 189: 603±610. 
Kita, K., Konishi, K., and Anraku, Y. (1984) Terminal oxidases of Escherichia coli 
aerobic respiratory chain. II. Purification and properties of cytochrome b558-d complex 
from cells grown with limited oxygen and evidence of branched electron-carrying 
systems. J Biol Chem 259: 3375±3381. 
Korshunov, S., and Imlay, J.A. (2010) Two sources of endogenous hydrogen peroxide 
in Escherichia coli. Mol Microbiol 75: 1389±1401. 
Kranz, R.G., and Gennis, R.B. (1983) Immunological Characterization of the 
cytochrome. J Biol Chem 258: 10614±10621. 
Kulasekara, H.D., and Blomfield, I.C. (1999) The molecular basis for the specificity of 
fimE in the phase variation of type 1 fimbriae of Escherichia coli K-12. Mol Microbiol 
31: 1171±1181. 
Larsen, M.H., Kallipolitis, B.H., Christiansen, J.K., Olsen, J.E., and Ingmer, H. (2006) 
The response regulator ResD modulates virulence gene expression in response to 
carbohydrates in Listeria monocytogenes. Mol Microbiol 61: 1622±1635. 
àDVLFD$0DQG-DJXV]W\Q-Krynicka, E.K. (2007) The role of Dsb proteins of Gram-
negative bacteria in the process of pathogenesis. FEMS Microbiol Rev 31: 626±36. 
Lau, S.H., Kaufmann, M.E., Livermore, D.M., Woodford, N., Willshaw, G. a, Cheasty, 
T., Stamper, K., Reddy, S., Cheesbrough, J., Bolton, F. J., Fox, A. J., Upton, M. (2008) 
UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong 
to the international O25:H4-ST131 clone. J Antimicrob Chemother 62: 1241±4. 
Lay, N. De, and Gottesman, S. (2012) A complex network of small non-coding RNAs 
regulate motility in Escherichia coli. Mol Microbiol 86: 524±538. 
/D]D]]HUD%DQG%HLQHUW+'1$ELQGLQJDQGGLPHUL]DWLRQRIWKH)Hí6-
containing FNR protein from Escherichia coli are regulated by oxygen. J Biol Chem 
271: 2762±2768. 
Lee, S.K., Newman, J.D., and Keasling, J.D. (2005) Catabolite repression of the 
propionate catabolic genes in Escherichia coli and Salmonella enterica: evidence for 
involvement of the cyclic AMP receptor protein. J Bacteriol 187: 2793±800. 
Lemieux, L., Calhoun, M., Thomas, J.W., Ingledew, W.J., and Gennisl, R.B. (1992) 
Determination of the ligands of the low spin heme of the cytochrome o ubiquinol 
oxidase complex using site-directed mutagenesis. J Biol Chem 267: 2105±2113. 
Linton, K.J., and Higgins, C.F. (1998) The Escherichia coli ATP-binding cassette 
(ABC) proteins. Mol Microbiol 28: 5±13. 
Liu, X., and Wulf, P. De (2004) Probing the ArcA-P modulon of Escherichia coli by 
whole genome transcriptional analysis and sequence recognition profiling. J Biol Chem 
279: 12588±12597. 




Escherichia coli suppresses the host inflammatory response via pathogenicity island 
genes sisA and sisB. Infect Immun 77: 5322±33. 
Loisel-Meyer, S., Jimenez de Bagues, M.P., Kohler, S., Liautard, J., and V, J.-M. (2005) 
Differential use of the two high-oxygen-affinity terminal oxidases of Brucella suis for 
in vitro and intramacrophagic multiplication. Infect Immun 73: 7768±7771. 
Lund, B., Lindberg, F., Marklund, B., and Normark, S. (1987) Galactopyranose-binding 
adhesin of uropathogenic Escherichia coli. Proc Natl Acad Sci 84: 5898±5902. 
Lundberg, J.O., Weitzberg, E., Cole, J.A., and Benjamin, N. (2004) Nitrate, bacteria and 
human health. Nat Rev Microbiol 2: 593±602. 
Majdalani, N., and Gottesman, S. (2005) The Rcs phosphorelay: a complex signal 
transduction system. Annu Rev Microbiol 59: 379±405. 
Majumder, A., Fang, M., Tsai, K.J., Ueguchi, C., Mizuno, T., and Wu, H.Y. (2001) 
LeuO expression in response to starvation for branched-chain amino acids. J Biol Chem 
276: 19046±51. 
Malpica, R., Franco, B., Rodriguez, C., Kwon, O., and Georgellis, D. (2004) 
Identification of a quinone-sensitive redox switch in the ArcB sensor kinase. 
Proceedings of the National Academy of Sciences of the United States of America 101: 
13318-13323. 
Martinez, A., and Kolter, R. (1997) Protection of DNA during oxidative stress by the 
nonspecific DNA-binding protein Dps. J Bacteriol 179: 5188±5194. 
Mason, M.G., Shepherd, M., Nicholls, P., Dobbin, P.S., Dodsworth, K.S., Poole, R.K., 
and Cooper, C.E. (2009) Cytochrome bd confers nitric oxide resistance to Escherichia 
coli. Nat Chem Biol 5: 94±6. 
Matsumoto, Y., Murai, M., Fujita, D., Sakamoto, K., Miyoshi, H., Yoshida, M., and 
Mogi, T. (2006) Mass spectrometric analysis of the ubiquinol-binding site in 
cytochrome bd from Escherichia coli. J Biol Chem 281: 1905±12. 
McClain, M., Blomfield, I., Eberhardt, K., and Eisenstein, B. (1993) Inversion-
independent phase variation of type 1 fimbriae in Escherichia coli. J Bacteriol 175: 
4335±4344. 
Ménard, R., Sansonetti, P., and Parsot, C. (1993) Nonpolar mutagenesis of the ipa genes 
defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. 
J Bacteriol 175: 5899±5906. 
Messens, J., Collet, J.F., Belle, K. Van, Brosens, E., Loris, R., and Wyns, L. (2007) The 
oxidase DsbA folds a protein with a nonconsecutive disulfide. J Biol Chem 282: 31302±
31307. 
Minagawa, S., Ogasawara, H., Kato, A., Yamamoto, K., Eguchi, Y., Oshima, T., Mori, 
H., Ishihama, A., Utsumi, R. (2003) Identification and molecular characterization of the 
Mg2+ stimulon of Escherichia coli. J Bacteriol 185: 3696±3702. 
Minghetti, K., Goswitz, V., and Gabriel, N. (1992) Modified, large-scale purification of 
the cytochrome o complex (bo-type oxidase) of Escherichia coli yields a two heme/one 
copper terminal oxidase with high specific. Biochemistry 31: 6917±6924. 
Missiakas, D., Georgopoulos, C., and Raina, S. (1993) Identification and 
characterization of the Escherichia coli gene dsbB , whose product is involved in the 




Mobley, H., Jarvis, K., Elwood, J., Whittle, D., Lockate, C., Russell, R., Johnson, D. E., 
Donnenberg, M. S., Warren, J. W. (1993) Isogenic P-fimbrial deletion mutants of 
pyelonephritogenic Escherichia coli - the role of alpha-Gal(1-4)beta-Gal binding in 
virulence of a wild-type strain. Mol Microbiol 10: 143±155. 
Mobley, H.L., and Green, D. (1990) Pyelonephritogenic Escherichia coli and killing of 
cultured human renal proximal tubular epithelial cells: role of hemolysin in some 
strains. Infect Immun 58: 1281±1289. 
Mogi, T., Akimoto, S., Endou, S., Watanabe-nakayama, T., Mizuochi-asai, E., and 
Miyoshi, H. (2006) Probing the ubiquinol-binding site in cytochrome bd by site-directed 
mutagenesis. Biochemistry 45: 7924±7930. 
Mogi, T., Endou, S., and Akimoto, S. (2006) Glutamates 99 and 107 in transmembrane 
helix III of subunit I of cytochrome bd are critical for binding of the heme b595-d 
binuclear center and enzyme activity. Biochemistry 45: 15785±15792. 
Monika, E.M., Goldman, B.S., Beckman, D.L., and Kranz, R.G. (1997) A thioreduction 
pathway tethered to the membrane for periplasmic cytochromes c biogenesis; in vitro 
and in vivo studies. J Mol Biol 271: 679±92. 
Mouslim, C., Latifi, T., and Groisman, E. (2003) Signal-dependent requirement for the 
co-activator protein RcsA in transcription of the RcsB-regulated ugd gene. J Biol Chem 
278: 50588±95. 
0RXVVDWRYD$.DQGW&2¶0DUD0/DQG7LHOHPDQ'3$73-binding 
cassette transporters in Escherichia coli. Biochim Biophys Acta - Biomembranes 1778: 
1757±1771. 
Muller, M., and Webster, R. (1997) Characterization of the tol-pal and cyd region of 
Escherichia coli K-12: transcript analysis and identification of two new proteins 
encoded by the cyd operon. J Bacteriol 179: 2077±2080. 
Neidhardt, F.C., Bloch, P.L., and Smith, D.F. (1974) Culture Medium for 
Enterobacteria. J Bacteriol 119: 736±747. 
Nicholson, D., and Neupert, W. (1989) Import of cytochrome c into mitochondria: 
reduction of heme, mediated by NADH and flavin nucleotides, is obligatory for its 
covalent linkage to apocytochrome c. Proc Natl Acad Sci USA 86: 4340±4344. 
Ogasawara, H., Hasegawa, A., Kanda, E., Miki, T., Yamamoto, K., and Ishihama, A. 
(2007) Genomic SELEX search for target promoters under the control of the PhoQP-
RstBA signal relay cascade. J Bacteriol 189: 4791±4799. 
Okamoto, K., Nomura, T., Fujii, Y., and Yamanaka, H. (1998) Contribution of the 
disulfide bond of the A subunit to the action of Escherichia coli heat-labile enterotoxin. 
J Bacteriol 180: 1368±1374. 
Omasits, U., Ahrens, C.H., Müller, S., and Wollscheid, B. (2014) Protter: interactive 
protein feature visualization and integration with experimental proteomic data. 
Bioinformatics 30: 884±886. 
Osborne, J., and Gennis, R. (1999) Sequence analysis of cytochrome bd oxidase 
suggests a revised topology for subunit I. Biochim Biophys Acta - Bioenerg 1410: 32±
50. 
Owens, R.A., and Hartman, P.E. (1986) Export of glutathione by some widely used 
Salmonella typhimurium and Escherichia coli strains. J Bacteriol 168: 109±114. 




and disease. Physiol Rev 87: 315±424. 
Padan, E., and Schuldiner, S. (1994) Molecular physiology of the Na+/H+ antiporter in 
Escherichia coli. J Exp Biol 196: 443±456. 
Pallen, M., and Matzke, N. (2006) From The origin of species to the origin of bacterial 
flagella. Nat Rev Microbiol 4: 784±790. 
Peek, J.A., and Taylor, R.K. (1992) Characterization of a periplasmic thiol:disulfide 
interchange protein required for the functional maturation of secreted virulence factors 
of Vibrio cholerae. Microbiology 89: 6210±6214. 
Phan, M.D., Peters, K.M., Sarkar, S., Lukowski, S.W., Allsopp, L.P., Gomes Moriel, 
D., Achard, M. E. S., Totsika, M., Marshall, V. M., Upton, M., Beatson, S., Schembri, 
M. A. (2013) The serum resistome of a globally disseminated multidrug resistant 
uropathogenic Escherichia coli clone. PLoS Genet 9: 1±18. 
Pittman, M.S., Corker, H., Wu, G., Binet, M.B., Moir, A.J.G., and Poole, R.K. (2002) 
Cysteine is exported from the Escherichia coli cytoplasm by CydDC, an ATP-binding 
cassette-type transporter required for cytochrome assembly. J Biol Chem 277: 49841±9. 
Pittman, M.S., Robinson, H.C., and Poole, R.K. (2005) A bacterial glutathione 
transporter (Escherichia coli CydDC) exports reductant to the periplasm. J Biol Chem 
280: 32254±61. 
Poock, S.R., Leach, E.R., Moir, J.W.B., Cole, J.A., and Richardson, D.J. (2002) 
Respiratory detoxification of nitric oxide by the cytochrome c nitrite reductase of 
Escherichia coli. J Biol Chem 277: 23664±9. 
Poole, R., and Hughes, M. (2000) New functions for the ancient globin family: bacterial 
responses to nitric oxide and nitrosative stress. Mol Microbiol 36: 775±783. 
Poole, R. k, Gibson, F., and Wu, G. (1994) The cydD gene product, component of a 
heterodimeric ABC transporter, is required for assembly of periplasmic cytochrome c 
and of cytochrome bd in Escherichia coli. FEMS Microbiol Lett 117: 217±223. 
Poole, R., Williams, H., Downie, A., and Gibson, F. (1989) Mutations affecting the 
cytochrome d-containing oxidase complex of Escherichia coli K12: identification and 
mapping of a fourth locus, cydD. J Gen Microbiol 135: 1865±1874. 
Poole, R.K., Anjum, M.F., Membrillo-Hernández, J., Kim, S. O., Hughes, M.N., and 
Stewart, V. (1996) Nitric oxide, nitrite, and Fnr regulation of hmp (flavohemoglobin) 
gene expression in Escherichia coli K-12. J Bacteriol 178: 5487±5492. 
Poole, R.K., Hatch, L.J., Cleeter, M., Gibson, G., Cox, G., and Wu, G. (1993) 
Cytochrome bd biosynthesis in Escherichia coli: the sequences of the cydC and cydD 
genes suggest that they encode the components of an ABC membrane transporter. Mol 
Microbiol 10: 421±430. 
Prigent-Combaret, C., Brombacher, E., Vidal, O., Ambert, A., Lejeune, P., Landini, P., 
and Dorel, C. (2001) Complex regulatory network controls initial adhesion and biofilm 
formation in Escherichia coli via regulation of the csgD gene. J Bacteriol 183: 7213±
23. 
Pullan, S.T., Gidley, M.D., Jones, R. a, Barrett, J., Stevanin, T.M., Read, R.C., Gidley, 
M. D., 
Jones, R., Barrett, J., Stevanin, T. M., Read, R. C., Green, J., Poole, R. K. (2007) Nitric 




regulators: unaltered methionine biosynthesis indicates lack of S-nitrosation. J Bacteriol 
189: 1845±55. 
Puustinen, A., Finel, M., and Haltia, T. (1991) Properties of the two terminal oxidases 
of Escherichia coli. Biochemistry 3: 3936±3942. 
Puustinen, A., and Wikstrom, M. (1991) The heme groups of cytochrome o from 
Escherichia coli. 88: 6122±6126. 
Quail, M. a., Dempsey, C.E., and Guest, J.R. (1994) Identification of a fatty acyl 
responsive regulator (FarR) in Escherichia coli. FEBS Lett 356: 183±187. 
Rabin, R., and Stewart, V. (1993) Dual response regulators (NarL and NarP) interact 
with dual sensors (NarX and NarQ) to control nitrate-and nitrite-regulated gene 
expression in Escherichia coli K-12. J Bacteriol 175: 3259±3268. 
Rahav-Manor, O., Karpel, R., Taglicht, D., Glaserz, G., Schuldiner, S., and Padan, E. 
(1992) NhaR, a protein homologous to a family of bacterial regulatory proteins (LysR), 
regulates nhaA, the sodium proton antiporter gene in Escherichia coli. J Biol Chem 267: 
10433±10438. 
Raina, S., and Missiakas, D. (1997) Making and breaking disulfide bonds. Annu Rev 
Microbiol 51: 179±202. 
Rappaport, F., Zhang, J., Vos, M.H., Gennis, R.B., and Borisov, V.B. (2010) Heme-
heme and heme-ligand interactions in the di-heme oxygen-reducing site of cytochrome 
bd from Escherichia coli revealed by nanosecond absorption spectroscopy. Biochim 
Biophys Acta 1797: 1657±64. 
Rezaïki, L., Cesselin, B., Yamamoto, Y., Vido, K., West, E. van, Gaudu, P., and Gruss, 
A. (2004) Respiration metabolism reduces oxidative and acid stress to improve long-
term survival of Lactococcus lactis. Mol Microbiol 53: 1331±42. 
Richard, H., and Foster, J.W. (2007) Sodium regulates Escherichia coli acid resistance, 
and influences GadX- and GadW-dependent activation of gadE. Microbiology 153: 
3154±61. 
5LGGOHV3:%ODNHOH\5/DQG=HUQHU%(OOPDQ¶VUHDJHQW-dithio-(2-
nitrobenzoic acid)²a reexamination. Anal Biochem 94: 75±81. 
Rietsch,  A., and Beckwith, J. (1998) The genetics of disulfide bond metabolism. Annu 
Rev Genet 32: 163±84. 
Rogers, B., Sidjabat, H.E., and Paterson, D.L. (2011) Escherichia coli O25b-ST131: a 
pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 66: 1±
14. 
Roos, V., Ulett, G.C., Schembri, M.A., and Klemm, P. (2006) The asymptomatic 
bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in 
human urine. Infect Immun 74: 615±24. 
Rothery, R.A., and Ingledew, W.J. (1989) The cytochromes of anaerobically 
Escherichia coli. J Biochem 261: 437±443. 
Saiki, K., Mogi, T., and Anraku, Y. (1992) Heme o biosynthesis in Escherichia coli: the 
cyoE gene in the cytochrome bo operon encodes a protoheme IX farnesyltransferase. 
Biochem Biophys Res Commun 189: 1491±1497. 
Salerno, J., Bolgiano, B., and Poole, R. (1990) Heme-copper and heme-heme 





Salmond, G.P.C., and Reeves, P.J. (1993) Membrance traffic wardens and protein 
secretion in Gram-negative bacteria. Trends Biochem Sci 18: 7±12. 
Sambrook, J., Fritsch, E.F., and Maniatis., T. (1989) Molecular cloning: A laboratory 
manual. Second edition. Volumes 1, 2, and 3. Current protocols in molecular biology. 
Volumes 1 and 2. . 
Sampaio, M.-M., Chevance, F., Dippel, R., Eppler, T., Schlegel, A., Boos, W., Lu, Y-J., 
Rock, C. O. (2004) Phosphotransferase-mediated transport of the osmolyte 2-O-alpha-
mannosyl-D-glycerate in Escherichia coli occurs by the product of the mngA (hrsA) 
gene and is regulated by the mngR (farR) gene product acting as repressor. J Biol Chem 
279: 5537±48. 
Sansonetti, P.J., Arondel, J., FontaiQH$'¶+DXWHYLOOH+DQG%HUQDUGLQL0/
(1991) OmpB (osmo-regulation) and icsA (cell-to-cell spread) mutants of Shigella 
flexneri: vaccine candidates and probes to study the pathogenesis of shigellosis. Vaccine 
9: 416±422. 
Saraste, M., Sibbalda, P.R., and Wittinghoferb, A. (1988) Cytochrome oxidase: 
Structure, function, and physiopathology. Ann N Y Acad Sci 550: 314±324. 
Sarti, P., Giuffré, A., Forte, E., Mastronicola, D., Barone, M.C., and Brunori, M. (2000) 
Nitric oxide and cytochrome c oxidase: mechanisms of inhibition and NO degradation. 
Biochem Biophys Res Commun 274: 183±7. 
Shahzad Asif, H.M., Rolfe, M.D., Green, J., Lawrence, N.D., Rattray, M., and 
Sanguinetti, G. (2010) TFInfer: A tool for probabilistic inference of transcription factor 
activities. Bioinformatics 26: 2635±2636. 
Shepherd, M. (2015) The CydDC ABC transporter of Escherichia coli: new roles for a 
reductant efflux pump. Biochem Soc Trans 43: 908±912. 
6KHSKHUG0+HDWK0'DQG3RROH5.1LN$ELQGVKHPH(?$Qew role for 
an Escherichia coli periplasmic. Biochemistry 46: 5030±5037. 
Shepherd, M., Sanguinetti, G., Cook, G.M., and Poole, R.K. (2010) Compensations for 
diminished terminal oxidase activity in Escherichia coli: cytochrome bd-II-mediated 
respiration and glutamate metabolism. J Biol Chem 285: 18464±72. 
Shi, L., Sohaskey, C.D., Kana, B.D., Dawes, S., North, R.J., Mizrahi, V., and Gennaro, 
M.L. (2005) Changes in energy metabolism of Mycobacterium tuberculosis in mouse 
lung and under in vitro conditions affecting aerobic respiration. Proc Natl Acad Sci 102: 
15629±15634. 
Shimizu, T., Tsutsuki, H., Matsumoto, A., Nakaya, H., and Noda, M. (2012) The nitric 
oxide reductase of enterohaemorrhagic Escherichia coli plays an important role for the 
survival within macrophages. Mol Microbiol 85: 492±512. 
Siegele, D.A., Imlay, K.R.C., and Imlay, J.A. (1996) The stationary phase exit defect of 
cydC (surB) mutants is due to the lack of a functional terminal cytochrome oxidase. J 
Bacteriol 178: 6091±6096. 
Sinha, S., Langford, P.R., and Kroll, J.S. (2004) Functional diversity of three different 
DsbA proteins from Neisseria meningitidis. Microbiology 150: 2993±3000. 
Sledjeski, D., and Gottesman, S. (1996) Osmotic shock induction of capsule synthesis in 




Smirnova, G., Muzyka, N., and Oktyabrsky, O. (2012) Transmembrane glutathione 
cycling in growing Escherichia coli cells. Microbiol Res 167: 166±72. 
Sørensen, M.A., and Pedersen, S. (1991) Cysteine, even in low concentrations, induces 
transient amino acid starvation in Escherichia coli. J Bacteriol 173: 5244±5246. 
Spinner, F., Cheesman, M., Thomson, A., Kaysser, T., Gennis, R., Peng, Q., and 
Peterson, J. (1995) The haem b558 component of the cytochrome bd quinol oxidase 
complex from Escherichia coli has histidine-methionine axial ligation. J Biochem 308: 
641±644. 
Spiro, S. (2006) Nitric oxide-sensing mechanisms in Escherichia coli. Biochem Soc 
Trans 34: 200±202. 
Squires, C., Lee, F., and Yanofsky, C. (1975) Interaction of the trp repressor and RNA 
polymerase with the trp operon. J Mol Biol 92: 93±111. 
Stafford, G.P., Ogi, T., and Hughes, C. (2005) Binding and transcriptional activation of 
non-flagellar genes by the Escherichia coli flagellar master regulator FlhD2C2. 
Microbiology 151: 1779±1788. 
Stafford, S.J., Humphreys, D.P., and Lund, P.A. (1999) Mutations in dsbA and dsbB, 
but not dsbC, lead to an enhanced sensitivity of Escherichia coli to Hg2+ and Cd2+. 
FEMS Microbiol Lett 174: 179±184. 
Stamler, J.S., Simon, D.I., Osborne, J.A., Mullins, M.E., Jarakit, O., Michel, T., Singel, 
D. J. 
Loscalzo, J. (1992) S-1LWURV\ODWLRQRISURWHLQVZLWKQLWULFR[LGH(?6\QWKHVLVDQG
characterization of biologically active compounds. Proc Natl Acad Sci USA 89: 444±
448. 
Stamler, J.S., Singel, D.J., and Loscalzo, J. (1992) Biochemistry of nitric oxide and 
redox-activated forms. Science (80- ) 258: 1898±1902. 
Stenberg, F., Heijne, G. von, and Daley, D.O. (2007) Assembly of the cytochrome bo3 
complex. J Mol Biol 371: 765±73. 
Stoyanov, J. V, Magnani, D., and Solioz, M. (2003) Measurement of cytoplasmic 
copper, silver, and gold with a lux biosensor shows copper and silver, but not gold, 
efflux by the CopA ATPase of Escherichia coli. FEBS Lett 546: 391±394. 
Stuehr, D.J. (1999) Mammalian nitric oxide synthases. Biochim Biophys Acta - 
Bioenerg 1411: 217±230. 
Sturr, M.G., Krulwich, T.A., and Hicks, D.B. (1996) Purification of a cytochrome bd 
terminal oxidase encoded by the Escherichia coli app locus from a delta cyo delta cyd 
strain complemented by genes from Bacillus firmus OF4. J Bacteriol 178: 1742±1749. 
Sun, J., Kahlow, M., Kaysser, T., and Osborne, J. (1996) Resonance Raman 
spectroscopic identification of a histidine ligand of b595 and the nature of the ligation 
of chlorin d in the fully reduced Escherichia coli cytochrome. Biochemistry 35: 2403±
2412. 
Suzuki, H., Hashimoto, W., and Kumagai, H. (1993) Escherichia coli K-12 can utilize 
an exogenous gamma-glutamyl peptide as an amino acid source, for which gamma-
glutamyltranspeptidase is essential. J Bacteriol 175: 6038±6040. 
Suzuki, H., Kamatani, S., Kim, E.S., and Kumagai, H. (2001) Aminopeptidases A, B, 




Bacteriol 183: 1489±1490. 
Suzuki, H., Koyanagi, T., Izuka, S., Onishi, A., and Kumagai, H. (2005) The yliA, -B, -
C, and -D genes of Escherichia coli K-12 encode a novel glutathione importer with an 
ATP-binding cassette. J Bacteriol 187: 5861±7. 
Suzuki, H., Kumagai, H., and Tochikura, T. (1987) Isolation, genetic mapping, and 
characterization of Escherichia coli K-12 mutants lacking gamma-
glutamyltranspeptidase. J Bacteriol 169: 3926±3931. 
Tamegai, H., Kawano, H., Ishii, A., Chikuma, S., Nakasone, K., and Kato, C. (2005) 
Pressure-regulated biosynthesis of cytochrome bd in piezo- and psychrophilic deep-sea 
bacterium Shewanella violacea DSS12. Extremophiles 9: 247±53. 
Thanassi, D.G., and Hultgren, S.J. (2000) Assembly of complex organelles: pilus 
biogenesis in Gram-negative bacteria as a model system. Methods 20: 111±126. 
Thony-meyer, L., and Kunzler, P. (1997) Translocation to the periplasm and signal 
sequence cleavage of preapocytochrome c depend on sec and lep, but not on the ccm 
gene products. Eur J Biochem 246: 794±799. 
Todorovic, S., Justino, M.C., Wellenreuther, G., Hildebrandt, P., Murgida, D.H., 
Meyer-Klaucke, W., and Saraiva, L.M. (2008) Iron-sulfur repair YtfE protein from 
Escherichia coli: structural characterization of the di-iron center. J Biol Inorg Chem 13: 
765±70. 
Totsika, M., Beatson, S. a, Sarkar, S., Phan, M.-D., Petty, N.K., Bachmann, N., Szubert, 
M., Sidjabat, H. E., Paterson, D. L., Upton, M., Schembri, M. (2011) Insights into a 
multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 
lineage: genome analysis and virulence mechanisms. PLoS One 6: 1±11. 
Totsika, M., Heras, B., Wurpel, D.J., and Schembri, M.A. (2009) Characterization of 
two homologous disulfide bond systems involved in virulence factor biogenesis in 
uropathogenic Escherichia coli CFT073. J Bacteriol 191: 3901±3908. 
Totsika, M., Kostakioti, M., Hannan, T.J., Upton, M., Beatson, S. a, Janetka, J.W., 
Hultgren, S. J., Schembri, M. A. (2013) A FimH inhibitor prevents acute bladder 
infection and treats chronic cystitis caused by multidrug-resistant uropathogenic 
Escherichia coli ST131. J Infect Dis 208: 921±8. 
Truong, Q.L., Cho, Y., Barate, A.K., Kim, S., and Hahn, T.-W. (2014) Characterization 
and protective property of Brucella abortus cydC and looP mutants. Clin vaccine 
Immunol 21: 1573±80. 
Tseng, C.P., Albrecht, J., Gunsalus, R.P., Tseng, C., and Albrecht, J. (1996) Effect of 
microaerophilic cell growth conditions on expression of the aerobic (cyoABCDE and 
cydAB) and anaerobic (narGHJI, frdABCD, and dmsABC) respiratory pathway genes in 
Escherichia coli. J Bacteriol 178: 1094±1098. 
7XFNHU1DQG'¶DXWUHDX[%'1$ELQGLQJDFWLYLW\RIWKHEscherichia coli 
nitric oxide sensor NorR suggests a conserved target sequence in diverse proteobacteria. 
J Bacteriol 186: 6656±6660. 
Turner,  a. K., Barber, L.Z., Wigley, P., Muhammad, S., Jones, M. a., Lovell, M. A.,  
Hulme, S., Barrow, P. A. (2003) Contribution of proton-translocating proteins to the 
virulence of Salmonella enterica Serovars Typhimurium, Gallinarum, and Dublin in 
chickens and mice. Infect Immun 71: 3392±3401. 




functions directly as a transcriptional repressor. EMBO J 12: 1039±1046. 
Unden, G., Becker, S., Bongaerts, J., and Six, S. (1995) O2-sensing and O2-dependent 
gene-regulation in facultatively anaerobic bacteria. Arch Microbiol 164: 81±90. 
VanOrsdel, C.E., Bhatt, S., Allen, R.J., Brenner, E.P., Hobson, J.J., Jamil, A., Haynes, 
B. M. 
Genson, A. M., Hemm, M. R. (2013) The Escherichia coli CydX protein is a member of 
the CydAB cytochrome bd oxidase complex and is required for cytochrome bd oxidase 
activity. J Bacteriol 195: 3640±50. 
Vicente, J.B., Scandurra, F.M., Rodrigues, J. V, Brunori, M., Sarti, P., Teixeira, M., and 
Giuffrè, A. (2007) Kinetics of electron transfer from NADH to the Escherichia coli 
nitric oxide reductase flavorubredoxin. FEBS J 274: 677±86. 
Vicente, J.B., and Teixeira, M. (2005) Redox and spectroscopic properties of the 
Escherichia coli nitric oxide-detoxifying system involving flavorubredoxin and its 
NADH-oxidizing redox partner. J Biol Chem 280: 34599±608. 
Vine, C.E., and Cole, J.A. (2011) Nitrosative stress in Escherichia coli: reduction of 
nitric oxide. Biochem Soc Trans 39: 213±5. 
Vos, M., Borisov, V., Liebl, U., Martin, J., and Konstantinov, A. (2000) Femtosecond 
resolution of ligand-heme interactions in the high-affinity quinol oxidase bd: A di-heme 
active site? Proc Natl Acad Sci 97: 1554±1559. 
Ward, A., Reyes, C.L., Yu, J., Roth, C.B., and Chang, G. (2007) Flexibility in the ABC 
transporter MsbA: Alternating access with a twist. Proc Natl Acad Sci U S A 104: 
19005±10. 
Watmough, N.J., Butland, G., Cheesman, M.R., Moir, J.W.B., Richardson, D.J., and 
Spiro, S. (1999) Nitric oxide in bacteria: synthesis and consumption. Biochim Biophys 
Acta - Bioenerg 1411: 456±474. 
Way, S.S., Borczuk, A.C., and Goldberg, M. (1999) Adaptive immune response to 
Shigella flexneri 2a cydC in Immunocompetent mice and mice lacking immunoglobulin 
A. Infect Immun 67: 2001±2004. 
Way, S.S., Sallustio, S., Magliozzo, R.S., and Goldberg, M.B. (1999) Impact of either 
elevated or decreased levels of cytochrome bd expression on Shigella flexneri virulence. 
J Bacteriol 181: 1229±1237. 
Welch, R.A., Burland, V., Iii, G.P., Redford, P., Roesch, P., Rasko, D., Redford, P., 
Buckles, E. L., Liou, S., Boutin, A., Hackett, J., Stroud, D., Mayhew, G F., Rose, D J., 
Zhou, S., Schwartz, D. C., Perna, N. T., Mobley, H. L. T. (2002) Extensive mosaic 
structure revealed by the complete genome sequence of uropathogenic Escherichia coli. 
Proc Natl Acad Sci 99: 17020±17024. 
Wiriyathanawudhiwong, N., Ohtsu, I., Li, Z.-D., Mori, H., and Takagi, H. (2009) The 
outer membrane TolC is involved in cysteine tolerance and overproduction in 
Escherichia coli. Appl Microbiol Biotechnol 81: 903±913. 
Wonderen, J.H. van, Burlat, B., Richardson, D.J., Cheesman, M.R., and Butt, J.N. 
(2008) The nitric oxide reductase activity of cytochrome c nitrite reductase from 
Escherichia coli. J Biol Chem 283: 9587±94. 
Woodford, N., Reddy, S., Fagan, E.J., Hill, R.L.R., Hopkins, K.L., Kaufmann, M.E., 
Kistler, J., Palepou, M-F. I., Pike, R., Ward, M. E., Cheesbrough, J., Livermore, D. M. 




Escherichia coli and Klebsiella spp. in the UK and Ireland. J Antimicrob Chemother 59: 
102±5. 
Wullt, B., Bergsten, G., Connell, H., Röllano, P., Gebretsadik, N., Hull, R., and 
Svanborg, C. (2000) P fimbriae enhance the early establishment of Escherichia coli in 
the human urinary tract. Mol Microbiol 38: 456±464. 
Yamada, S., Awano, N., Inubushi, K., Maeda, E., Nakamori, S., Nishino, K., 
Yamaguchi, A., Takagi, H. (2006) Effect of drug transporter genes on cysteine export 
and overproduction in Escherichia coli. Appl Environ Microbiol 72: 4735±4742. 
Yamamoto, K., Hirao, K., Oshima, T., Aiba, H., Utsumi, R., and Ishihama, A. (2005) 
Functional characterization in vitro of all two-component signal transduction systems 
from Escherichia coli. J Biol Chem 280: 1448±56. 
Yamamoto, K., and Ishihama, A. (2005) Transcriptional response of Escherichia coli to 
external copper. Mol Microbiol 56: 215±27. 
Yamamoto, Y., Poyart, C., Trieu-Cuot, P., Lamberet, G., Gruss, A., and Gaudu, P. 
(2005) Respiration metabolism of Group B Streptococcus is activated by environmental 
haem and quinone and contributes to virulence. Mol Microbiol 56: 525±34. 
Yamashita, M., Shepherd, M., Booth, W.I., Xie, H., Postis, V., Nyathi, Y., Tzokov, S. 
B., Poole,  R. K., Baldwin, S., Bullough, P. (2014) Structure and function of the 
bacterial heterodimeric ABC transporter CydDC: stimulation of ATPase activity by 
thiol and heme compounds. J Biol Chem 289: 23177±88. 
Yu, H., Sato, E.F., Nagata, K., Nishikawa, M., Kashiba, M., Arakawa, T., Kobayashi, 
K., Tamura, T., Inoue, M. (1997) Oxygen-dependent regulation of the respiration and 
growth of Escherichia coli by nitric oxide. FEBS Lett 409: 161±165. 
Yu, J., Edwards-Jones, B., Neyrolles, O., and Kroll, J.S. (2000) Key role for DsbA in 
cell-to-cell spread of Shigella flexneri, permitting secretion of Ipa proteins into 
interepithelial protrusions. Infect Immun 68: 6449±6456. 
Yu, J., Webb, H., and Hirst, T. (1992) A homologue of the Escherichia coli DsbA 
protein involved in disulphide bond formation is required for enterotoxin biogenesis in 
Vibrio cholerae. Mol Microbiol 6: 1949 ±1958. 
Zhang, J., Hellwig, P., Osborne, J.P., and Gennis, R.B. (2004) Arginine 391 in subunit I 
of the cytochrome bd quinol oxidase from Escherichia coli stabilizes the reduced form 
of the hemes and is essential for quinol oxidase activity. J Biol Chem 279: 53980±7. 
Zhang, H. Z. & Donnenberg, M.S. (1996) DsbA is required for stability of the type IV 
pilin of enteropathogenic Escherichia coli. Mol Microbiol 21: 787±797. 
Zhao, G., Ceci, P., Ilari, A., Giangiacomo, L., Laue, T.M., Chiancone, E., and Chasteen, 
N.D. (2002) Iron and hydrogen peroxide detoxification properties of DNA-binding 
protein from starved cells. A ferritin-like DNA-binding protein of Escherichia coli. J 
Biol Chem 277: 27689±96. 
Zhou, Y., Larson, J.D., Bottoms, C. a, Arturo, E.C., Henzl, M.T., Jenkins, J.L., Nix, J. 
C., 
Becker, D. F.,Tanner, J. J. (2008) Structural basis of the transcriptional regulation of the 
proline utilization regulon by multifunctional PutA. J Mol Biol 381: 174±88. 
Zhou, Z., White, K. a., Polissi, A., Georgopoulos, C., and Raetz, C.R.H. (1998) 
Function of Escherichia coli MsbA, an essential ABC family transporter, in lipid A and 





Zumft, W. (1997) Cell biology and molecular basis of denitrification. Microbiol Mol 












Appendix A-1. Reference 1D-1H NMR data for succinate  
Taken from the Madison metabolite consortium database website. The 1D-1H NMR 
data for succinate standard produces a single peak at a chemical shift of 2.4, similar to 
that seen in NMR data for wild type but not cydD derived metabolites.   
 
Appendix A-2. Reference 1D-1H NMR data for D-mannitol  
Taken from the Madison metabolite consortium database website. The 1D-1H NMR 
data for D-mannitol produces a large peak at a chemical shift around 3.75 with other 
smaller peaks surrounding it, this is similar to that seen in NMR data for wild type but 





Appendix A-3. Reference 1D-1H NMR data for NAD 




Appendix A-4 Reference 1D-1H NMR data for betaine  
Taken from the Madison metabolite consortium database website. The 1D-1H NMR 
data for betaine standard produces a large peak at a chemical shift of around 3.27, 









Appendix A-5. Reference 1D-1H NMR data for L-methionine  
The 1D-1H NMR data for methionine standard produces a large peak at a chemical shift 
of around 2.15, similar to that seen in NMR data for cydD but not wild type derived 






Appendix A-6 Reference 1D-1H NMR data for fumarate  
Taken from the Madison metabolite consortium database website. The 1D-1H NMR 










Appendix C-1. CydD and CydC amino acids sequences compared 
between non-pathogenic E. coli and two UPEC strains 
Alignment of CydD and CydC amino acid sequences taken from non-pathogenic 
MG1655 and Keio strains, compared to UPEC strains EC958 and CFT073. Sequences 
were aligned using Bioedit free software (v7.2.5). Amino acids are coloured to allow 







































































Appendix C-2. Sequencing data for CFT073 cydDC 
After Ȝ-Red mutagenesis of a wild type CFT073 strain (MS5) to replace the cydDC 
operon with a chloramphenicol cassette, a resultant colony was sent for sequencing to 
confirm the replacement. Here the sequences in order show that of sequencing data for 
the resultant CFT073 electroporation colony to be tested (CFT073 MS5 electroporated), 
the sequence of pKD3, the original source of the chloramphenicol resistance cassette, 
the sequencing data of MG1655 cydDC::Cm (MS14) and the start of cydD or end of 
cydC. Sequencing data that used A primer 3 (forward) or B primer 4 (reverse) was 
aligned (using Bioedit v7.2.5) to show that 50bp into the cydD gene of the 
electroporation strain (position 250 A), the chloramphenicol gene starts and 50bp 
inwards from the end of cydC (position 250 B) the Cm cassette ends. This data 
concludes that in the electroporated strain designated MS115, the cydDC operon has 
successfully been replaced by the Cm resistance cassette creating a cydDC knockout 















Appendix C-3. CFU isolated from mouse kidney 
In this model of infection and the time frame used, we would not expect to see bacteria 
within the kidneys, and the presence of bacteria is likely to suggest that the catheter had 
been placed too far into the urethra. The presence of bacteria was tested by counting 
CFU isolated from the kidneys of infected mice. Here the Log10 number of wild type 
(circles) and cydDC mutant (squares) CFU for each mouse is represented. 
 
 
 
 
